🕷️ Crawler Inspector

URL Lookup

Direct Parameter Lookup

Raw Queries and Responses

1. Shard Calculation

Query:

Response:

Calculated Shard: 60 (from laksa085)

2. Crawled Status Check

Query:

curl -X POST \
  'http://laksa060.int.ahrefs:8124/' \
  -H 'Content-Type: text/plain' \
  -H 'X-ClickHouse-Database: crawler3' \
  -H 'Authorization: Basic YXBpOg==' \
  -d 'SELECT getAhrefsURLFromUnparsed(src_unparsed) AS found_url, ifNull(toUnixTimestamp(download_stamp), 0) AS crawl_time, ifNull(toUnixTimestamp(props_url_first_seen), 0) AS first_indexed_time, download_http_code AS http_code, src_unparsed AS src_unparsed, src_root_hash AS src_root_hash, history_drop_reason AS history_drop_reason, meta_title AS meta_title, meta_descriptions AS meta_descriptions, attrs_boilerpipe_text AS attrs_boilerpipe_text, attrs_markdown AS attrs_markdown, attrs_readable_markdown AS attrs_readable_markdown, meta_canonical AS meta_canonical FROM crawler3.page_info_local FINAL PREWHERE (src_root_hash, src_unparsed) IN ((getAhrefsRootHashFromUnparsed(getAhrefsUnparsedNoserviceFromURL(\'https://adaa.org/find-help/treatment-help/medication-options\')), getAhrefsUnparsedNoserviceFromURL(\'https://adaa.org/find-help/treatment-help/medication-options\'))) FORMAT JSONEachRow'

Response:

{"found_url":"https:\/\/adaa.org\/find-help\/treatment-help\/medication-options","crawl_time":1775871132,"first_indexed_time":1613983954,"http_code":200,"src_unparsed":"org,adaa!\/find-help\/treatment-help\/medication-options s443","src_root_hash":"15493478601857663260","history_drop_reason":null,"meta_title":"Medication and Other Treatment Options for Anxiety Disorders and Depression","meta_descriptions":[],"attrs_boilerpipe_text":"Medication can be a safe, effective, and evidence-based option for treating anxiety disorders and depression. Many people take medication alone or in combination\nwith therapy\nto help manage symptoms and improve daily functioning.\nIt's essential to recognize that medication is only one component of a comprehensive treatment approach. Other evidence-based options, such as psychotherapy, transcranial magnetic stimulation (TMS), and electroconvulsive therapy (ECT), may be recommended depending on an individual’s needs and treatment goals. These approaches can be used alone or in combination with medication to maximize effectiveness.\nFinding the right medication or treatment plan often requires patience, collaboration with a healthcare provider, and adjustments along the way. When used appropriately, medications can significantly reduce symptoms of anxiety and depression and support a return to balance and quality of life.\nAlways consult a healthcare provider before starting, changing, or stopping medication. The right treatment depends on your symptoms, medical history, and individual needs. Finding the right medication—whether antidepressants, anti-anxiety medications, or a combination, often takes time, patience, and close collaboration with your doctor or nurse practitioner.\nDiscussing Medications - What You Need to Know: \nUse these guidelines to talk to your health care professional about medications:\nTo avoid potentially dangerous drug interactions, let your mental health care provider know all medications you are taking, including prescriptions and over-the-counter drugs, herbal or dietary supplements, and vitamins. And make sure your family doctor knows you are taking medicines for an anxiety disorder.\nLearn when to take a new medication and how, such as on an empty stomach or with food, in the morning or evening, and how frequently.\nFind out how long it should take for the medication to start working and what you should expect when this happens.\nAsk: How will the medication help me? What side effects might occur? Should I avoid any foods or beverages? Are drug interactions with other prescriptions a possibility? How often should you see the doctor for a medication check-up?\nAsk for the prescribing physician’s after-hours phone number in case you develop side effects.\nA good source of information about medications and over-the-counter products is your pharmacist, who should have information about all your prescriptions to advise you about possible drug interactions, side effects, and instructions for use.\nIf your physician does not want to spend the time to answer your questions, you may need a referral to a different physician.\nMedications are commonly prescribed by physicians (family practice, pediatricians, OB-GYNs, psychiatrists), as well as nurse practitioners in many states.\nThere are four major classes of medications that are used in the treatment of anxiety disorders\n:\nQ&A\nWhat to Ask Your Doctor Before Starting a New Antidepressant or an Emerging Treatment\nIs this new drug\/treatment appropriate for me?\nWhat are the drawbacks, if any of this new treatment?\nWhat might be the benefits over my current regimen?\nIs the price (typically high when a drug is new) worth the added benefit?\nIs this treatment ready for widespread use?  Meaning, does it have safety established? Do we know how long people need to be on this treatment? Do we know about any long term issues that could result from this?\nNo\nSelective Serotonin Reuptake Inhibitors (SSRIs)\nSSRIs relieve symptoms by blocking the reabsorption, or reuptake, of serotonin by certain nerve cells in the brain. This leaves more serotonin available, which improves mood. SSRIs (citalopram, escitalopram, fluoxetine, paroxetine, and sertraline) generally produced fewer side effects when compared with tricyclic antidepressants. However, common side effects include insomnia or sleepiness, sexual dysfunction, and weight gain. They are considered an effective treatment for all anxiety disorders, although the treatment of obsessive-compulsive disorder, or OCD, typically requires higher doses.\nRead this blog about SSRIs and Benzodiazepines\n.\nTrintellix (vortioxetine) is a prescription antidepressant used to treat major depressive disorder in adults. It works by affecting serotonin activity in the brain, which can help improve mood, cognition, and overall functioning.\nViibryd (vilazodone) is a prescription antidepressant used to treat major depressive disorder (MDD) in adults. It works by increasing serotonin activity in the brain and is classified as a selective serotonin reuptake inhibitor (SSRI) and partial serotonin receptor.\nTo learn more in-depth about Selective Serotonin Reuptake Inhibitors (SSRIs), check out\nADAA's Patient Guide to Mood and Anxiety Disorders\n.\nNo\nSerotonin-Norepinephrine Reuptake Inhibitors (SNRIs)\nThe serotonin-norepinephrine reuptake inhibitor, or SNRI, class (venlafaxine and duloxetine) is notable for a dual mechanism of action: increasing the levels of the neurotransmitters serotonin and norepinephrine by inhibiting their reabsorption into cells in the brain. As with other medications, side effects may occur, including stomach upset, insomnia, headache, sexual dysfunction, weight gain and minor increase in blood pressure. These medications are considered as effective as SSRIs, so they are also considered a first-line treatment for the treatment of anxiety disorders, but not for obsessive compulsive disorder, where SSRI’s are the preferred first line treatment.\nPristiq\nis used to treat major depressive disorder in adults. It works by increasing levels of serotonin and norepinephrine in the brain to help improve mood, energy, and interest in daily activities.\nFetzima\nis prescribed for major depressive disorder in adults. It helps balance serotonin and norepinephrine, with a relatively stronger effect on norepinephrine, which may improve mood, concentration, and physical energy.\nTo learn more in-depth about Selective Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), check out\nADAA's Patient Guide to Mood and Anxiety Disorders\n.\nNo\nBenzodiazepines\nThis class of drugs is frequently used for short-term management of anxiety and as an add on treatment, in treatment resistant anxiety disorders. They are not recommended as a treatment for Post Traumatic Stress Disorder. Benzodiazepines (alprazolam, clonazepam, diazepam, and lorazepam) are highly effective in promoting relaxation and reducing muscular tension and other physical symptoms of anxiety. Long-term use may require increased doses to achieve the same effect, which may lead to problems related to tolerance and dependence.\nRead this blog post about SSRIs and Benzodiazepines\n.\nTo learn more in-depth about Benzodiazepines, check out\nADAA's Patient Guide to Mood and Anxiety Disorders\n.\nNo\nTricyclic Antidepressants\nConcerns about long-term use of the benzodiazepines led many doctors to favor tricyclic antidepressants (amitriptyline, imipramine, and nortriptyline). Although effective in the treatment of some anxiety disorders(but not Social Anxiety Disorder), they can cause significant side effects, including orthostatic hypotension (drop in blood pressure on standing), constipation, urinary retention, dry mouth, and blurry vision. \nContact your physician if you experience side effects, even if you are not sure a symptom is caused by a medication. Do not stop taking a medication without consulting with the prescribing physician; abrupt discontinuation may cause other health risks. \nMedications will work only if they are taken according the explicit instructions of your physician, but they may not resolve all symptoms of an anxiety disorder.\nLearn more about how antidepressants work.\nTo learn more in-depth about Tricyclic Antidepressants, check out\nADAA's Patient Guide to Mood and Anxiety Disorders\n.\nNo\nEmerging Medications\nKetamine (Esketamine)\nKetamine represents a major step forward in the treatment of depression and suicide prevention. Read\nADAA's Public Statement \nregarding 2019 FDA approved nasal spray medication- Spravato (esketamine) for treatment resistant depression,\navailable only at a certified doctor’s office or clinic. \nTo learn more in-depth about\nKetamine (Esketamine)\n,\ncheck out\nADAA's Patient Guide to Mood and Anxiety Disorders\n.\nKetamine: A Rising Star in Mental Health Treatment\n, ADAA blog post\nKetamine Fact Sheet\n(Infographic)\nResearchers discover positive effects of intravenous ketamine for treatment-resistant depression\n, Baylor College of Medicine, Sanjay Mathews, MD\nAdditional Research Studies About Ketamine and Psychedelics: Posted April 2021\nAMJ Psychiatry 2020 Issue: \nS\nynthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation\n, \nRoger S. McIntyre, M.D., Joshua D. Rosenblat, M.D., M.Sc., (ADAA President Elect and CMO) Charles B. Nemeroff, M.D., Ph.D., Gerard Sanacora, M.D., Ph.D., (ADAA member) James W. Murrough, M.D., Ph.D., Michael Berk, Ph.D., M.B.B.Ch., Elisa Brietzke, M.D., Ph.D., Seetal Dodd, Ph.D.,Philip Gorwood, M.D., Ph.D., Roger Ho, M.D., M.B.B.S., Dan V. Iosifescu, M.D., Carlos Lopez Jaramillo, M.D., Ph.D., Siegfried Kasper, M.D., Kevin Kratiuk, B.Pharm., Jung Goo Lee, M.D., Ph.D., Yena Lee, H.B.Sc., Leanna M.W. Lui, Rodrigo B. Mansur, M.D., Ph.D., George I. Papakostas, M.D., Mehala Subramaniapillai, M.Sc., (ADAA member) Michael Thase, M.D., Eduard Vieta, M.D., Ph.D., Allan H. Young, M.Phil., M.B.Ch.B., Carlos A. Zarate, Jr., M.D., Stephen Stahl, M.D., Ph.D.\nIn this article, an international group of mood disorder experts provides a synthesis of the literature with respect to the efficacy, safety, and tolerability of ketamine and esketamine in adults with treatment-resistant depression. The authors also provide guidance for the implementation of these agents in clinical practice, with particular attention to practice parameters at point of care. Areas of consensus and future research vistas are discussed.\nA Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders\n, JAMA Psychiatry, April 2017, Gerard Sanacora, MD, PhD; Mark A. Frye, MD; William McDonald, MD; ADAA Board Member Sanjay J. Mathew, MD; Mason S. Turner, MD; ADAA member Alan F. Schatzberg, MD; Paul Summergrad, MD; ADAA Board Member and Chief Medical Officer Charles B. Nemeroff, MD, PhD; for the American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments\nEfficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study\n,\n American Journal, 2018\nDouble-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)\n, Molecular Psychiatry, September 2018\nMedical Marijuana\/Cannabis\/CBD \nCan CBD Help with My Anxiety and Depression?\n ADAA blog post\nPsychedelics\nSeveral psychedelic medicines including psilocybin and MDMA are undergoing FDA-regulated clinical trials for treatment-resistant depression, PTSD, and related conditions. However, as of late 2025, none have received U.S. regulatory approval and they remain classified as DEA Schedule 1 drugs.    \nAs this is a rapidly evolving area, ADAA is committed to providing timely updates on this topic as new data emerges. Learn more:\nPsychedelic Therapy: Promises and Problems\n, ADAA Professional Webinar (Recorded live October 27,2022)\nSingle-Dose Psilocybin for a Treatment-Resistant Episode\n - New England Journal if Medicine, November 3, 2022\nHow MDMA Resensitizes the Brain, \nNature, September 28, 2022\nMDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study\n, Nature Medicine, October 2021\nHallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine\n, The Journal of Neuroscience, February 3, 2021\nPsychedelics and Psychedelic-Assisted Psychotherapy\n. \nAMJ Psychiatry 2020 Issue:\n \nCollin M. Reiff, M.D., Elon E. Richman, M.D., (ADAA President Elect and CMO) Charles B. Nemeroff, M.D., Ph.D., Linda L. Carpenter, M.D., Alik S. Widge, M.D., Ph.D., Carolyn I. Rodriguez, M.D., Ph.D., (ADAA member) Ned H. Kalin, M.D., William M. McDonald, M.D., and the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research\nObjective\n: The authors provide an evidenced-based summary of the literature on the clinical application of psychedelic drugs in psychiatric disorders.\nResults\n: The most significant database exists for MDMA and psilocybin, which have been designated by the U.S. Food and Drug Administration (FDA) as “breakthrough therapies” for posttraumatic stress disorder (PTSD) and treatment-resistant depression, respectively. The research on LSD and ayahuascais observational, but available evidence suggests that these agents may have therapeutic effects in specific psychiatric disorders.\nConclusions\n: Randomized clinical trials support the efficacy of MDMA in the treatment of PTSD and psilocybin in the treatment of depression and cancer-related anxiety. The research to support the use of LSD and ayahuasca in the treatment of psychiatric disorders is preliminary, although promising. Overall, the database is insufficient for FDA approval of any psychedelic compound for routine clinical use in psychiatric disorders at this time, but continued research on the efficacy of psychedelics for the treatment of psychiatric disorders is warranted.\nTo learn more in-depth about medications, check out\nADAA's Patient Guide to Mood and Anxiety Disorders\n.\nNo\nMedications That Can Help with Obsessive–Compulsive Disorder (OCD)\nMedications can help reduce the symptoms of obsessive–compulsive disorder (OCD). The most prescribed are a type of antidepressant called SSRIs (selective serotonin reuptake inhibitors) (see above). Although their name suggests they are only for depression, SSRIs are also effective in treating OCD. These medicines work by helping to balance brain chemicals that affect mood, anxiety, and repetitive thoughts or behaviors.\nIt may take several weeks to start noticing improvements. Your doctor will work with you to find the right dose, explain possible side effects, and answer any questions you have. Medication is often most effective when combined with therapy, especially cognitive behavioral therapy (CBT) that is designed for OCD.\nADAA Resources\nThe Role of Antipsychotics in OCD\nMedication for Treatment of OCD: Understanding the Options\nWhat is Obsessive- Compulsive Disorder?\n(website page)\nWhat is Obsessive-Compulsive Disorder (OCD)?\n(short video)\nTo learn more in-depth about OCD and medication, check out\nADAA's Patient Guide to Mood and Anxiety Disorders\n.\n \nNo\nMedications and Cognitive Behavioral Therapy (CBT) for Postpartum Depression\nPostpartum depression can be treated with certain antidepressant medicines that help balance brain chemicals linked to mood. These medicines can ease sadness, worry, and low energy, making it easier for new parents to feel better and care for themselves and their baby.\nIn addition to medication,\nCognitive Behavioral Therapy (CBT)\nis a highly effective treatment for postpartum depression. CBT helps individuals recognize and change unhelpful thought patterns, develop healthier coping strategies, and build problem-solving skills. It focuses on the connection between thoughts, emotions, and behaviors, empowering new parents to manage stress, reduce negative thinking, and improve overall well-being.\nPostpartum depression can be treated with certain antidepressant medicines that help balance brain chemicals linked to mood. These medicines can ease sadness, worry, and low energy, making it easier for new parents to feel better and care for themselves and their baby.\nLearn more about CBT and other therapy types\nLearn more about postpartum disorders\nLearn about postpartum depression\nWhat is Postpartum Depression?\n(ADAA Video)\nWatch ADAA's Video on CBT\nThe Wisdom of Cognitive Behavioral Therapy (CBT): The Perfect Gift for New Moms   \nTo learn more in-depth about Postpartum Depression and medication, check out\nADAA's Patient Guide to Mood and Anxiety Disorders\n.\n \nNo\nBrain Treatments for Anxiety and Depression\nElectroconvulsive Therapy (ECT) a\nnd\nTranscranial Magnetic Stimulation (TMS)\nare brain treatments that may help people with depression and anxiety when other treatments, like medicine or\ntalk therapy\n, have not worked. \nElectroconvulsive therapy (ECT)\nis useful for patients who are not responding well to medications or are suicidal. ECT is an effective treatment for patients who do not respond to drug therapy, are psychotic, or are suicidal or dangerous to themselves. Onset of action may be more rapid than that of drug treatments, with benefit often seen within one week of commencing treatment. The indications for the use of ECT include the following:    \nFailure of drug therapies\nHistory of good response to ECT     \nPatient preference     \nHigh risk of suicide\nHigh risk of medical morbidity and mortality\nAlthough advances in ECT treatment has improved the safety and tolerability of this modality there are some risks such as those associated with postictal confusion, and, more rarely, short-term memory difficulties.\nTranscranial Magnetic Stimulation,\nknown as TMS or rTMS, may be a safe, effective, and noninvasive option for people who have depression that has not improved with medications. TMS creates a magnetic field to induce a small electric current in a specific part of the brain; the current comes from the magnetic field created by an electromagnetic coil that delivers pulses through the scalp. TMS is an FDA-approved treatment and recently (June 2019), the Brainsway Deep TMS device was approved for the treatment of OCD. There is ongoing research on the use of TMS to treat PTSD and other mental health conditions.\nTMS does not require sedation, is non-invasive and is virtually pain-free. With modern safety techniques, there is a less than 0.1% risk of seizure or loss of consciousness with TMS. Those receiving TMS usually are treated four or five times every week for four to six weeks. Research shows that TMS produces few side effects. Each treatment session lasts about 40 minutes. A new form of TMS called theta burst stimulation was recently approved by the FDA for the treatment of depression; sessions of theta burst stimulation last only about 10 minutes but still are provided daily for several weeks.\nTo find out if TMS is the right treatment for you, speak to your therapist, doctor, or other mental health treatment provider. Your insurance may provide reimbursement for this treatment.\nLearn more about TMS\nTo learn more in-depth about TMS check out\nADAA's Patient Guide to Mood and Anxiety Disorders\n.\nNo\nADAA Medication Information Resources\nPsychiatric Medication in Pregnancy and Lactation: What Can Women Take?\n, ADAA webinar\nDear ChatGPT, Can You See Me? The Limits of AI in Healing Anxiety and Emotional Pain\n, ADAA blog post\nMedication for Treatment of OCD: Understanding the Options\n, ADAA blog post\nSSRIs and Benzodiazepines for General Anxiety Disorders (GAD)\n, ADAA blog post\nAnxiety Medication Guide for Parents\n, AACAP.org, written by ADAA member John Walkup, MD\nCan CBD Help with My Anxiety and Depression?\n - ADAA web page\nPsychotropic Medications: What You Should Ask Your Doctor\n - ADAA blog post\nFor My Anxiety or Depression: Should I Use Medication or Therapy \n- ADAA webinar\nGeneralized Anxiety Disorder (GAD)\n- ADAA Brochure\nDepression\n - ADAA Brochure\nLearn about mental health therapy types\nVisit ADAA's Find Your Therapist Directory to find a provider near you\nTo learn more about medication and mental health therapy types check out\nADAA's Patient Guide to Mood and Anxiety Disorders\n.\nNo\nImportant Resources and Patient Assistance Programs\nMost pharmaceutical companies offer patient-assistance programs for uninsured patients. These programs provide prescribed medication at little to no cost. Eligibility varies; see the \nPartnership for Prescription Assistance website\n for more information, or \ncontact companies directly\n about their patient assistance programs.\nA New Patient Assistance Program Offering from Janssen. For Insured Patients Who Are Facing Access and Affordability Challenges. A Quick Reference Guide\nNeedyMeds\n is a 501(c)(3) national non-profit information resource dedicated to helping people locate assistance programs to help them afford their medications and other healthcare costs.  \nAlliance for Safe Online Pharmacies\nThe Alliance for Safe Online Pharmacies (ASOP Global), a 501(c)(4) non-profit organization is dedicated to protecting consumers around the world, ensuring safe access to medications, and combating illegal online drug sellers.\nVisit ADAA's Find Your Therapist Directory to find a provider near you\nNo\n#ffffff\nBoost Search Results\nOff","attrs_markdown":"![](https:\/\/www.facebook.com\/tr?id=1547202075599663&ev=PageView&noscript=1)\n\n[Skip to main content](https:\/\/adaa.org\/find-help\/treatment-help\/medication-options#main-content)\n\n[![Nav Bar Logo](https:\/\/adaa.org\/sites\/default\/files\/menu-logos\/nav-bar-logo-image.png) Anxiety & Depression Association of America Triumphing Through Science, Treatment, and Education](https:\/\/adaa.org\/)\n\n- [For the public](https:\/\/adaa.org\/)\n- [For Professionals](https:\/\/adaa.org\/professionals)\n- [ADAA Conference](https:\/\/adaa.org\/adaa-conference-2026)\n\n- [About ADAA](https:\/\/adaa.org\/find-help\/treatment-help\/medication-options)\n  - About Us\n  - [ADAA's Impact, Strategic Plan, and Finances](https:\/\/adaa.org\/about-adaa\/adaa-reports)\n  - [ADAA's Mission\/Vision and History](https:\/\/adaa.org\/about-adaa\/mission)\n  - [ADAA's 2025-2028 Strategic Plan](https:\/\/adaa.org\/sites\/default\/files\/ADAA%20STRATEGIC%20PLAN%20INFOGRAPHIC%202.pdf)\n  - [ADAA's Board of Directors](https:\/\/adaa.org\/about-adaa\/board-directors)\n  - [ADAA's Team](https:\/\/adaa.org\/about-adaa\/adaa-staff)\n  - [Join the ADAA Team](https:\/\/adaa.org\/professionals\/adaa-job-opportunities)\n  - [ADAA's Partners](https:\/\/adaa.org\/about-adaa\/partners)\n  - [Advertise with ADAA](https:\/\/adaa.org\/about-adaa\/advertise-with-adaa)\n  - [Donating to ADAA](https:\/\/adaa.org\/get-involved)\n  - [Contact ADAA](https:\/\/adaa.org\/contact-us)\n  \n  - News & Media\n  - [Press Room](https:\/\/adaa.org\/about-adaa\/news-media\/press-room)\n  - [Position Papers](https:\/\/adaa.org\/professionals\/education\/position-papers)\n  - [Members in the News](https:\/\/adaa.org\/professionals\/membership\/members-in-the-news)\n- [Newsletter Signups](https:\/\/adaa.org\/adaa-newsletters)\n  - [Triumph and Insights Signup](https:\/\/adaa.org\/adaa-newsletters)\n- [Ways to Give](https:\/\/adaa.org\/ways-to-give)\n  - [Ways to Give](https:\/\/adaa.org\/ways-to-give)\n  - [Donate Online](https:\/\/adaa.org\/donate)\n  - [Matching Gift Program](https:\/\/adaa.org\/matching-gift-program)\n  - [Share Your Story](https:\/\/adaa.org\/educational-resources\/from-our-community\/stories-of-triumph)\n- [Events](https:\/\/adaa.org\/calendar)\n\n[Donate Today](https:\/\/donate.adaa.org\/give\/322300)\n\n- [What Are Anxiety and Depression?](https:\/\/adaa.org\/understanding-anxiety)\n  - [What Are Anxiety and Depression?](https:\/\/adaa.org\/understanding-anxiety)\n  - [Depression](https:\/\/adaa.org\/understanding-anxiety\/depression)\n    - [What is Depression?](https:\/\/adaa.org\/understanding-anxiety\/depression)\n    - [Depression FAQs](https:\/\/adaa.org\/understanding-anxiety\/depression\/faqs)\n    - [Symptoms](https:\/\/adaa.org\/understanding-anxiety\/depression\/symptoms)\n    - [Treatment & Management](https:\/\/adaa.org\/understanding-anxiety\/depression\/treatment-management)\n    - [Tips to Manage Depression](https:\/\/adaa.org\/understanding-anxiety\/depression\/tips)\n    - [Postpartum Disorders](https:\/\/adaa.org\/find-help-for\/women\/postpartum-disorders)\n    - [What is Seasonal Affective Disorder (SAD)](https:\/\/adaa.org\/understanding-anxiety\/depression\/SAD)\n    - [Major Depressive Disorder (MDD) Peer to Peer Community](https:\/\/healthunlocked.com\/mdd-support)\n    - [Facts & Statistics](https:\/\/adaa.org\/understanding-anxiety\/depression\/facts-statistics)\n  - [Anxiety Disorders](https:\/\/adaa.org\/understanding-anxiety\/generalized-anxiety-disorder-gad)\n    - [What is Generalized Anxiety Disorder (GAD)?](https:\/\/adaa.org\/understanding-anxiety\/generalized-anxiety-disorder-gad)\n    - [Tips to Manage Anxiety and Stress](https:\/\/adaa.org\/tips)\n    - [GAD Myths & Realities](https:\/\/adaa.org\/understanding-anxiety\/generalized-anxiety-disorder-gad\/myths-realities)\n    - [Health Anxiety](https:\/\/adaa.org\/understanding-anxiety\/related-illnesses\/health-anxiety)\n    - [Facts & Statistics](https:\/\/adaa.org\/understanding-anxiety\/facts-statistics)\n    - [Panic Disorder](https:\/\/adaa.org\/understanding-anxiety\/panic-disorder)\n    - [What are Phobias?](https:\/\/adaa.org\/understanding-anxiety\/additional-disorders\/phobias)\n    - [What is Selective Mutism?](https:\/\/adaa.org\/understanding-anxiety\/additional-disorders\/selective-mutism)\n  - [Social Anxiety Disorder](https:\/\/adaa.org\/understanding-anxiety\/social-anxiety-disorder)\n  - [Obsessive-Compulsive & Related Disorders](https:\/\/adaa.org\/understanding-anxiety\/co-occurring-disorders\/obsessive-compulsive-disorder)\n    - [What is OCD?](https:\/\/adaa.org\/understanding-anxiety\/co-occurring-disorders\/obsessive-compulsive-disorder)\n    - [Body Dysmorphic Disorder](https:\/\/adaa.org\/understanding-anxiety\/body-dysmorphic-disorder)\n    - [Body-Focused Repetitive Behaviors (BFRBs)](https:\/\/adaa.org\/understanding-anxiety\/co-occurring-disorders\/body-focused-repetitive-behaviors)\n  - [Related Disorders](https:\/\/adaa.org\/understanding-anxiety\/co-occurring-disorders)\n    - [What are Related Disorders?](https:\/\/adaa.org\/understanding-anxiety\/co-occurring-disorders)\n    - [Adult ADHD (Attention Deficit Hyperactive Disorder)](https:\/\/adaa.org\/understanding-anxiety\/related-illnesses\/other-related-conditions\/adult-adhd)\n    - [What is Autism Spectrum Disorder (ASD)?](https:\/\/adaa.org\/understanding-anxiety\/autism-anxiety-depression)\n    - [BDD (Body Dysmorphic Disorder)](https:\/\/adaa.org\/understanding-anxiety\/body-dysmorphic-disorder)\n    - [Chronic Pain](https:\/\/adaa.org\/understanding-anxiety\/related-illnesses\/other-related-conditions\/chronic-pain)\n    - [Chronic Illness\/Disease](https:\/\/adaa.org\/understanding-anxiety\/chronic-illness-disease-anxiety-depression)\n    - [Eating Disorders](https:\/\/adaa.org\/understanding-anxiety\/related-illnesses\/eating-disorders)\n    - [Fibromyalgia](https:\/\/adaa.org\/understanding-anxiety\/related-illnesses\/other-related-conditions\/fibromyalgia)\n    - [What is Grief Disorder and Grief?](https:\/\/adaa.org\/understanding-anxiety\/related-illnesses\/other-related-conditions\/grief)\n    - [Headaches](https:\/\/adaa.org\/understanding-anxiety\/related-illnesses\/headaches)\n    - [Health Anxiety](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer\/health-anxiety-what-it-and-how-beat-it)\n    - [What is Hoarding Disorder?](https:\/\/adaa.org\/understanding-anxiety\/what-is-hoarding-disorder)\n    - [Irritable Bowel Syndrome (IBS)](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer\/overcoming-irritable-bowel-syndrome-ibs)\n    - [Sleep Disorders](https:\/\/adaa.org\/understanding-anxiety\/related-illnesses\/sleep-disorders)\n    - [Substance Abuse](https:\/\/adaa.org\/understanding-anxiety\/co-occurring-disorders\/substance-abuse)\n  - [Stress](https:\/\/adaa.org\/understanding-anxiety\/additional-disorders\/stress)\n  - [Post-Traumatic Stress Disorder (PTSD)](https:\/\/adaa.org\/understanding-anxiety\/posttraumatic-stress-disorder-ptsd)\n  - [Postpartum Disorders](https:\/\/adaa.org\/find-help-for\/women\/postpartum-disorders)\n  - [Trauma](https:\/\/adaa.org\/understanding-anxiety\/trauma)\n  - [Bipolar Disorder](https:\/\/adaa.org\/understanding-anxiety\/co-occurring-disorders\/bipolar-disorder)\n  - [Suicide and Prevention](https:\/\/adaa.org\/understanding-anxiety\/suicide)\n  - [Other Conditions](https:\/\/adaa.org\/node\/7167)\n  - [Stories of Triumph](https:\/\/adaa.org\/educational-resources\/from-our-community\/stories-of-triumph)\n  - [Clinical Trials](https:\/\/adaa.org\/understanding-anxiety\/clinical-trials)\n  - [Facts & Statistics](https:\/\/adaa.org\/understanding-anxiety\/facts-statistics)\n- [Find Help](https:\/\/adaa.org\/find-help)\n  - [How Can I Find Help?](https:\/\/adaa.org\/find-help)\n  - [Find Your ADAA Therapist](https:\/\/findyourtherapist.adaa.org\/)\n  - [ADAA Online Peer to Peer Communities](https:\/\/adaa.org\/find-help\/support)\n  - [Free Webinars](https:\/\/adaa.org\/resources-news\/from-adaa-experts\/webinars)\n  - [\"What is...?\" ADAA Mental Health Animated Videos](https:\/\/adaa.org\/resources-news\/from-adaa-experts\/animated-videos)\n  - [Blogs](https:\/\/adaa.org\/blog)\n  - [Treatment Help](https:\/\/adaa.org\/find-help\/treatment-help)\n    - [Overview](https:\/\/adaa.org\/find-help\/treatment-help)\n    - [Find Your ADAA Therapist](https:\/\/findyourtherapist.adaa.org\/)\n    - [Mental Health Therapy Types](https:\/\/adaa.org\/find-help\/treatment-help\/types-of-therapy)\n    - [Types of Mental Health Care Professionals](https:\/\/adaa.org\/find-help\/treatment-help\/types-of-therapy\/types-of-mental-health-care-professionals)\n    - [Choosing a Mental Health Therapist](https:\/\/adaa.org\/finding-help\/treatment\/choosing-therapist)\n    - [Medication and Other Treatment Options for Anxiety Disorders and Depression](https:\/\/adaa.org\/find-help\/treatment-help\/medication-options)\n    - [Residential Treatment Centers](https:\/\/adaa.org\/find-help\/treatment-help\/residential-treatment-centers)\n    - [Self-Help Books](https:\/\/adaa.org\/books)\n    - [Recursos En Español](https:\/\/adaa.org\/recursos\/en-espanol)\n    - [Integrative Behavioral Health](https:\/\/adaa.org\/find-help\/treatment-help\/integrative-behavioral-health-mindfulness-yoga-meditation)\n    - [Pediatric Brochure for Pediatric Primary Care Providers and Parents](https:\/\/adaa.org\/find-help\/by-demographics\/children-anxiety-brochure-pediatric-care)\n  - [Support](https:\/\/adaa.org\/find-help\/support)\n    - [ADAA's Online Peer-to-Peer Communities](https:\/\/adaa.org\/find-help\/support)\n    - [Find Your ADAA Therapist](https:\/\/findyourtherapist.adaa.org\/)\n    - [Self-help Books by ADAA Members](https:\/\/adaa.org\/books)\n    - [Recursos en Espanol](https:\/\/adaa.org\/recursos\/en-espanol)\n    - [Community Resources](https:\/\/adaa.org\/find-help\/support\/community-resources)\n  - [By Demographics](https:\/\/adaa.org\/find-help\/by-demographics)\n    - [Overview](https:\/\/adaa.org\/find-help\/by-demographics)\n    - [AMEMSA Communities](https:\/\/adaa.org\/find-help\/by-demographics\/amemsa-communities)\n    - [Asian Americans and Pacific Islanders](https:\/\/adaa.org\/find-help\/by-demographics\/asian-pacific-islanders)\n    - [BIPOC Communities](https:\/\/adaa.org\/find-help\/by-demographics\/bipoc-resources)\n    - [Black and African American Communities](https:\/\/adaa.org\/find-help\/by-demographics\/black-african-american-communities)\n    - [Caregivers](https:\/\/adaa.org\/find-help\/by-demographics\/caregivers)\n    - [Children](https:\/\/adaa.org\/find-help\/by-demographics\/children)\n    - [Diversity, Equity, and Inclusion Resources - Community](https:\/\/adaa.org\/find-help\/by-demographics\/diversity-equity-inclusion-resources)\n    - [Friends & Relatives](https:\/\/adaa.org\/find-help\/by-demographics\/friends-relatives)\n    - [Latiné\/Hispanic Communities](https:\/\/adaa.org\/find-help\/by-demographics\/latinx-hispanics)\n    - [LGBTQ+ Community](https:\/\/adaa.org\/find-help\/by-demographics\/lgbtq)\n    - [Low Income](https:\/\/adaa.org\/find-help\/by-demographics\/low-income)\n    - [Men's Mental Health](https:\/\/adaa.org\/find-help\/by-demographics\/mens-mental-health)\n    - [Multiracial Communities](https:\/\/adaa.org\/find-help\/by-demographics\/multiracial-communities)\n    - [Native and Indigenous Communities](https:\/\/adaa.org\/find-help\/by-demographics\/native-indigenous-communities)\n    - [Older Adults](https:\/\/adaa.org\/find-help\/by-demographics\/older-adults)\n    - [Teens\/College Students](https:\/\/adaa.org\/find-help\/by-demographics\/teens-college-students-anxiety-depression)\n    - [Veterans & Military Families](https:\/\/adaa.org\/find-help\/by-demographics\/veterans-military-families)\n    - [Women & Girls](https:\/\/adaa.org\/find-help\/by-demographics\/women-young-girls)\n  - [By Disorder](https:\/\/adaa.org\/find-help-for\/by-disorder)\n    - [Overview](https:\/\/adaa.org\/find-help-for\/by-disorder)\n    - [General Anxiety](https:\/\/adaa.org\/understanding-anxiety\/generalized-anxiety-disorder-gad)\n    - [Co-Ocurring Disorders](https:\/\/adaa.org\/understanding-anxiety\/co-occurring-disorders)\n    - [Depression](https:\/\/adaa.org\/understanding-anxiety\/depression)\n    - [Obsessive-Compulsive Disorder (OCD)](https:\/\/adaa.org\/understanding-anxiety\/co-occurring-disorders\/obsessive-compulsive-disorder)\n    - [Post-Traumatic Stress Disorder (PTSD)](https:\/\/adaa.org\/understanding-anxiety\/posttraumatic-stress-disorder-ptsd)\n  - [Self-Help Books](https:\/\/adaa.org\/books)\n  - [Recursos en Espanol](https:\/\/adaa.org\/recursos\/en-espanol)\n- [Learn and Share](https:\/\/adaa.org\/educational-resources)\n  - [Overview](https:\/\/adaa.org\/educational-resources)\n  - [Webinars, Podcasts, and Videos](https:\/\/adaa.org\/educational-resources\/from-adaa-experts)\n    - [Overview](https:\/\/adaa.org\/educational-resources\/from-adaa-experts)\n    - [Webinars](https:\/\/adaa.org\/resources-news\/from-adaa-experts\/webinars)\n    - [Videos and Podcasts](https:\/\/adaa.org\/resources-news\/from-adaa-experts\/videos)\n    - [\"What is...?\" ADAA Mental Health Animated Videos](https:\/\/adaa.org\/resources-news\/from-adaa-experts\/animated-videos)\n    - [ADAA Inside Mental Health Podcast Series](https:\/\/adaa.org\/resources\/from-adaa-experts\/inside-mental-health-podcast)\n    - [Members in the News](https:\/\/adaa.org\/professionals\/membership\/members-in-the-news)\n  - [Blogs, Self-Help Books, Infographics, Newsletters and more](https:\/\/adaa.org\/educational-resources\/from-adaa-experts)\n    - [Overview](https:\/\/adaa.org\/educational-resources\/from-adaa-experts)\n    - [Blogs](https:\/\/adaa.org\/blog)\n    - [Self-Help Books and Reading List](https:\/\/adaa.org\/books)\n    - [Triumph E-Newsletter](https:\/\/adaa.org\/educational-resources\/from-adaa-experts\/triumph-enewsletter)\n    - [Infographics](https:\/\/adaa.org\/educational-resources\/from-adaa-experts\/infographics)\n    - [Brochures](https:\/\/adaa.org\/educational-resources\/from-adaa-experts\/downloadable-brochures)\n  - [Read and Share Personal Stories](https:\/\/adaa.org\/educational-resources\/from-our-community\/stories-of-triumph)\n    - [Read Personal Mental Health Stories](https:\/\/adaa.org\/educational-resources\/from-our-community\/stories-of-triumph)\n    - [Share Your Personal Mental Health Story](https:\/\/adaa.org\/understand-anxiety-depression\/share-your-story)\n- [Personal Stories](https:\/\/adaa.org\/educational-resources\/from-our-community\/stories-of-triumph)\n\n- [Find Your Therapist](https:\/\/members.adaa.org\/page\/FATMain)\n\n- [For the public](https:\/\/adaa.org\/)\n- [For Professionals](https:\/\/adaa.org\/professionals)\n- [ADAA Conference](https:\/\/adaa.org\/adaa-conference-2026)\n\n[![Nav Bar Logo](https:\/\/adaa.org\/sites\/default\/files\/menu-logos\/Mobile%20Logo.svg)](https:\/\/adaa.org\/)\n\n[![Donate](https:\/\/adaa.org\/sites\/default\/files\/2022-10\/Donate%20Today.png) Donate Today](https:\/\/donate.adaa.org\/give\/322300)\n\n[![Button Image](https:\/\/adaa.org\/sites\/default\/files\/menu-logos\/Find%20a%20therapist%20icon.svg) Find Your Therapist](https:\/\/members.adaa.org\/page\/FATMain)\n\n[![Button Image](https:\/\/adaa.org\/themes\/bootstrap_sass\/images\/magnifying-glass-regular-blue.svg) Search](https:\/\/search-icon.com\/)\n\n[![Hamburger](https:\/\/adaa.org\/themes\/bootstrap_sass\/images\/nav-bar-hamburger-image.svg) Menu](https:\/\/adaa.org\/find-help\/treatment-help\/medication-options)\n\nTriumphing Through Science,   \n Treatment, and Education\n\n[Donate Today](https:\/\/donate.adaa.org\/give\/322300)\n\n- [For the public](https:\/\/adaa.org\/)\n- [For Professionals](https:\/\/adaa.org\/professionals)\n- [ADAA Conference](https:\/\/adaa.org\/adaa-conference-2026)\n\n- [Home](https:\/\/adaa.org\/)\n- [What Are Anxiety and Depression?](https:\/\/adaa.org\/understanding-anxiety)\n- [Find Help](https:\/\/adaa.org\/find-help)\n- [Learn and Share](https:\/\/adaa.org\/educational-resources)\n- [Personal Stories](https:\/\/adaa.org\/educational-resources\/from-our-community\/stories-of-triumph)\n\n- GO BACK\n- [What Are Anxiety and Depression?](https:\/\/adaa.org\/understanding-anxiety)\n- [What Are Anxiety and Depression?](https:\/\/adaa.org\/understanding-anxiety)\n- [Depression](https:\/\/adaa.org\/understanding-anxiety\/depression)\n- [Anxiety Disorders](https:\/\/adaa.org\/understanding-anxiety\/generalized-anxiety-disorder-gad)\n- [Social Anxiety Disorder](https:\/\/adaa.org\/understanding-anxiety\/social-anxiety-disorder)\n- [Obsessive-Compulsive & Related Disorders](https:\/\/adaa.org\/understanding-anxiety\/co-occurring-disorders\/obsessive-compulsive-disorder)\n- [Related Disorders](https:\/\/adaa.org\/understanding-anxiety\/co-occurring-disorders)\n- [Stress](https:\/\/adaa.org\/understanding-anxiety\/additional-disorders\/stress)\n- [Post-Traumatic Stress Disorder (PTSD)](https:\/\/adaa.org\/understanding-anxiety\/posttraumatic-stress-disorder-ptsd)\n- [Postpartum Disorders](https:\/\/adaa.org\/find-help-for\/women\/postpartum-disorders)\n- [Trauma](https:\/\/adaa.org\/understanding-anxiety\/trauma)\n- [Bipolar Disorder](https:\/\/adaa.org\/understanding-anxiety\/co-occurring-disorders\/bipolar-disorder)\n- [Suicide and Prevention](https:\/\/adaa.org\/understanding-anxiety\/suicide)\n- [Other Conditions](https:\/\/adaa.org\/node\/7167)\n- [Stories of Triumph](https:\/\/adaa.org\/educational-resources\/from-our-community\/stories-of-triumph)\n- [Clinical Trials](https:\/\/adaa.org\/understanding-anxiety\/clinical-trials)\n- [Facts & Statistics](https:\/\/adaa.org\/understanding-anxiety\/facts-statistics)\n\n- GO BACK\n- [Find Help](https:\/\/adaa.org\/find-help)\n- [How Can I Find Help?](https:\/\/adaa.org\/find-help)\n- [Find Your ADAA Therapist](https:\/\/findyourtherapist.adaa.org\/)\n- [ADAA Online Peer to Peer Communities](https:\/\/adaa.org\/find-help\/support)\n- [Free Webinars](https:\/\/adaa.org\/resources-news\/from-adaa-experts\/webinars)\n- [\"What is...?\" ADAA Mental Health Animated Videos](https:\/\/adaa.org\/resources-news\/from-adaa-experts\/animated-videos)\n- [Blogs](https:\/\/adaa.org\/blog)\n- [Treatment Help](https:\/\/adaa.org\/find-help\/treatment-help)\n- [Support](https:\/\/adaa.org\/find-help\/support)\n- [By Demographics](https:\/\/adaa.org\/find-help\/by-demographics)\n- [By Disorder](https:\/\/adaa.org\/find-help-for\/by-disorder)\n- [Self-Help Books](https:\/\/adaa.org\/books)\n- [Recursos en Espanol](https:\/\/adaa.org\/recursos\/en-espanol)\n\n- GO BACK\n- [Learn and Share](https:\/\/adaa.org\/educational-resources)\n- [Overview](https:\/\/adaa.org\/educational-resources)\n- [Webinars, Podcasts, and Videos](https:\/\/adaa.org\/educational-resources\/from-adaa-experts)\n- [Blogs, Self-Help Books, Infographics, Newsletters and more](https:\/\/adaa.org\/educational-resources\/from-adaa-experts)\n- [Read and Share Personal Stories](https:\/\/adaa.org\/educational-resources\/from-our-community\/stories-of-triumph)\n\n- GO BACK\n- [Depression](https:\/\/adaa.org\/understanding-anxiety\/depression)\n- [What is Depression?](https:\/\/adaa.org\/understanding-anxiety\/depression)\n- [Depression FAQs](https:\/\/adaa.org\/understanding-anxiety\/depression\/faqs)\n- [Symptoms](https:\/\/adaa.org\/understanding-anxiety\/depression\/symptoms)\n- [Treatment & Management](https:\/\/adaa.org\/understanding-anxiety\/depression\/treatment-management)\n- [Tips to Manage Depression](https:\/\/adaa.org\/understanding-anxiety\/depression\/tips)\n- [Postpartum Disorders](https:\/\/adaa.org\/find-help-for\/women\/postpartum-disorders)\n- [What is Seasonal Affective Disorder (SAD)](https:\/\/adaa.org\/understanding-anxiety\/depression\/SAD)\n- [Major Depressive Disorder (MDD) Peer to Peer Community](https:\/\/healthunlocked.com\/mdd-support)\n- [Facts & Statistics](https:\/\/adaa.org\/understanding-anxiety\/depression\/facts-statistics)\n\n- GO BACK\n- [Anxiety Disorders](https:\/\/adaa.org\/understanding-anxiety\/generalized-anxiety-disorder-gad)\n- [What is Generalized Anxiety Disorder (GAD)?](https:\/\/adaa.org\/understanding-anxiety\/generalized-anxiety-disorder-gad)\n- [Tips to Manage Anxiety and Stress](https:\/\/adaa.org\/tips)\n- [GAD Myths & Realities](https:\/\/adaa.org\/understanding-anxiety\/generalized-anxiety-disorder-gad\/myths-realities)\n- [Health Anxiety](https:\/\/adaa.org\/understanding-anxiety\/related-illnesses\/health-anxiety)\n- [Facts & Statistics](https:\/\/adaa.org\/understanding-anxiety\/facts-statistics)\n- [Panic Disorder](https:\/\/adaa.org\/understanding-anxiety\/panic-disorder)\n- [What are Phobias?](https:\/\/adaa.org\/understanding-anxiety\/additional-disorders\/phobias)\n- [What is Selective Mutism?](https:\/\/adaa.org\/understanding-anxiety\/additional-disorders\/selective-mutism)\n\n- GO BACK\n- [Obsessive-Compulsive & Related Disorders](https:\/\/adaa.org\/understanding-anxiety\/co-occurring-disorders\/obsessive-compulsive-disorder)\n- [What is OCD?](https:\/\/adaa.org\/understanding-anxiety\/co-occurring-disorders\/obsessive-compulsive-disorder)\n- [Body Dysmorphic Disorder](https:\/\/adaa.org\/understanding-anxiety\/body-dysmorphic-disorder)\n- [Body-Focused Repetitive Behaviors (BFRBs)](https:\/\/adaa.org\/understanding-anxiety\/co-occurring-disorders\/body-focused-repetitive-behaviors)\n\n- GO BACK\n- [Related Disorders](https:\/\/adaa.org\/understanding-anxiety\/co-occurring-disorders)\n- [What are Related Disorders?](https:\/\/adaa.org\/understanding-anxiety\/co-occurring-disorders)\n- [Adult ADHD (Attention Deficit Hyperactive Disorder)](https:\/\/adaa.org\/understanding-anxiety\/related-illnesses\/other-related-conditions\/adult-adhd)\n- [What is Autism Spectrum Disorder (ASD)?](https:\/\/adaa.org\/understanding-anxiety\/autism-anxiety-depression)\n- [BDD (Body Dysmorphic Disorder)](https:\/\/adaa.org\/understanding-anxiety\/body-dysmorphic-disorder)\n- [Chronic Pain](https:\/\/adaa.org\/understanding-anxiety\/related-illnesses\/other-related-conditions\/chronic-pain)\n- [Chronic Illness\/Disease](https:\/\/adaa.org\/understanding-anxiety\/chronic-illness-disease-anxiety-depression)\n- [Eating Disorders](https:\/\/adaa.org\/understanding-anxiety\/related-illnesses\/eating-disorders)\n- [Fibromyalgia](https:\/\/adaa.org\/understanding-anxiety\/related-illnesses\/other-related-conditions\/fibromyalgia)\n- [What is Grief Disorder and Grief?](https:\/\/adaa.org\/understanding-anxiety\/related-illnesses\/other-related-conditions\/grief)\n- [Headaches](https:\/\/adaa.org\/understanding-anxiety\/related-illnesses\/headaches)\n- [Health Anxiety](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer\/health-anxiety-what-it-and-how-beat-it)\n- [What is Hoarding Disorder?](https:\/\/adaa.org\/understanding-anxiety\/what-is-hoarding-disorder)\n- [Irritable Bowel Syndrome (IBS)](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer\/overcoming-irritable-bowel-syndrome-ibs)\n- [Sleep Disorders](https:\/\/adaa.org\/understanding-anxiety\/related-illnesses\/sleep-disorders)\n- [Substance Abuse](https:\/\/adaa.org\/understanding-anxiety\/co-occurring-disorders\/substance-abuse)\n\n- GO BACK\n- [Treatment Help](https:\/\/adaa.org\/find-help\/treatment-help)\n- [Overview](https:\/\/adaa.org\/find-help\/treatment-help)\n- [Find Your ADAA Therapist](https:\/\/findyourtherapist.adaa.org\/)\n- [Mental Health Therapy Types](https:\/\/adaa.org\/find-help\/treatment-help\/types-of-therapy)\n- [Types of Mental Health Care Professionals](https:\/\/adaa.org\/find-help\/treatment-help\/types-of-therapy\/types-of-mental-health-care-professionals)\n- [Choosing a Mental Health Therapist](https:\/\/adaa.org\/finding-help\/treatment\/choosing-therapist)\n- [Medication and Other Treatment Options for Anxiety Disorders and Depression](https:\/\/adaa.org\/find-help\/treatment-help\/medication-options)\n- [Residential Treatment Centers](https:\/\/adaa.org\/find-help\/treatment-help\/residential-treatment-centers)\n- [Self-Help Books](https:\/\/adaa.org\/books)\n- [Recursos En Español](https:\/\/adaa.org\/recursos\/en-espanol)\n- [Integrative Behavioral Health](https:\/\/adaa.org\/find-help\/treatment-help\/integrative-behavioral-health-mindfulness-yoga-meditation)\n- [Pediatric Brochure for Pediatric Primary Care Providers and Parents](https:\/\/adaa.org\/find-help\/by-demographics\/children-anxiety-brochure-pediatric-care)\n\n- GO BACK\n- [Support](https:\/\/adaa.org\/find-help\/support)\n- [ADAA's Online Peer-to-Peer Communities](https:\/\/adaa.org\/find-help\/support)\n- [Find Your ADAA Therapist](https:\/\/findyourtherapist.adaa.org\/)\n- [Self-help Books by ADAA Members](https:\/\/adaa.org\/books)\n- [Recursos en Espanol](https:\/\/adaa.org\/recursos\/en-espanol)\n- [Community Resources](https:\/\/adaa.org\/find-help\/support\/community-resources)\n\n- GO BACK\n- [By Demographics](https:\/\/adaa.org\/find-help\/by-demographics)\n- [Overview](https:\/\/adaa.org\/find-help\/by-demographics)\n- [AMEMSA Communities](https:\/\/adaa.org\/find-help\/by-demographics\/amemsa-communities)\n- [Asian Americans and Pacific Islanders](https:\/\/adaa.org\/find-help\/by-demographics\/asian-pacific-islanders)\n- [BIPOC Communities](https:\/\/adaa.org\/find-help\/by-demographics\/bipoc-resources)\n- [Black and African American Communities](https:\/\/adaa.org\/find-help\/by-demographics\/black-african-american-communities)\n- [Caregivers](https:\/\/adaa.org\/find-help\/by-demographics\/caregivers)\n- [Children](https:\/\/adaa.org\/find-help\/by-demographics\/children)\n- [Diversity, Equity, and Inclusion Resources - Community](https:\/\/adaa.org\/find-help\/by-demographics\/diversity-equity-inclusion-resources)\n- [Friends & Relatives](https:\/\/adaa.org\/find-help\/by-demographics\/friends-relatives)\n- [Latiné\/Hispanic Communities](https:\/\/adaa.org\/find-help\/by-demographics\/latinx-hispanics)\n- [LGBTQ+ Community](https:\/\/adaa.org\/find-help\/by-demographics\/lgbtq)\n- [Low Income](https:\/\/adaa.org\/find-help\/by-demographics\/low-income)\n- [Men's Mental Health](https:\/\/adaa.org\/find-help\/by-demographics\/mens-mental-health)\n- [Multiracial Communities](https:\/\/adaa.org\/find-help\/by-demographics\/multiracial-communities)\n- [Native and Indigenous Communities](https:\/\/adaa.org\/find-help\/by-demographics\/native-indigenous-communities)\n- [Older Adults](https:\/\/adaa.org\/find-help\/by-demographics\/older-adults)\n- [Teens\/College Students](https:\/\/adaa.org\/find-help\/by-demographics\/teens-college-students-anxiety-depression)\n- [Veterans & Military Families](https:\/\/adaa.org\/find-help\/by-demographics\/veterans-military-families)\n- [Women & Girls](https:\/\/adaa.org\/find-help\/by-demographics\/women-young-girls)\n\n- GO BACK\n- [By Disorder](https:\/\/adaa.org\/find-help-for\/by-disorder)\n- [Overview](https:\/\/adaa.org\/find-help-for\/by-disorder)\n- [General Anxiety](https:\/\/adaa.org\/understanding-anxiety\/generalized-anxiety-disorder-gad)\n- [Co-Ocurring Disorders](https:\/\/adaa.org\/understanding-anxiety\/co-occurring-disorders)\n- [Depression](https:\/\/adaa.org\/understanding-anxiety\/depression)\n- [Obsessive-Compulsive Disorder (OCD)](https:\/\/adaa.org\/understanding-anxiety\/co-occurring-disorders\/obsessive-compulsive-disorder)\n- [Post-Traumatic Stress Disorder (PTSD)](https:\/\/adaa.org\/understanding-anxiety\/posttraumatic-stress-disorder-ptsd)\n\n- GO BACK\n- [Webinars, Podcasts, and Videos](https:\/\/adaa.org\/educational-resources\/from-adaa-experts)\n- [Overview](https:\/\/adaa.org\/educational-resources\/from-adaa-experts)\n- [Webinars](https:\/\/adaa.org\/resources-news\/from-adaa-experts\/webinars)\n- [Videos and Podcasts](https:\/\/adaa.org\/resources-news\/from-adaa-experts\/videos)\n- [\"What is...?\" ADAA Mental Health Animated Videos](https:\/\/adaa.org\/resources-news\/from-adaa-experts\/animated-videos)\n- [ADAA Inside Mental Health Podcast Series](https:\/\/adaa.org\/resources\/from-adaa-experts\/inside-mental-health-podcast)\n- [Members in the News](https:\/\/adaa.org\/professionals\/membership\/members-in-the-news)\n\n- GO BACK\n- [Blogs, Self-Help Books, Infographics, Newsletters and more](https:\/\/adaa.org\/educational-resources\/from-adaa-experts)\n- [Overview](https:\/\/adaa.org\/educational-resources\/from-adaa-experts)\n- [Blogs](https:\/\/adaa.org\/blog)\n- [Self-Help Books and Reading List](https:\/\/adaa.org\/books)\n- [Triumph E-Newsletter](https:\/\/adaa.org\/educational-resources\/from-adaa-experts\/triumph-enewsletter)\n- [Infographics](https:\/\/adaa.org\/educational-resources\/from-adaa-experts\/infographics)\n- [Brochures](https:\/\/adaa.org\/educational-resources\/from-adaa-experts\/downloadable-brochures)\n\n- GO BACK\n- [Read and Share Personal Stories](https:\/\/adaa.org\/educational-resources\/from-our-community\/stories-of-triumph)\n- [Read Personal Mental Health Stories](https:\/\/adaa.org\/educational-resources\/from-our-community\/stories-of-triumph)\n- [Share Your Personal Mental Health Story](https:\/\/adaa.org\/understand-anxiety-depression\/share-your-story)\n\n- [Find Your Therapist](https:\/\/members.adaa.org\/page\/FATMain)\n\n- [About ADAA](https:\/\/adaa.org\/find-help\/treatment-help\/medication-options)\n  - [About Us](https:\/\/adaa.org\/find-help\/treatment-help\/medication-options)\n    - [ADAA's Impact, Strategic Plan, and Finances](https:\/\/adaa.org\/about-adaa\/adaa-reports)\n    - [ADAA's Mission\/Vision and History](https:\/\/adaa.org\/about-adaa\/mission)\n    - [ADAA's 2025-2028 Strategic Plan](https:\/\/adaa.org\/sites\/default\/files\/ADAA%20STRATEGIC%20PLAN%20INFOGRAPHIC%202.pdf)\n    - [ADAA's Board of Directors](https:\/\/adaa.org\/about-adaa\/board-directors)\n    - [ADAA's Team](https:\/\/adaa.org\/about-adaa\/adaa-staff)\n    - [Join the ADAA Team](https:\/\/adaa.org\/professionals\/adaa-job-opportunities)\n    - [ADAA's Partners](https:\/\/adaa.org\/about-adaa\/partners)\n    - [Advertise with ADAA](https:\/\/adaa.org\/about-adaa\/advertise-with-adaa)\n    - [Donating to ADAA](https:\/\/adaa.org\/get-involved)\n    - [Contact ADAA](https:\/\/adaa.org\/contact-us)\n  - [News & Media](https:\/\/adaa.org\/find-help\/treatment-help\/medication-options)\n    - [Press Room](https:\/\/adaa.org\/about-adaa\/news-media\/press-room)\n    - [Position Papers](https:\/\/adaa.org\/professionals\/education\/position-papers)\n    - [Members in the News](https:\/\/adaa.org\/professionals\/membership\/members-in-the-news)\n- [Newsletter Signups](https:\/\/adaa.org\/adaa-newsletters)\n  - [Triumph and Insights Signup](https:\/\/adaa.org\/adaa-newsletters)\n- [Ways to Give](https:\/\/adaa.org\/ways-to-give)\n  - [Ways to Give](https:\/\/adaa.org\/ways-to-give)\n  - [Donate Online](https:\/\/adaa.org\/donate)\n  - [Matching Gift Program](https:\/\/adaa.org\/matching-gift-program)\n  - [Share Your Story](https:\/\/adaa.org\/educational-resources\/from-our-community\/stories-of-triumph)\n- [Events](https:\/\/adaa.org\/calendar)\n\n- [Home](https:\/\/adaa.org\/professionals)\n- [Conference](https:\/\/adaa.org\/adaa-conference-2026)\n- [Education\/CE](https:\/\/adaa.org\/professionals\/education)\n- [Membership](https:\/\/adaa.org\/professionals\/membership)\n- [Resources](https:\/\/adaa.org\/professionals\/research-practice)\n\n- GO BACK\n- [Education\/CE](https:\/\/adaa.org\/professionals\/education)\n- [Overview](https:\/\/adaa.org\/professionals\/education)\n- [ADAA Webinars & Continuing Education](https:\/\/adaa.org\/professionals\/education\/webinars)\n- [Member Blogs](https:\/\/adaa.org\/professionals\/education\/blog)\n- [Member Books & Publications](https:\/\/adaa.org\/professionals\/research-practice\/publications\/member-publications)\n- [Resources for Early Career and Student Mental Health Professionals](https:\/\/adaa.org\/early-career-professionals-resources)\n- [Resources for Underrepresented Communities](https:\/\/adaa.org\/professionals\/education\/dei\/resources)\n\n- GO BACK\n- [Membership](https:\/\/adaa.org\/professionals\/membership)\n- [Become a Member\/Rejoin](https:\/\/adaa.org\/professionals\/membership)\n- [Institutional\/Group Membership](https:\/\/adaa.org\/professionals\/Institutional-Memberships)\n- [Managing Your Directory Profile](https:\/\/adaa.org\/professionals\/managing-FYT-profile)\n- [ADAA Professional Committees, Groups and the Scientific Council](https:\/\/adaa.org\/professionals\/committees-sigs\/committees-councils-program)\n- [Special Interest Groups (SIGs)](https:\/\/adaa.org\/professionals\/committees-sigs\/special-interest-groups)\n- [ADAA's Public\/Client Resources](https:\/\/adaa.org\/)\n- [ADAA Mental Health Career Center](https:\/\/adaa.careerwebsite.com\/home\/index.cfm)\n- [Awards Programs](https:\/\/adaa.societyconference.com\/v2\/)\n- [ADAA Member Content](https:\/\/adaa.org\/professionals\/membership\/members-in-the-news)\n- [Member FAQs](https:\/\/adaa.org\/professionals\/membership\/faqs)\n\n- GO BACK\n- [Resources](https:\/\/adaa.org\/professionals\/research-practice)\n- [ADAA Journal of Mood & Anxiety Disorders](https:\/\/adaa.org\/professionals\/journal)\n- [ADAA Patient Guide to Mood and Anxiety Disorders](https:\/\/adaa.org\/books\/patient-guide-to-mood-and-anxiety-disorders)\n- [Stay Current with ADAA’s Professional Insights Newsletter](https:\/\/adaa.org\/professionals\/research-practice\/publications\/insights-enewsletter)\n- [Find Your Therapist](https:\/\/adaa.org\/find-help\/support\/ask-an-adaa-therapist)\n- [Member Publications](https:\/\/adaa.org\/professionals\/research-practice\/publications\/member-publications)\n- [ADAA Journal of Mood & Anxiety Disorders ®](https:\/\/adaa.org\/professionals\/journal)\n- [Member Research News](https:\/\/adaa.org\/professionals\/research-practice\/publications\/member-research-news)\n- [Events](https:\/\/adaa.org\/calendar)\n- [Early Career and Student Mental Health Professionals Resources](https:\/\/adaa.org\/early-career-professionals-resources)\n- [ADAA Resources for the Public](https:\/\/adaa.org\/)\n- [Position Papers signed by ADAA Leadership](https:\/\/adaa.org\/professionals\/education\/position-papers)\n- [Mental Health Resources for Clinicians](https:\/\/adaa.org\/professionals\/research-practice\/Mental-Health-Resources-for-Clinicians)\n- [Clinical Trials](https:\/\/adaa.trialstoday.org\/)\n- [ADAA Mental Health Career Center](https:\/\/adaa.careerwebsite.com\/home\/index.cfm)\n- [Resources for Underrepresented Communities](https:\/\/adaa.org\/professionals\/education\/dei\/resources)\n\n- GO BACK\n- [ADAA Webinars & Continuing Education](https:\/\/adaa.org\/professionals\/education\/webinars)\n- [Live and On-Demand Webinars](https:\/\/adaa.org\/professionals\/education\/webinars)\n- [Webinar FAQs](https:\/\/adaa.org\/professionals\/education\/professional-webinar-faq)\n- [CE\/CME Information](https:\/\/adaa.org\/professionals\/education\/ce-credits)\n\n- GO BACK\n- [Awards Programs](https:\/\/adaa.societyconference.com\/v2\/)\n- [Awards Overview](https:\/\/adaa.org\/conference\/awards-programs)\n- [Alies Muskin Career Development Leadership Program](https:\/\/adaa.org\/conference\/conference-education\/career-development)\n- [Klein Early Career Investigator Award](https:\/\/adaa.org\/conference\/conference-education\/donald-f-klein-award)\n- [Member Recognition Awards](https:\/\/adaa.org\/resources-professionals\/conference-education\/awards\/member-award-winners)\n- [Membership Award for Early Career Professionals](https:\/\/adaa.org\/conference\/conference-education\/membership-scholarship)\n- [Poster Awards](https:\/\/adaa.org\/conference\/poster-awards)\n- [Become a Mentor](https:\/\/adaa.org\/conference\/awards\/cdlp-mentorship)\n\n- GO BACK\n- [ADAA Member Content](https:\/\/adaa.org\/professionals\/membership\/members-in-the-news)\n- [Member Community](https:\/\/community.adaa.org\/home)\n- [Member Blogs](https:\/\/adaa.org\/professionals\/education\/blog)\n- [Members in the News](https:\/\/adaa.org\/professionals\/membership\/members-in-the-news)\n- [Member Publications](https:\/\/adaa.org\/books)\n- [Early Career and Student Mental Health Professionals Resources](https:\/\/adaa.org\/early-career-professionals-resources)\n\n- [Join\/ Renew](https:\/\/members.adaa.org\/page\/join)\n- [Member Community](https:\/\/community.adaa.org\/home)\n- [Find Your Therapist](https:\/\/findyourtherapist.adaa.org\/)\n- [Search](https:\/\/search-icon.com\/)\n\n- [About ADAA](https:\/\/adaa.org\/find-help\/treatment-help\/medication-options)\n  - [About Us](https:\/\/adaa.org\/find-help\/treatment-help\/medication-options)\n    - [ADAA's Impact, Strategic Plan, and Finances](https:\/\/adaa.org\/about-adaa\/adaa-reports)\n    - [ADAA's Mission\/Vision and History](https:\/\/adaa.org\/about-adaa\/mission)\n    - [ADAA's 2025-2028 Strategic Plan](https:\/\/adaa.org\/sites\/default\/files\/ADAA%20STRATEGIC%20PLAN%20INFOGRAPHIC%202.pdf)\n    - [ADAA's Board of Directors](https:\/\/adaa.org\/about-adaa\/board-directors)\n    - [ADAA's Team](https:\/\/adaa.org\/about-adaa\/adaa-staff)\n    - [Join the ADAA Team](https:\/\/adaa.org\/professionals\/adaa-job-opportunities)\n    - [ADAA's Partners](https:\/\/adaa.org\/about-adaa\/partners)\n    - [Advertise with ADAA](https:\/\/adaa.org\/about-adaa\/advertise-with-adaa)\n    - [Donating to ADAA](https:\/\/adaa.org\/get-involved)\n    - [Contact ADAA](https:\/\/adaa.org\/contact-us)\n  - [News & Media](https:\/\/adaa.org\/find-help\/treatment-help\/medication-options)\n    - [Press Room](https:\/\/adaa.org\/about-adaa\/news-media\/press-room)\n    - [Position Papers](https:\/\/adaa.org\/professionals\/education\/position-papers)\n    - [Members in the News](https:\/\/adaa.org\/professionals\/membership\/members-in-the-news)\n- [Newsletter Signups](https:\/\/adaa.org\/adaa-newsletters)\n  - [Triumph and Insights Signup](https:\/\/adaa.org\/adaa-newsletters)\n- [Ways to Give](https:\/\/adaa.org\/ways-to-give)\n  - [Ways to Give](https:\/\/adaa.org\/ways-to-give)\n  - [Donate Online](https:\/\/adaa.org\/donate)\n  - [Matching Gift Program](https:\/\/adaa.org\/matching-gift-program)\n  - [Share Your Story](https:\/\/adaa.org\/educational-resources\/from-our-community\/stories-of-triumph)\n- [Events](https:\/\/adaa.org\/calendar)\n\n- [Home](https:\/\/adaa.org\/adaa-conference-2026)\n- [General Conference Information](https:\/\/adaa.org\/adaa-conference-2026)\n\n- GO BACK\n- [General Conference Information](https:\/\/adaa.org\/adaa-conference-2026)\n- [Submissions](https:\/\/adaa.societyconference.com\/v2\/#card\/submission)\n- [Registration](https:\/\/adaa.societyconference.com\/v2\/#card\/registration)\n- [2026 Conference Committee](https:\/\/adaa.org\/conference\/conference-committee)\n- [2026 Conference Awards Program](https:\/\/adaa.org\/conference\/awards-programs)\n- [Conference Blogs](https:\/\/adaa.org\/conference\/blog)\n- [Future and Past ADAA Conferences](https:\/\/adaa.org\/conference\/future-past-conferences)\n\n- [\\#ADAA2026 News](https:\/\/adaa.informz.net\/adaa\/pages\/ADAA_Conference_Email_Sign_Up)\n- [Search](https:\/\/search-icon.com\/)\n\n- [About ADAA](https:\/\/adaa.org\/find-help\/treatment-help\/medication-options)\n  - [About Us](https:\/\/adaa.org\/find-help\/treatment-help\/medication-options)\n    - [ADAA's Impact, Strategic Plan, and Finances](https:\/\/adaa.org\/about-adaa\/adaa-reports)\n    - [ADAA's Mission\/Vision and History](https:\/\/adaa.org\/about-adaa\/mission)\n    - [ADAA's 2025-2028 Strategic Plan](https:\/\/adaa.org\/sites\/default\/files\/ADAA%20STRATEGIC%20PLAN%20INFOGRAPHIC%202.pdf)\n    - [ADAA's Board of Directors](https:\/\/adaa.org\/about-adaa\/board-directors)\n    - [ADAA's Team](https:\/\/adaa.org\/about-adaa\/adaa-staff)\n    - [Join the ADAA Team](https:\/\/adaa.org\/professionals\/adaa-job-opportunities)\n    - [ADAA's Partners](https:\/\/adaa.org\/about-adaa\/partners)\n    - [Advertise with ADAA](https:\/\/adaa.org\/about-adaa\/advertise-with-adaa)\n    - [Donating to ADAA](https:\/\/adaa.org\/get-involved)\n    - [Contact ADAA](https:\/\/adaa.org\/contact-us)\n  - [News & Media](https:\/\/adaa.org\/find-help\/treatment-help\/medication-options)\n    - [Press Room](https:\/\/adaa.org\/about-adaa\/news-media\/press-room)\n    - [Position Papers](https:\/\/adaa.org\/professionals\/education\/position-papers)\n    - [Members in the News](https:\/\/adaa.org\/professionals\/membership\/members-in-the-news)\n- [Newsletter Signups](https:\/\/adaa.org\/adaa-newsletters)\n  - [Triumph and Insights Signup](https:\/\/adaa.org\/adaa-newsletters)\n- [Ways to Give](https:\/\/adaa.org\/ways-to-give)\n  - [Ways to Give](https:\/\/adaa.org\/ways-to-give)\n  - [Donate Online](https:\/\/adaa.org\/donate)\n  - [Matching Gift Program](https:\/\/adaa.org\/matching-gift-program)\n  - [Share Your Story](https:\/\/adaa.org\/educational-resources\/from-our-community\/stories-of-triumph)\n- [Events](https:\/\/adaa.org\/calendar)\n\n# Medication and Other Treatment Options for Anxiety Disorders and Depression\n![Medication Options](https:\/\/adaa.org\/sites\/default\/files\/2023-08\/iStock-1383621461%20purchased%20istock%20small%20bad%20thoughts%20OCD.jpg)\n\nMedication can be a safe, effective, and evidence-based option for treating anxiety disorders and depression. Many people take medication alone or in combination [with therapy](https:\/\/adaa.org\/find-help\/treatment-help\/types-of-therapy) to help manage symptoms and improve daily functioning.\n\nIt's essential to recognize that medication is only one component of a comprehensive treatment approach. Other evidence-based options, such as psychotherapy, transcranial magnetic stimulation (TMS), and electroconvulsive therapy (ECT), may be recommended depending on an individual’s needs and treatment goals. These approaches can be used alone or in combination with medication to maximize effectiveness.\n\nFinding the right medication or treatment plan often requires patience, collaboration with a healthcare provider, and adjustments along the way. When used appropriately, medications can significantly reduce symptoms of anxiety and depression and support a return to balance and quality of life.\n\nAlways consult a healthcare provider before starting, changing, or stopping medication. The right treatment depends on your symptoms, medical history, and individual needs. Finding the right medication—whether antidepressants, anti-anxiety medications, or a combination, often takes time, patience, and close collaboration with your doctor or nurse practitioner.\n\n**Discussing Medications - What You Need to Know:**\n\n**Use these guidelines to talk to your health care professional about medications:**\n\n- To avoid potentially dangerous drug interactions, let your mental health care provider know all medications you are taking, including prescriptions and over-the-counter drugs, herbal or dietary supplements, and vitamins. And make sure your family doctor knows you are taking medicines for an anxiety disorder.\n- Learn when to take a new medication and how, such as on an empty stomach or with food, in the morning or evening, and how frequently.\n- Find out how long it should take for the medication to start working and what you should expect when this happens.\n- Ask: How will the medication help me? What side effects might occur? Should I avoid any foods or beverages? Are drug interactions with other prescriptions a possibility? How often should you see the doctor for a medication check-up?\n- Ask for the prescribing physician’s after-hours phone number in case you develop side effects.\n- A good source of information about medications and over-the-counter products is your pharmacist, who should have information about all your prescriptions to advise you about possible drug interactions, side effects, and instructions for use.\n\nIf your physician does not want to spend the time to answer your questions, you may need a referral to a different physician.\n\nMedications are commonly prescribed by physicians (family practice, pediatricians, OB-GYNs, psychiatrists), as well as nurse practitioners in many states.\n\n**There are four major classes of medications that are used in the treatment of anxiety disorders**:\n\nQ\\&A\n\n#### What to Ask Your Doctor Before Starting a New Antidepressant or an Emerging Treatment\n1. Is this new drug\/treatment appropriate for me?\n2. What are the drawbacks, if any of this new treatment?\n3. What might be the benefits over my current regimen?\n4. Is the price (typically high when a drug is new) worth the added benefit?\n5. Is this treatment ready for widespread use? Meaning, does it have safety established? Do we know how long people need to be on this treatment? Do we know about any long term issues that could result from this?\n\nNo\n\n#### Selective Serotonin Reuptake Inhibitors (SSRIs)\nSSRIs relieve symptoms by blocking the reabsorption, or reuptake, of serotonin by certain nerve cells in the brain. This leaves more serotonin available, which improves mood. SSRIs (citalopram, escitalopram, fluoxetine, paroxetine, and sertraline) generally produced fewer side effects when compared with tricyclic antidepressants. However, common side effects include insomnia or sleepiness, sexual dysfunction, and weight gain. They are considered an effective treatment for all anxiety disorders, although the treatment of obsessive-compulsive disorder, or OCD, typically requires higher doses. [Read this blog about SSRIs and Benzodiazepines](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer\/ssris-and-benzodiazepines-general-anxiety).\n\n- Trintellix (vortioxetine) is a prescription antidepressant used to treat major depressive disorder in adults. It works by affecting serotonin activity in the brain, which can help improve mood, cognition, and overall functioning.\n- Viibryd (vilazodone) is a prescription antidepressant used to treat major depressive disorder (MDD) in adults. It works by increasing serotonin activity in the brain and is classified as a selective serotonin reuptake inhibitor (SSRI) and partial serotonin receptor.\n\nTo learn more in-depth about Selective Serotonin Reuptake Inhibitors (SSRIs), check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https:\/\/adaa.org\/node\/7421).\n\nNo\n\n#### Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)\nThe serotonin-norepinephrine reuptake inhibitor, or SNRI, class (venlafaxine and duloxetine) is notable for a dual mechanism of action: increasing the levels of the neurotransmitters serotonin and norepinephrine by inhibiting their reabsorption into cells in the brain. As with other medications, side effects may occur, including stomach upset, insomnia, headache, sexual dysfunction, weight gain and minor increase in blood pressure. These medications are considered as effective as SSRIs, so they are also considered a first-line treatment for the treatment of anxiety disorders, but not for obsessive compulsive disorder, where SSRI’s are the preferred first line treatment.\n\n- **Pristiq** is used to treat major depressive disorder in adults. It works by increasing levels of serotonin and norepinephrine in the brain to help improve mood, energy, and interest in daily activities.\n- **Fetzima** is prescribed for major depressive disorder in adults. It helps balance serotonin and norepinephrine, with a relatively stronger effect on norepinephrine, which may improve mood, concentration, and physical energy.\n\nTo learn more in-depth about Selective Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https:\/\/adaa.org\/node\/7421).\n\nNo\n\n#### Benzodiazepines\nThis class of drugs is frequently used for short-term management of anxiety and as an add on treatment, in treatment resistant anxiety disorders. They are not recommended as a treatment for Post Traumatic Stress Disorder. Benzodiazepines (alprazolam, clonazepam, diazepam, and lorazepam) are highly effective in promoting relaxation and reducing muscular tension and other physical symptoms of anxiety. Long-term use may require increased doses to achieve the same effect, which may lead to problems related to tolerance and dependence. [Read this blog post about SSRIs and Benzodiazepines](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer\/ssris-and-benzodiazepines-general-anxiety).\n\nTo learn more in-depth about Benzodiazepines, check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https:\/\/adaa.org\/node\/7421).\n\nNo\n\n#### Tricyclic Antidepressants\nConcerns about long-term use of the benzodiazepines led many doctors to favor tricyclic antidepressants (amitriptyline, imipramine, and nortriptyline). Although effective in the treatment of some anxiety disorders(but not Social Anxiety Disorder), they can cause significant side effects, including orthostatic hypotension (drop in blood pressure on standing), constipation, urinary retention, dry mouth, and blurry vision.\n\nContact your physician if you experience side effects, even if you are not sure a symptom is caused by a medication. Do not stop taking a medication without consulting with the prescribing physician; abrupt discontinuation may cause other health risks.\n\nMedications will work only if they are taken according the explicit instructions of your physician, but they may not resolve all symptoms of an anxiety disorder. [Learn more about how antidepressants work.](https:\/\/adaa.org\/sites\/default\/files\/SomberQuestions_Antidepressants.pdf)\n\nTo learn more in-depth about Tricyclic Antidepressants, check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https:\/\/adaa.org\/node\/7421).\n\nNo\n\n#### Emerging Medications\n**Ketamine (Esketamine)**\n\nKetamine represents a major step forward in the treatment of depression and suicide prevention. Read [ADAA's Public Statement](https:\/\/adaa.org\/sites\/default\/files\/ADAA%20March%202019%20FDA%20Esketamine%20Statement_0.pdf) regarding 2019 FDA approved nasal spray medication- Spravato (esketamine) for treatment resistant depression,available only at a certified doctor’s office or clinic.\n\nTo learn more in-depth about **Ketamine (Esketamine)****,** check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https:\/\/adaa.org\/node\/7421).\n\n- [Ketamine: A Rising Star in Mental Health Treatment](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer-professional\/ketamine-rising-star-mental-health), ADAA blog post\n- [Ketamine Fact Sheet](https:\/\/adaa.org\/sites\/default\/files\/2024-02\/Ketamine%202024%20Fact%20Sheet.pdf) (Infographic)\n- [Researchers discover positive effects of intravenous ketamine for treatment-resistant depression](http:\/\/bcm.edu\/news\/researchers-discover-positive-effects-of-intravenous-ketamine-for-treatment-resistant-depression), Baylor College of Medicine, Sanjay Mathews, MD\n\n**Additional Research Studies About Ketamine and Psychedelics: Posted April 2021**\n\nAMJ Psychiatry 2020 Issue: [S*ynthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation*](https:\/\/adaa.org\/sites\/default\/files\/module%20images\/%231153%20Amer%20J%20Psy%20Synthesizing%20the%20Evidence%20for%20Ketamine%20and%20Esketamine%20in%20Treatment-Resistant%20Depression.pdf)*,* Roger S. McIntyre, M.D., Joshua D. Rosenblat, M.D., M.Sc., (ADAA President Elect and CMO) Charles B. Nemeroff, M.D., Ph.D., Gerard Sanacora, M.D., Ph.D., (ADAA member) James W. Murrough, M.D., Ph.D., Michael Berk, Ph.D., M.B.B.Ch., Elisa Brietzke, M.D., Ph.D., Seetal Dodd, Ph.D.,Philip Gorwood, M.D., Ph.D., Roger Ho, M.D., M.B.B.S., Dan V. Iosifescu, M.D., Carlos Lopez Jaramillo, M.D., Ph.D., Siegfried Kasper, M.D., Kevin Kratiuk, B.Pharm., Jung Goo Lee, M.D., Ph.D., Yena Lee, H.B.Sc., Leanna M.W. Lui, Rodrigo B. Mansur, M.D., Ph.D., George I. Papakostas, M.D., Mehala Subramaniapillai, M.Sc., (ADAA member) Michael Thase, M.D., Eduard Vieta, M.D., Ph.D., Allan H. Young, M.Phil., M.B.Ch.B., Carlos A. Zarate, Jr., M.D., Stephen Stahl, M.D., Ph.D.\n\nIn this article, an international group of mood disorder experts provides a synthesis of the literature with respect to the efficacy, safety, and tolerability of ketamine and esketamine in adults with treatment-resistant depression. The authors also provide guidance for the implementation of these agents in clinical practice, with particular attention to practice parameters at point of care. Areas of consensus and future research vistas are discussed.\n\n[A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders](https:\/\/adaa.org\/sites\/default\/files\/Ketamine%20JAMA%20Journal%20Article%20-%20Charlie%20Nemeroff.pdf), JAMA Psychiatry, April 2017, Gerard Sanacora, MD, PhD; Mark A. Frye, MD; William McDonald, MD; ADAA Board Member Sanjay J. Mathew, MD; Mason S. Turner, MD; ADAA member Alan F. Schatzberg, MD; Paul Summergrad, MD; ADAA Board Member and Chief Medical Officer Charles B. Nemeroff, MD, PhD; for the American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments\n\n[*Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study*](https:\/\/adaa.org\/sites\/default\/files\/Canuso-AJP-2018.pdf)*,* American Journal, 2018\n\n[*Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)*](https:\/\/adaa.org\/sites\/default\/files\/Fava_et_al-2018-Molecular_Psychiatry.pdf), Molecular Psychiatry, September 2018\n\n**Medical Marijuana\/Cannabis\/CBD**\n\n- [Can CBD Help with My Anxiety and Depression?](https:\/\/adaa.org\/understanding-anxiety\/cbd) ADAA blog post\n\n**Psychedelics**\n\nSeveral psychedelic medicines including psilocybin and MDMA are undergoing FDA-regulated clinical trials for treatment-resistant depression, PTSD, and related conditions. However, as of late 2025, none have received U.S. regulatory approval and they remain classified as DEA Schedule 1 drugs.\n\nAs this is a rapidly evolving area, ADAA is committed to providing timely updates on this topic as new data emerges. Learn more:\n\n- [Psychedelic Therapy: Promises and Problems](https:\/\/adaa.org\/webinar\/professional\/psychedelic-therapy-problems-and-promises), ADAA Professional Webinar (Recorded live October 27,2022)\n- [Single-Dose Psilocybin for a Treatment-Resistant Episode](https:\/\/adaa.org\/sites\/default\/files\/Goodwin-NEJM-2022-PsilocybinTRD.pdf) - New England Journal if Medicine, November 3, 2022\n- [How MDMA Resensitizes the Brain,](https:\/\/www.nature.com\/articles\/d41586-022-02871-w) Nature, September 28, 2022\n- [MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study](https:\/\/adaa.org\/sites\/default\/files\/MDMAPTSD-NatMed2021.pdf), Nature Medicine, October 2021\n- [Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine](https:\/\/adaa.org\/sites\/default\/files\/DeGregorio-Hallucinogens-JNeuro2021.pdf), The Journal of Neuroscience, February 3, 2021\n- [*Psychedelics and Psychedelic-Assisted Psychotherapy*](https:\/\/adaa.org\/sites\/default\/files\/module%20images\/%231128%20AJP%20-%20Psychedelics%20and%20Psychedelic%20Assisted%20Psychotherapy.pdf)***.*** **AMJ Psychiatry 2020 Issue:**Collin M. Reiff, M.D., Elon E. Richman, M.D., (ADAA President Elect and CMO) Charles B. Nemeroff, M.D., Ph.D., Linda L. Carpenter, M.D., Alik S. Widge, M.D., Ph.D., Carolyn I. Rodriguez, M.D., Ph.D., (ADAA member) Ned H. Kalin, M.D., William M. McDonald, M.D., and the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research\n  - Objective: The authors provide an evidenced-based summary of the literature on the clinical application of psychedelic drugs in psychiatric disorders.\n  - Results: The most significant database exists for MDMA and psilocybin, which have been designated by the U.S. Food and Drug Administration (FDA) as “breakthrough therapies” for posttraumatic stress disorder (PTSD) and treatment-resistant depression, respectively. The research on LSD and ayahuascais observational, but available evidence suggests that these agents may have therapeutic effects in specific psychiatric disorders.\n  - Conclusions: Randomized clinical trials support the efficacy of MDMA in the treatment of PTSD and psilocybin in the treatment of depression and cancer-related anxiety. The research to support the use of LSD and ayahuasca in the treatment of psychiatric disorders is preliminary, although promising. Overall, the database is insufficient for FDA approval of any psychedelic compound for routine clinical use in psychiatric disorders at this time, but continued research on the efficacy of psychedelics for the treatment of psychiatric disorders is warranted.\n- To learn more in-depth about medications, check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https:\/\/adaa.org\/node\/7421).\n\nNo\n\n#### Medications That Can Help with Obsessive–Compulsive Disorder (OCD)\nMedications can help reduce the symptoms of obsessive–compulsive disorder (OCD). The most prescribed are a type of antidepressant called SSRIs (selective serotonin reuptake inhibitors) (see above). Although their name suggests they are only for depression, SSRIs are also effective in treating OCD. These medicines work by helping to balance brain chemicals that affect mood, anxiety, and repetitive thoughts or behaviors.  \nIt may take several weeks to start noticing improvements. Your doctor will work with you to find the right dose, explain possible side effects, and answer any questions you have. Medication is often most effective when combined with therapy, especially cognitive behavioral therapy (CBT) that is designed for OCD.\n\n**ADAA Resources**\n\n- [The Role of Antipsychotics in OCD](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/professional\/role-antipsychotics-ocd)\n- [Medication for Treatment of OCD: Understanding the Options](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer-professional\/medication-treatment-ocd)\n- [What is Obsessive- Compulsive Disorder?](https:\/\/adaa.org\/understanding-anxiety\/co-occurring-disorders\/obsessive-compulsive-disorder) (website page)\n- [What is Obsessive-Compulsive Disorder (OCD)?](https:\/\/adaa.org\/about-adaa\/press-room\/multimedia\/what-obsessive-compulsive-disorder-ocd) (short video)\n- To learn more in-depth about OCD and medication, check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https:\/\/adaa.org\/node\/7421).\n\nNo\n\n#### Medications and Cognitive Behavioral Therapy (CBT) for Postpartum Depression\nPostpartum depression can be treated with certain antidepressant medicines that help balance brain chemicals linked to mood. These medicines can ease sadness, worry, and low energy, making it easier for new parents to feel better and care for themselves and their baby.\n\nIn addition to medication, **Cognitive Behavioral Therapy (CBT)** is a highly effective treatment for postpartum depression. CBT helps individuals recognize and change unhelpful thought patterns, develop healthier coping strategies, and build problem-solving skills. It focuses on the connection between thoughts, emotions, and behaviors, empowering new parents to manage stress, reduce negative thinking, and improve overall well-being.\n\nPostpartum depression can be treated with certain antidepressant medicines that help balance brain chemicals linked to mood. These medicines can ease sadness, worry, and low energy, making it easier for new parents to feel better and care for themselves and their baby.\n\n- [Learn more about CBT and other therapy types](https:\/\/adaa.org\/find-help\/treatment-help\/types-of-therapy)\n- [Learn more about postpartum disorders](https:\/\/adaa.org\/find-help-for\/women\/postpartum-disorders?utm_source=chatgpt.com)\n- [Learn about postpartum depression](https:\/\/adaa.org\/living-with-anxiety\/women\/postpartum-depression)\n- [What is Postpartum Depression?](https:\/\/youtu.be\/6kV2_L3uSS0) (ADAA Video)\n- [Watch ADAA's Video on CBT](https:\/\/adaa.org\/about-adaa\/press-room\/multimedia\/what-cbt-cognitive-behavioral-therapy)\n- [The Wisdom of Cognitive Behavioral Therapy (CBT): The Perfect Gift for New Moms](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer\/wisdom-cognitive-behavioral-therapy-cbt-perfect)\n- To learn more in-depth about Postpartum Depression and medication, check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https:\/\/adaa.org\/node\/7421).\n\nNo\n\n#### Brain Treatments for Anxiety and Depression\n**Electroconvulsive Therapy (ECT) a**nd **Transcranial Magnetic Stimulation (TMS)** are brain treatments that may help people with depression and anxiety when other treatments, like medicine or [talk therapy](https:\/\/adaa.org\/find-help\/treatment-help\/types-of-therapy), have not worked.\n\n**Electroconvulsive therapy (ECT)** is useful for patients who are not responding well to medications or are suicidal. ECT is an effective treatment for patients who do not respond to drug therapy, are psychotic, or are suicidal or dangerous to themselves. Onset of action may be more rapid than that of drug treatments, with benefit often seen within one week of commencing treatment. The indications for the use of ECT include the following:\n\n- Failure of drug therapies\n- History of good response to ECT\n- Patient preference\n- High risk of suicide\n- High risk of medical morbidity and mortality\n\nAlthough advances in ECT treatment has improved the safety and tolerability of this modality there are some risks such as those associated with postictal confusion, and, more rarely, short-term memory difficulties.\n\n**Transcranial Magnetic Stimulation,** known as TMS or rTMS, may be a safe, effective, and noninvasive option for people who have depression that has not improved with medications. TMS creates a magnetic field to induce a small electric current in a specific part of the brain; the current comes from the magnetic field created by an electromagnetic coil that delivers pulses through the scalp. TMS is an FDA-approved treatment and recently (June 2019), the Brainsway Deep TMS device was approved for the treatment of OCD. There is ongoing research on the use of TMS to treat PTSD and other mental health conditions.\n\nTMS does not require sedation, is non-invasive and is virtually pain-free. With modern safety techniques, there is a less than 0.1% risk of seizure or loss of consciousness with TMS. Those receiving TMS usually are treated four or five times every week for four to six weeks. Research shows that TMS produces few side effects. Each treatment session lasts about 40 minutes. A new form of TMS called theta burst stimulation was recently approved by the FDA for the treatment of depression; sessions of theta burst stimulation last only about 10 minutes but still are provided daily for several weeks.\n\nTo find out if TMS is the right treatment for you, speak to your therapist, doctor, or other mental health treatment provider. Your insurance may provide reimbursement for this treatment.\n\n- [Learn more about TMS](https:\/\/adaa.org\/finding-help\/transcranial-magnetic-stimulation)\n- To learn more in-depth about TMS check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https:\/\/adaa.org\/node\/7421).\n\nNo\n\n#### ADAA Medication Information Resources\n- [Psychiatric Medication in Pregnancy and Lactation: What Can Women Take?](https:\/\/adaa.org\/webinar\/consumer\/psychiatric-medication-pregnancy-and-lactation-what-can-women-take), ADAA webinar\n- [Dear ChatGPT, Can You See Me? The Limits of AI in Healing Anxiety and Emotional Pain](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer\/ai-imits-with-healing-anxiety), ADAA blog post\n- [Medication for Treatment of OCD: Understanding the Options](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer-professional\/medication-treatment-ocd), ADAA blog post\n- [SSRIs and Benzodiazepines for General Anxiety Disorders (GAD)](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer\/ssris-and-benzodiazepines-general-anxiety), ADAA blog post\n- [Anxiety Medication Guide for Parents](https:\/\/adaa.org\/sites\/default\/files\/anxiety-parents-medication-guide.pdf), AACAP.org, written by ADAA member John Walkup, MD\n- [Can CBD Help with My Anxiety and Depression?](https:\/\/adaa.org\/understanding-anxiety\/cbd) - ADAA web page\n- [Psychotropic Medications: What You Should Ask Your Doctor](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer\/psychotropic-medications-what-you-should-ask) - ADAA blog post\n- [For My Anxiety or Depression: Should I Use Medication or Therapy](https:\/\/adaa.org\/webinar\/consumer\/my-anxiety-or-depression-should-i-use-medication-or-therapy) \\- ADAA webinar\n- [Generalized Anxiety Disorder (GAD)](https:\/\/adaa.org\/sites\/default\/files\/ADAA%20General%20Anxiety%20Brochure%20vF_digital.pdf) \\- ADAA Brochure\n- [Depression](https:\/\/adaa.org\/sites\/default\/files\/ADAA%20Depression%20Brochure%20Final.pdf) - ADAA Brochure\n- [Learn about mental health therapy types](https:\/\/adaa.org\/find-help\/treatment-help\/types-of-therapy)\n- [Visit ADAA's Find Your Therapist Directory to find a provider near you](https:\/\/findyourtherapist.adaa.org\/)\n- To learn more about medication and mental health therapy types check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https:\/\/adaa.org\/node\/7421).\n\nNo\n\n#### Important Resources and Patient Assistance Programs\nMost pharmaceutical companies offer patient-assistance programs for uninsured patients. These programs provide prescribed medication at little to no cost. Eligibility varies; see the [Partnership for Prescription Assistance website](https:\/\/www.pparx.org\/) for more information, or contact companies directly about their patient assistance programs.\n\n- [A New Patient Assistance Program Offering from Janssen. For Insured Patients Who Are Facing Access and Affordability Challenges. A Quick Reference Guide](https:\/\/adaa.org\/sites\/default\/files\/New%20Patient%20Assistance%20Offering%20From%20Janssen%20-%20Quick%20Reference%20Guide.pdf)\n- [NeedyMeds](http:\/\/www.needymeds.org\/) is a 501(c)(3) national non-profit information resource dedicated to helping people locate assistance programs to help them afford their medications and other healthcare costs.\n\n[Alliance for Safe Online Pharmacies](https:\/\/buysaferx.pharmacy\/)\n\nThe Alliance for Safe Online Pharmacies (ASOP Global), a 501(c)(4) non-profit organization is dedicated to protecting consumers around the world, ensuring safe access to medications, and combating illegal online drug sellers.\n\n[Visit ADAA's Find Your Therapist Directory to find a provider near you](https:\/\/findyourtherapist.adaa.org\/)\n\nNo\n\n\\#ffffff\n\nBoost Search Results\n\nOff\n\n[![What Is.. youtube series](https:\/\/adaa.org\/sites\/default\/files\/ADAA-what-is-eudcational-videos.png)](https:\/\/www.youtube.com\/playlist?list=PLfw5WkuDE3-4MY3fHAAIOUNVWWHzqcKzL)\n\n[Advertisement](https:\/\/adaa.org\/advertising \"More about the ads we serve\") [![Better Help Small](https:\/\/adaa.org\/sites\/default\/files\/Betterhelp_Logo_Simplified_0.png)](https:\/\/www.betterhelp.com\/online-therapy\/)\n\n[Advertisement](https:\/\/adaa.org\/advertising \"More about the ads we serve\")\n\nEducational Resources\n\nTips & Strategies from our Member Experts and Public Community\n\nBlock reference\n\n[![Image of woman with insomnia](https:\/\/adaa.org\/sites\/default\/files\/styles\/large\/public\/2026-03\/iStock-1629208680%20purchased%20insomnia%20female%20large_0.jpg?itok=VCOWinqc)](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer\/perimenopause-menopausal-transition-and-mental-health)   [![Image of woman with insomnia](https:\/\/adaa.org\/sites\/default\/files\/styles\/large\/public\/2026-03\/iStock-1629208680%20purchased%20insomnia%20female%20large.jpg?itok=4vXxy34I)](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer\/perimenopause-menopausal-transition-and-mental-health)\n\nBlog\n\n[Menopausal Transition and Mental Health: You're Not Crazy](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer\/perimenopause-menopausal-transition-and-mental-health)\n\nThe menopausal transition remains a period that is confusing for many women and medical doctors…\n\n[Read More](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer\/perimenopause-menopausal-transition-and-mental-health)\n\n[Load More](https:\/\/adaa.org\/find-help\/treatment-help\/medication-options \"Load more\")\n\nWebinar\n\n[PMDD: When the Menstrual Cycle Affects Mental Health](https:\/\/adaa.org\/webinar\/consumer\/pmdd-when-menstrual-cycle-affects-mental-health)\n\nThis presentation will review the symptoms of premenstrual dysphoric disorder (PMDD) and how to…\n\n[Read More](https:\/\/adaa.org\/webinar\/consumer\/pmdd-when-menstrual-cycle-affects-mental-health)\n\n[Load More](https:\/\/adaa.org\/find-help\/treatment-help\/medication-options \"Load more\")\n\n[![Ale Lasas smiling while she helps two people hold hands and meditate](https:\/\/adaa.org\/sites\/default\/files\/styles\/large\/public\/2026-03\/Ale%20Lasas.jpg?itok=cwK21OmK)](https:\/\/adaa.org\/living-with-anxiety\/personal-stories\/burnout-mental-health-finding-community)\n\nPERSONAL STORY\n\n[When High Performance Hid My Struggle With Mental Health](https:\/\/adaa.org\/living-with-anxiety\/personal-stories\/burnout-mental-health-finding-community)\n\nAle Lasas shares her experience with anxiety, depression, ADHD, and severe burnout and how…\n\n[Read More](https:\/\/adaa.org\/living-with-anxiety\/personal-stories\/burnout-mental-health-finding-community)\n\n[Load More](https:\/\/adaa.org\/find-help\/treatment-help\/medication-options \"Load more\")\n\n[Go to Educational Resources](https:\/\/adaa.org\/educational-resources)\n\nTake Action\n\nFind Help. Learn More. Support ADAA.\n\n[![Post Image](https:\/\/adaa.org\/sites\/default\/files\/styles\/img350x200\/public\/module%20images\/donate-today.png?itok=-sgVrK2m)](https:\/\/adaa.org\/donate)\n\n[Donate Today](https:\/\/adaa.org\/donate)\n\nYour support changes lives. Thank you\\!\n\n[Learn More](https:\/\/adaa.org\/donate)\n\n[![Post Image](https:\/\/adaa.org\/sites\/default\/files\/styles\/img350x200\/public\/module%20images\/get-involved-today.png?itok=grsh0NTP)](https:\/\/adaa.org\/ways-to-give)\n\n[Get Involved Today](https:\/\/adaa.org\/ways-to-give)\n\nShare your personal story.  \n Start a fundraiser.  \n Shop to support our mission and more.\n\n[Learn More](https:\/\/adaa.org\/ways-to-give)\n\n[![Post Image](https:\/\/adaa.org\/sites\/default\/files\/styles\/img350x200\/public\/2021-02\/find-therapist.png?itok=Tg0AqYcY)](https:\/\/findyourtherapist.adaa.org\/)\n\n[ADAA's Find Your Therapist](https:\/\/findyourtherapist.adaa.org\/)\n\nADAA’s Find Your Therapist Directory connects YOU with licensed mental health professionals who are experts in anxiety, depression, OCD, PTSD and co-occurring disorders.\n\n[Learn More](https:\/\/findyourtherapist.adaa.org\/)\n\n[![Post Image](https:\/\/adaa.org\/sites\/default\/files\/styles\/img350x200\/public\/module%20images\/Triumph%20Newsletter_Public%20Link%20Module.png?itok=HH1M9xqv)](https:\/\/adaa.informz.net\/adaa\/pages\/Triumph_Subscribe_page)\n\n[Triumph - Learn, Share Your Story, Access Resources](https:\/\/adaa.informz.net\/adaa\/pages\/Triumph_Subscribe_page)\n\nADAA's free monthly newsletter for our public community. Subscribe today\\!\n\n[Subscribe](https:\/\/adaa.informz.net\/adaa\/pages\/Triumph_Subscribe_page)\n\n[![Post Image](https:\/\/adaa.org\/sites\/default\/files\/styles\/img350x200\/public\/2023-08\/ADAA%20Free%20Peer-to-Peer%20Communities%20800%20X%20600.png?itok=36iLC_Z1)](https:\/\/adaa.org\/find-help\/support)\n\n[Free Peer to Peer Support Communities](https:\/\/adaa.org\/find-help\/support)\n\nADAA's four free online peer-to-peer communities for people suffering from mental health disorders provides a safe space for support, sharing experiences, and connecting with others.\n\n[Learn More](https:\/\/adaa.org\/find-help\/support)\n\n[![Post Image](https:\/\/adaa.org\/sites\/default\/files\/styles\/img350x200\/public\/thumbnails-feature\/books-small.png?itok=FFVC8h8y)](https:\/\/adaa.org\/books)\n\n[ADAA Self-Help Books – Bookstore\/Reading List](https:\/\/adaa.org\/books)\n\nExplore self-help and research-focused mental health books focusing on anxiety disorders and depression written by ADAA mental health experts. Purchases through Amazon benefit ADAA.\n\n[Learn More](https:\/\/adaa.org\/books)\n\nShare:\n\n[Facebook](https:\/\/adaa.org\/#facebook)\n\n[X](https:\/\/adaa.org\/#x)\n\n[LinkedIn](https:\/\/adaa.org\/#linkedin)\n\n[Email](https:\/\/adaa.org\/#email)\n\nThis page was updated 10\/15\/25\n\n![Logo](https:\/\/adaa.org\/sites\/default\/files\/menu-logos\/Footer%20Logo.svg)\n\n***If you are in crisis please dial 988 for the Suicide & Crisis Lifeline.*** ***Please note that ADAA is not a direct service organization. ADAA does not provide psychiatric, psychological, or medical advice, diagnosis, or treatment.***\n\n[Donate Today](https:\/\/donate.adaa.org\/give\/322300#!\/donation\/checkout) [Find Your Therapist](https:\/\/members.adaa.org\/page\/FATMain)\n\nContact us\n\n8701 Georgia Avenue\n\nSuite \\#412\n\nSilver Spring, MD 20910\n\n[Contact Us Now](https:\/\/adaa.org\/contact-us)\n\n[Professional Site](https:\/\/adaa.org\/professionals) [Conference Site](https:\/\/adaa.org\/adaa-conference-2026)\n\n- [Find Help](https:\/\/adaa.org\/find-help)\n- [What Are Anxiety and Depression?](https:\/\/adaa.org\/understanding-anxiety)\n- [Resources & News](https:\/\/adaa.org\/educational-resources)\n- [About ADAA](https:\/\/adaa.org\/about-adaa\/mission)\n- [Impact Report](https:\/\/adaa.org\/sites\/default\/files\/ADAA%202025%20Impact%20Report.pdf)\n\n- [Get Involved](https:\/\/adaa.org\/donate)\n- [Partnerships](https:\/\/adaa.org\/about-adaa\/partners)\n- [Media Kit](https:\/\/adaa.org\/about-adaa\/advertise-with-adaa)\n- [Media Inquiries](https:\/\/adaa.org\/about-adaa\/press-room\/media-inquiries)\n- [Triumph Newsletter](https:\/\/adaa.informz.net\/adaa\/pages\/Triumph_Subscribe_page)\n\n[FAQs](https:\/\/adaa.org\/professionals\/membership\/faqs)\n\n- [Do I have an anxiety disorder?](https:\/\/adaa.org\/understanding-anxiety\/faqs#n16)\n- [Are there different types of depression?](https:\/\/adaa.org\/understanding-anxiety\/depression\/faqs)\n- [What causes anxiety disorders?](https:\/\/adaa.org\/understanding-anxiety\/faqs#n17)\n- [How do I find the right mental health professional?](https:\/\/adaa.org\/understanding-anxiety\/faqs#n20)\n\nFollow Us\n\n- [Twitter](https:\/\/twitter.com\/ADAA_Anxiety)\n- [Facebook](https:\/\/www.facebook.com\/AnxietyAndDepressionAssociationOfAmerica?notif_t=page_new_likes)\n- [Instagram](https:\/\/www.instagram.com\/anxietyanddepression_adaa\/?hl=en)\n- [Youtube](https:\/\/www.youtube.com\/user\/GotAnxiety)\n- [Linkedin](https:\/\/www.linkedin.com\/company\/anxiety-and-depression-association-of-america\/)\n\nFounded in 1979, ADAA is an international nonprofit organization dedicated to the prevention, treatment, and cure of anxiety, depression, OCD, PTSD, and co-occurring disorders through aligning research, practice and education.\n\n[![American Brain Coalition Proud Member](https:\/\/adaa.org\/sites\/default\/files\/2021-03\/2008-ABC-member-seal-NP-1080.png)](https:\/\/www.americanbraincoalition.org\/)     [![https:\/\/www.americanbraincoalition.org\/](https:\/\/adaa.org\/sites\/default\/files\/2021-03\/GuideStar.1_0.png)](https:\/\/www.guidestar.org\/profile\/52-1248820)     [![Combined Federal Campaign (CFC)](https:\/\/adaa.org\/sites\/default\/files\/2021-03\/CFCLogo2011.png)](https:\/\/www.opm.gov\/combined-federal-campaign\/)     [![National Institute for Behavioral Health](https:\/\/adaa.org\/sites\/default\/files\/2021-03\/nimh-logo.png)](https:\/\/www.nimh.nih.gov\/outreach\/partnership-program\/index.shtml)     [![Mental Health Liaison Group](https:\/\/adaa.org\/sites\/default\/files\/2021-03\/MHLGLogo-1_0.png)](https:\/\/www.mhlg.org\/)     [![Health and Medical Research](https:\/\/adaa.org\/sites\/default\/files\/2021-03\/HMRLogo_Web.png)](https:\/\/www.hmr.org\/home\/)\n\n© 2026 ADAA. All rights reserved.\n\n- [Privacy Policy](https:\/\/adaa.org\/privacy-policy)\n- [Website Disclaimer](https:\/\/adaa.org\/website-disclaimer)\n- [Webinar Notice](https:\/\/adaa.org\/webinar-notice)\n\n## We use cookies on this site to enhance your user experience\nBy clicking the Accept button, you agree to us doing so.\n\nMore info\n\nAccept\n\nNo, thanks\n\n✓\n\nThanks for sharing\\!\n\n[AddToAny](https:\/\/www.addtoany.com\/ \"Share Buttons\")\n\n[More…](https:\/\/adaa.org\/find-help\/treatment-help\/medication-options#addtoany \"Show all\")","attrs_readable_markdown":"Medication can be a safe, effective, and evidence-based option for treating anxiety disorders and depression. Many people take medication alone or in combination [with therapy](https:\/\/adaa.org\/find-help\/treatment-help\/types-of-therapy) to help manage symptoms and improve daily functioning.\n\nIt's essential to recognize that medication is only one component of a comprehensive treatment approach. Other evidence-based options, such as psychotherapy, transcranial magnetic stimulation (TMS), and electroconvulsive therapy (ECT), may be recommended depending on an individual’s needs and treatment goals. These approaches can be used alone or in combination with medication to maximize effectiveness.\n\nFinding the right medication or treatment plan often requires patience, collaboration with a healthcare provider, and adjustments along the way. When used appropriately, medications can significantly reduce symptoms of anxiety and depression and support a return to balance and quality of life.\n\nAlways consult a healthcare provider before starting, changing, or stopping medication. The right treatment depends on your symptoms, medical history, and individual needs. Finding the right medication—whether antidepressants, anti-anxiety medications, or a combination, often takes time, patience, and close collaboration with your doctor or nurse practitioner.\n\n**Discussing Medications - What You Need to Know:**\n\n**Use these guidelines to talk to your health care professional about medications:**\n\n- To avoid potentially dangerous drug interactions, let your mental health care provider know all medications you are taking, including prescriptions and over-the-counter drugs, herbal or dietary supplements, and vitamins. And make sure your family doctor knows you are taking medicines for an anxiety disorder.\n- Learn when to take a new medication and how, such as on an empty stomach or with food, in the morning or evening, and how frequently.\n- Find out how long it should take for the medication to start working and what you should expect when this happens.\n- Ask: How will the medication help me? What side effects might occur? Should I avoid any foods or beverages? Are drug interactions with other prescriptions a possibility? How often should you see the doctor for a medication check-up?\n- Ask for the prescribing physician’s after-hours phone number in case you develop side effects.\n- A good source of information about medications and over-the-counter products is your pharmacist, who should have information about all your prescriptions to advise you about possible drug interactions, side effects, and instructions for use.\n\nIf your physician does not want to spend the time to answer your questions, you may need a referral to a different physician.\n\nMedications are commonly prescribed by physicians (family practice, pediatricians, OB-GYNs, psychiatrists), as well as nurse practitioners in many states.\n\n**There are four major classes of medications that are used in the treatment of anxiety disorders**:\n\nQ\\&A\n\nWhat to Ask Your Doctor Before Starting a New Antidepressant or an Emerging Treatment\n\n1. Is this new drug\/treatment appropriate for me?\n2. What are the drawbacks, if any of this new treatment?\n3. What might be the benefits over my current regimen?\n4. Is the price (typically high when a drug is new) worth the added benefit?\n5. Is this treatment ready for widespread use? Meaning, does it have safety established? Do we know how long people need to be on this treatment? Do we know about any long term issues that could result from this?\n\nNo\n\nSelective Serotonin Reuptake Inhibitors (SSRIs)\n\nSSRIs relieve symptoms by blocking the reabsorption, or reuptake, of serotonin by certain nerve cells in the brain. This leaves more serotonin available, which improves mood. SSRIs (citalopram, escitalopram, fluoxetine, paroxetine, and sertraline) generally produced fewer side effects when compared with tricyclic antidepressants. However, common side effects include insomnia or sleepiness, sexual dysfunction, and weight gain. They are considered an effective treatment for all anxiety disorders, although the treatment of obsessive-compulsive disorder, or OCD, typically requires higher doses. [Read this blog about SSRIs and Benzodiazepines](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer\/ssris-and-benzodiazepines-general-anxiety).\n\n- Trintellix (vortioxetine) is a prescription antidepressant used to treat major depressive disorder in adults. It works by affecting serotonin activity in the brain, which can help improve mood, cognition, and overall functioning.\n- Viibryd (vilazodone) is a prescription antidepressant used to treat major depressive disorder (MDD) in adults. It works by increasing serotonin activity in the brain and is classified as a selective serotonin reuptake inhibitor (SSRI) and partial serotonin receptor.\n\nTo learn more in-depth about Selective Serotonin Reuptake Inhibitors (SSRIs), check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https:\/\/adaa.org\/node\/7421).\n\nNo\n\nSerotonin-Norepinephrine Reuptake Inhibitors (SNRIs)\n\nThe serotonin-norepinephrine reuptake inhibitor, or SNRI, class (venlafaxine and duloxetine) is notable for a dual mechanism of action: increasing the levels of the neurotransmitters serotonin and norepinephrine by inhibiting their reabsorption into cells in the brain. As with other medications, side effects may occur, including stomach upset, insomnia, headache, sexual dysfunction, weight gain and minor increase in blood pressure. These medications are considered as effective as SSRIs, so they are also considered a first-line treatment for the treatment of anxiety disorders, but not for obsessive compulsive disorder, where SSRI’s are the preferred first line treatment.\n\n- **Pristiq** is used to treat major depressive disorder in adults. It works by increasing levels of serotonin and norepinephrine in the brain to help improve mood, energy, and interest in daily activities.\n- **Fetzima** is prescribed for major depressive disorder in adults. It helps balance serotonin and norepinephrine, with a relatively stronger effect on norepinephrine, which may improve mood, concentration, and physical energy.\n\nTo learn more in-depth about Selective Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https:\/\/adaa.org\/node\/7421).\n\nNo\n\nBenzodiazepines\n\nThis class of drugs is frequently used for short-term management of anxiety and as an add on treatment, in treatment resistant anxiety disorders. They are not recommended as a treatment for Post Traumatic Stress Disorder. Benzodiazepines (alprazolam, clonazepam, diazepam, and lorazepam) are highly effective in promoting relaxation and reducing muscular tension and other physical symptoms of anxiety. Long-term use may require increased doses to achieve the same effect, which may lead to problems related to tolerance and dependence. [Read this blog post about SSRIs and Benzodiazepines](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer\/ssris-and-benzodiazepines-general-anxiety).\n\nTo learn more in-depth about Benzodiazepines, check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https:\/\/adaa.org\/node\/7421).\n\nNo\n\nTricyclic Antidepressants\n\nConcerns about long-term use of the benzodiazepines led many doctors to favor tricyclic antidepressants (amitriptyline, imipramine, and nortriptyline). Although effective in the treatment of some anxiety disorders(but not Social Anxiety Disorder), they can cause significant side effects, including orthostatic hypotension (drop in blood pressure on standing), constipation, urinary retention, dry mouth, and blurry vision.\n\nContact your physician if you experience side effects, even if you are not sure a symptom is caused by a medication. Do not stop taking a medication without consulting with the prescribing physician; abrupt discontinuation may cause other health risks.\n\nMedications will work only if they are taken according the explicit instructions of your physician, but they may not resolve all symptoms of an anxiety disorder. [Learn more about how antidepressants work.](https:\/\/adaa.org\/sites\/default\/files\/SomberQuestions_Antidepressants.pdf)\n\nTo learn more in-depth about Tricyclic Antidepressants, check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https:\/\/adaa.org\/node\/7421).\n\nNo\n\nEmerging Medications\n\n**Ketamine (Esketamine)**\n\nKetamine represents a major step forward in the treatment of depression and suicide prevention. Read [ADAA's Public Statement](https:\/\/adaa.org\/sites\/default\/files\/ADAA%20March%202019%20FDA%20Esketamine%20Statement_0.pdf) regarding 2019 FDA approved nasal spray medication- Spravato (esketamine) for treatment resistant depression,available only at a certified doctor’s office or clinic.\n\nTo learn more in-depth about **Ketamine (Esketamine)****,** check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https:\/\/adaa.org\/node\/7421).\n\n- [Ketamine: A Rising Star in Mental Health Treatment](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer-professional\/ketamine-rising-star-mental-health), ADAA blog post\n- [Ketamine Fact Sheet](https:\/\/adaa.org\/sites\/default\/files\/2024-02\/Ketamine%202024%20Fact%20Sheet.pdf) (Infographic)\n- [Researchers discover positive effects of intravenous ketamine for treatment-resistant depression](http:\/\/bcm.edu\/news\/researchers-discover-positive-effects-of-intravenous-ketamine-for-treatment-resistant-depression), Baylor College of Medicine, Sanjay Mathews, MD\n\n**Additional Research Studies About Ketamine and Psychedelics: Posted April 2021**\n\nAMJ Psychiatry 2020 Issue: [S*ynthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation*](https:\/\/adaa.org\/sites\/default\/files\/module%20images\/%231153%20Amer%20J%20Psy%20Synthesizing%20the%20Evidence%20for%20Ketamine%20and%20Esketamine%20in%20Treatment-Resistant%20Depression.pdf)*,* Roger S. McIntyre, M.D., Joshua D. Rosenblat, M.D., M.Sc., (ADAA President Elect and CMO) Charles B. Nemeroff, M.D., Ph.D., Gerard Sanacora, M.D., Ph.D., (ADAA member) James W. Murrough, M.D., Ph.D., Michael Berk, Ph.D., M.B.B.Ch., Elisa Brietzke, M.D., Ph.D., Seetal Dodd, Ph.D.,Philip Gorwood, M.D., Ph.D., Roger Ho, M.D., M.B.B.S., Dan V. Iosifescu, M.D., Carlos Lopez Jaramillo, M.D., Ph.D., Siegfried Kasper, M.D., Kevin Kratiuk, B.Pharm., Jung Goo Lee, M.D., Ph.D., Yena Lee, H.B.Sc., Leanna M.W. Lui, Rodrigo B. Mansur, M.D., Ph.D., George I. Papakostas, M.D., Mehala Subramaniapillai, M.Sc., (ADAA member) Michael Thase, M.D., Eduard Vieta, M.D., Ph.D., Allan H. Young, M.Phil., M.B.Ch.B., Carlos A. Zarate, Jr., M.D., Stephen Stahl, M.D., Ph.D.\n\nIn this article, an international group of mood disorder experts provides a synthesis of the literature with respect to the efficacy, safety, and tolerability of ketamine and esketamine in adults with treatment-resistant depression. The authors also provide guidance for the implementation of these agents in clinical practice, with particular attention to practice parameters at point of care. Areas of consensus and future research vistas are discussed.\n\n[A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders](https:\/\/adaa.org\/sites\/default\/files\/Ketamine%20JAMA%20Journal%20Article%20-%20Charlie%20Nemeroff.pdf), JAMA Psychiatry, April 2017, Gerard Sanacora, MD, PhD; Mark A. Frye, MD; William McDonald, MD; ADAA Board Member Sanjay J. Mathew, MD; Mason S. Turner, MD; ADAA member Alan F. Schatzberg, MD; Paul Summergrad, MD; ADAA Board Member and Chief Medical Officer Charles B. Nemeroff, MD, PhD; for the American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments\n\n[*Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study*](https:\/\/adaa.org\/sites\/default\/files\/Canuso-AJP-2018.pdf)*,* American Journal, 2018\n\n[*Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)*](https:\/\/adaa.org\/sites\/default\/files\/Fava_et_al-2018-Molecular_Psychiatry.pdf), Molecular Psychiatry, September 2018\n\n**Medical Marijuana\/Cannabis\/CBD**\n\n- [Can CBD Help with My Anxiety and Depression?](https:\/\/adaa.org\/understanding-anxiety\/cbd) ADAA blog post\n\n**Psychedelics**\n\nSeveral psychedelic medicines including psilocybin and MDMA are undergoing FDA-regulated clinical trials for treatment-resistant depression, PTSD, and related conditions. However, as of late 2025, none have received U.S. regulatory approval and they remain classified as DEA Schedule 1 drugs.\n\nAs this is a rapidly evolving area, ADAA is committed to providing timely updates on this topic as new data emerges. Learn more:\n\n- [Psychedelic Therapy: Promises and Problems](https:\/\/adaa.org\/webinar\/professional\/psychedelic-therapy-problems-and-promises), ADAA Professional Webinar (Recorded live October 27,2022)\n- [Single-Dose Psilocybin for a Treatment-Resistant Episode](https:\/\/adaa.org\/sites\/default\/files\/Goodwin-NEJM-2022-PsilocybinTRD.pdf) - New England Journal if Medicine, November 3, 2022\n- [How MDMA Resensitizes the Brain,](https:\/\/www.nature.com\/articles\/d41586-022-02871-w) Nature, September 28, 2022\n- [MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study](https:\/\/adaa.org\/sites\/default\/files\/MDMAPTSD-NatMed2021.pdf), Nature Medicine, October 2021\n- [Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine](https:\/\/adaa.org\/sites\/default\/files\/DeGregorio-Hallucinogens-JNeuro2021.pdf), The Journal of Neuroscience, February 3, 2021\n- [*Psychedelics and Psychedelic-Assisted Psychotherapy*](https:\/\/adaa.org\/sites\/default\/files\/module%20images\/%231128%20AJP%20-%20Psychedelics%20and%20Psychedelic%20Assisted%20Psychotherapy.pdf)***.*** **AMJ Psychiatry 2020 Issue:**Collin M. Reiff, M.D., Elon E. Richman, M.D., (ADAA President Elect and CMO) Charles B. Nemeroff, M.D., Ph.D., Linda L. Carpenter, M.D., Alik S. Widge, M.D., Ph.D., Carolyn I. Rodriguez, M.D., Ph.D., (ADAA member) Ned H. Kalin, M.D., William M. McDonald, M.D., and the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research\n  - Objective: The authors provide an evidenced-based summary of the literature on the clinical application of psychedelic drugs in psychiatric disorders.\n  - Results: The most significant database exists for MDMA and psilocybin, which have been designated by the U.S. Food and Drug Administration (FDA) as “breakthrough therapies” for posttraumatic stress disorder (PTSD) and treatment-resistant depression, respectively. The research on LSD and ayahuascais observational, but available evidence suggests that these agents may have therapeutic effects in specific psychiatric disorders.\n  - Conclusions: Randomized clinical trials support the efficacy of MDMA in the treatment of PTSD and psilocybin in the treatment of depression and cancer-related anxiety. The research to support the use of LSD and ayahuasca in the treatment of psychiatric disorders is preliminary, although promising. Overall, the database is insufficient for FDA approval of any psychedelic compound for routine clinical use in psychiatric disorders at this time, but continued research on the efficacy of psychedelics for the treatment of psychiatric disorders is warranted.\n- To learn more in-depth about medications, check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https:\/\/adaa.org\/node\/7421).\n\nNo\n\nMedications That Can Help with Obsessive–Compulsive Disorder (OCD)\n\nMedications can help reduce the symptoms of obsessive–compulsive disorder (OCD). The most prescribed are a type of antidepressant called SSRIs (selective serotonin reuptake inhibitors) (see above). Although their name suggests they are only for depression, SSRIs are also effective in treating OCD. These medicines work by helping to balance brain chemicals that affect mood, anxiety, and repetitive thoughts or behaviors.  \nIt may take several weeks to start noticing improvements. Your doctor will work with you to find the right dose, explain possible side effects, and answer any questions you have. Medication is often most effective when combined with therapy, especially cognitive behavioral therapy (CBT) that is designed for OCD.\n\n**ADAA Resources**\n\n- [The Role of Antipsychotics in OCD](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/professional\/role-antipsychotics-ocd)\n- [Medication for Treatment of OCD: Understanding the Options](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer-professional\/medication-treatment-ocd)\n- [What is Obsessive- Compulsive Disorder?](https:\/\/adaa.org\/understanding-anxiety\/co-occurring-disorders\/obsessive-compulsive-disorder) (website page)\n- [What is Obsessive-Compulsive Disorder (OCD)?](https:\/\/adaa.org\/about-adaa\/press-room\/multimedia\/what-obsessive-compulsive-disorder-ocd) (short video)\n- To learn more in-depth about OCD and medication, check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https:\/\/adaa.org\/node\/7421).\n\nNo\n\nMedications and Cognitive Behavioral Therapy (CBT) for Postpartum Depression\n\nPostpartum depression can be treated with certain antidepressant medicines that help balance brain chemicals linked to mood. These medicines can ease sadness, worry, and low energy, making it easier for new parents to feel better and care for themselves and their baby.\n\nIn addition to medication, **Cognitive Behavioral Therapy (CBT)** is a highly effective treatment for postpartum depression. CBT helps individuals recognize and change unhelpful thought patterns, develop healthier coping strategies, and build problem-solving skills. It focuses on the connection between thoughts, emotions, and behaviors, empowering new parents to manage stress, reduce negative thinking, and improve overall well-being.\n\nPostpartum depression can be treated with certain antidepressant medicines that help balance brain chemicals linked to mood. These medicines can ease sadness, worry, and low energy, making it easier for new parents to feel better and care for themselves and their baby.\n\n- [Learn more about CBT and other therapy types](https:\/\/adaa.org\/find-help\/treatment-help\/types-of-therapy)\n- [Learn more about postpartum disorders](https:\/\/adaa.org\/find-help-for\/women\/postpartum-disorders?utm_source=chatgpt.com)\n- [Learn about postpartum depression](https:\/\/adaa.org\/living-with-anxiety\/women\/postpartum-depression)\n- [What is Postpartum Depression?](https:\/\/youtu.be\/6kV2_L3uSS0) (ADAA Video)\n- [Watch ADAA's Video on CBT](https:\/\/adaa.org\/about-adaa\/press-room\/multimedia\/what-cbt-cognitive-behavioral-therapy)\n- [The Wisdom of Cognitive Behavioral Therapy (CBT): The Perfect Gift for New Moms](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer\/wisdom-cognitive-behavioral-therapy-cbt-perfect)\n- To learn more in-depth about Postpartum Depression and medication, check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https:\/\/adaa.org\/node\/7421).\n\nNo\n\nBrain Treatments for Anxiety and Depression\n\n**Electroconvulsive Therapy (ECT) a**nd **Transcranial Magnetic Stimulation (TMS)** are brain treatments that may help people with depression and anxiety when other treatments, like medicine or [talk therapy](https:\/\/adaa.org\/find-help\/treatment-help\/types-of-therapy), have not worked.\n\n**Electroconvulsive therapy (ECT)** is useful for patients who are not responding well to medications or are suicidal. ECT is an effective treatment for patients who do not respond to drug therapy, are psychotic, or are suicidal or dangerous to themselves. Onset of action may be more rapid than that of drug treatments, with benefit often seen within one week of commencing treatment. The indications for the use of ECT include the following:\n\n- Failure of drug therapies\n- History of good response to ECT\n- Patient preference\n- High risk of suicide\n- High risk of medical morbidity and mortality\n\nAlthough advances in ECT treatment has improved the safety and tolerability of this modality there are some risks such as those associated with postictal confusion, and, more rarely, short-term memory difficulties.\n\n**Transcranial Magnetic Stimulation,** known as TMS or rTMS, may be a safe, effective, and noninvasive option for people who have depression that has not improved with medications. TMS creates a magnetic field to induce a small electric current in a specific part of the brain; the current comes from the magnetic field created by an electromagnetic coil that delivers pulses through the scalp. TMS is an FDA-approved treatment and recently (June 2019), the Brainsway Deep TMS device was approved for the treatment of OCD. There is ongoing research on the use of TMS to treat PTSD and other mental health conditions.\n\nTMS does not require sedation, is non-invasive and is virtually pain-free. With modern safety techniques, there is a less than 0.1% risk of seizure or loss of consciousness with TMS. Those receiving TMS usually are treated four or five times every week for four to six weeks. Research shows that TMS produces few side effects. Each treatment session lasts about 40 minutes. A new form of TMS called theta burst stimulation was recently approved by the FDA for the treatment of depression; sessions of theta burst stimulation last only about 10 minutes but still are provided daily for several weeks.\n\nTo find out if TMS is the right treatment for you, speak to your therapist, doctor, or other mental health treatment provider. Your insurance may provide reimbursement for this treatment.\n\n- [Learn more about TMS](https:\/\/adaa.org\/finding-help\/transcranial-magnetic-stimulation)\n- To learn more in-depth about TMS check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https:\/\/adaa.org\/node\/7421).\n\nNo\n\nADAA Medication Information Resources\n\n- [Psychiatric Medication in Pregnancy and Lactation: What Can Women Take?](https:\/\/adaa.org\/webinar\/consumer\/psychiatric-medication-pregnancy-and-lactation-what-can-women-take), ADAA webinar\n- [Dear ChatGPT, Can You See Me? The Limits of AI in Healing Anxiety and Emotional Pain](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer\/ai-imits-with-healing-anxiety), ADAA blog post\n- [Medication for Treatment of OCD: Understanding the Options](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer-professional\/medication-treatment-ocd), ADAA blog post\n- [SSRIs and Benzodiazepines for General Anxiety Disorders (GAD)](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer\/ssris-and-benzodiazepines-general-anxiety), ADAA blog post\n- [Anxiety Medication Guide for Parents](https:\/\/adaa.org\/sites\/default\/files\/anxiety-parents-medication-guide.pdf), AACAP.org, written by ADAA member John Walkup, MD\n- [Can CBD Help with My Anxiety and Depression?](https:\/\/adaa.org\/understanding-anxiety\/cbd) - ADAA web page\n- [Psychotropic Medications: What You Should Ask Your Doctor](https:\/\/adaa.org\/learn-from-us\/from-the-experts\/blog-posts\/consumer\/psychotropic-medications-what-you-should-ask) - ADAA blog post\n- [For My Anxiety or Depression: Should I Use Medication or Therapy](https:\/\/adaa.org\/webinar\/consumer\/my-anxiety-or-depression-should-i-use-medication-or-therapy) \\- ADAA webinar\n- [Generalized Anxiety Disorder (GAD)](https:\/\/adaa.org\/sites\/default\/files\/ADAA%20General%20Anxiety%20Brochure%20vF_digital.pdf) \\- ADAA Brochure\n- [Depression](https:\/\/adaa.org\/sites\/default\/files\/ADAA%20Depression%20Brochure%20Final.pdf) - ADAA Brochure\n- [Learn about mental health therapy types](https:\/\/adaa.org\/find-help\/treatment-help\/types-of-therapy)\n- [Visit ADAA's Find Your Therapist Directory to find a provider near you](https:\/\/findyourtherapist.adaa.org\/)\n- To learn more about medication and mental health therapy types check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https:\/\/adaa.org\/node\/7421).\n\nNo\n\nImportant Resources and Patient Assistance Programs\n\nMost pharmaceutical companies offer patient-assistance programs for uninsured patients. These programs provide prescribed medication at little to no cost. Eligibility varies; see the [Partnership for Prescription Assistance website](https:\/\/www.pparx.org\/) for more information, or contact companies directly about their patient assistance programs.\n\n- [A New Patient Assistance Program Offering from Janssen. For Insured Patients Who Are Facing Access and Affordability Challenges. A Quick Reference Guide](https:\/\/adaa.org\/sites\/default\/files\/New%20Patient%20Assistance%20Offering%20From%20Janssen%20-%20Quick%20Reference%20Guide.pdf)\n- [NeedyMeds](http:\/\/www.needymeds.org\/) is a 501(c)(3) national non-profit information resource dedicated to helping people locate assistance programs to help them afford their medications and other healthcare costs.\n\n[Alliance for Safe Online Pharmacies](https:\/\/buysaferx.pharmacy\/)\n\nThe Alliance for Safe Online Pharmacies (ASOP Global), a 501(c)(4) non-profit organization is dedicated to protecting consumers around the world, ensuring safe access to medications, and combating illegal online drug sellers.\n\n[Visit ADAA's Find Your Therapist Directory to find a provider near you](https:\/\/findyourtherapist.adaa.org\/)\n\nNo\n\n\\#ffffff\n\nBoost Search Results\n\nOff","meta_canonical":null}

3. Robots.txt Check

Query:

Response:

4. Spam/Ban Check

Query:

Response:

5. Seen Status Check

ℹ️ Skipped - page is already crawled

📄

INDEXABLE

✅

CRAWLED

9 hours ago

🤖

ROBOTS ALLOWED

Page Info Filters

Filter	Status	Condition	Details
HTTP status	PASS	`download_http_code = 200`	HTTP 200
Age cutoff	PASS	`download_stamp > now() - 6 MONTH`	0 months ago
History drop	PASS	`isNull(history_drop_reason)`	No drop reason
Spam/ban	PASS	`fh_dont_index != 1 AND ml_spam_score = 0`	ml_spam_score=0
Canonical	PASS	`meta_canonical IS NULL OR = '' OR = src_unparsed`	Not set

Page Details

Property	Value
URL	https://adaa.org/find-help/treatment-help/medication-options
Last Crawled	2026-04-11 01:32:12 (9 hours ago)
First Indexed	2021-02-22 08:52:34 (5 years ago)
HTTP Status Code	200
Meta Title	Medication and Other Treatment Options for Anxiety Disorders and Depression
Meta Description	null
Meta Canonical	null
Boilerpipe Text	Medication can be a safe, effective, and evidence-based option for treating anxiety disorders and depression. Many people take medication alone or in combination with therapy to help manage symptoms and improve daily functioning. It's essential to recognize that medication is only one component of a comprehensive treatment approach. Other evidence-based options, such as psychotherapy, transcranial magnetic stimulation (TMS), and electroconvulsive therapy (ECT), may be recommended depending on an individual’s needs and treatment goals. These approaches can be used alone or in combination with medication to maximize effectiveness. Finding the right medication or treatment plan often requires patience, collaboration with a healthcare provider, and adjustments along the way. When used appropriately, medications can significantly reduce symptoms of anxiety and depression and support a return to balance and quality of life. Always consult a healthcare provider before starting, changing, or stopping medication. The right treatment depends on your symptoms, medical history, and individual needs. Finding the right medication—whether antidepressants, anti-anxiety medications, or a combination, often takes time, patience, and close collaboration with your doctor or nurse practitioner. Discussing Medications - What You Need to Know: Use these guidelines to talk to your health care professional about medications: To avoid potentially dangerous drug interactions, let your mental health care provider know all medications you are taking, including prescriptions and over-the-counter drugs, herbal or dietary supplements, and vitamins. And make sure your family doctor knows you are taking medicines for an anxiety disorder. Learn when to take a new medication and how, such as on an empty stomach or with food, in the morning or evening, and how frequently. Find out how long it should take for the medication to start working and what you should expect when this happens. Ask: How will the medication help me? What side effects might occur? Should I avoid any foods or beverages? Are drug interactions with other prescriptions a possibility? How often should you see the doctor for a medication check-up? Ask for the prescribing physician’s after-hours phone number in case you develop side effects. A good source of information about medications and over-the-counter products is your pharmacist, who should have information about all your prescriptions to advise you about possible drug interactions, side effects, and instructions for use. If your physician does not want to spend the time to answer your questions, you may need a referral to a different physician. Medications are commonly prescribed by physicians (family practice, pediatricians, OB-GYNs, psychiatrists), as well as nurse practitioners in many states. There are four major classes of medications that are used in the treatment of anxiety disorders : Q&A What to Ask Your Doctor Before Starting a New Antidepressant or an Emerging Treatment Is this new drug/treatment appropriate for me? What are the drawbacks, if any of this new treatment? What might be the benefits over my current regimen? Is the price (typically high when a drug is new) worth the added benefit? Is this treatment ready for widespread use? Meaning, does it have safety established? Do we know how long people need to be on this treatment? Do we know about any long term issues that could result from this? No Selective Serotonin Reuptake Inhibitors (SSRIs) SSRIs relieve symptoms by blocking the reabsorption, or reuptake, of serotonin by certain nerve cells in the brain. This leaves more serotonin available, which improves mood. SSRIs (citalopram, escitalopram, fluoxetine, paroxetine, and sertraline) generally produced fewer side effects when compared with tricyclic antidepressants. However, common side effects include insomnia or sleepiness, sexual dysfunction, and weight gain. They are considered an effective treatment for all anxiety disorders, although the treatment of obsessive-compulsive disorder, or OCD, typically requires higher doses. Read this blog about SSRIs and Benzodiazepines . Trintellix (vortioxetine) is a prescription antidepressant used to treat major depressive disorder in adults. It works by affecting serotonin activity in the brain, which can help improve mood, cognition, and overall functioning. Viibryd (vilazodone) is a prescription antidepressant used to treat major depressive disorder (MDD) in adults. It works by increasing serotonin activity in the brain and is classified as a selective serotonin reuptake inhibitor (SSRI) and partial serotonin receptor. To learn more in-depth about Selective Serotonin Reuptake Inhibitors (SSRIs), check out ADAA's Patient Guide to Mood and Anxiety Disorders . No Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) The serotonin-norepinephrine reuptake inhibitor, or SNRI, class (venlafaxine and duloxetine) is notable for a dual mechanism of action: increasing the levels of the neurotransmitters serotonin and norepinephrine by inhibiting their reabsorption into cells in the brain. As with other medications, side effects may occur, including stomach upset, insomnia, headache, sexual dysfunction, weight gain and minor increase in blood pressure. These medications are considered as effective as SSRIs, so they are also considered a first-line treatment for the treatment of anxiety disorders, but not for obsessive compulsive disorder, where SSRI’s are the preferred first line treatment. Pristiq is used to treat major depressive disorder in adults. It works by increasing levels of serotonin and norepinephrine in the brain to help improve mood, energy, and interest in daily activities. Fetzima is prescribed for major depressive disorder in adults. It helps balance serotonin and norepinephrine, with a relatively stronger effect on norepinephrine, which may improve mood, concentration, and physical energy. To learn more in-depth about Selective Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), check out ADAA's Patient Guide to Mood and Anxiety Disorders . No Benzodiazepines This class of drugs is frequently used for short-term management of anxiety and as an add on treatment, in treatment resistant anxiety disorders. They are not recommended as a treatment for Post Traumatic Stress Disorder. Benzodiazepines (alprazolam, clonazepam, diazepam, and lorazepam) are highly effective in promoting relaxation and reducing muscular tension and other physical symptoms of anxiety. Long-term use may require increased doses to achieve the same effect, which may lead to problems related to tolerance and dependence. Read this blog post about SSRIs and Benzodiazepines . To learn more in-depth about Benzodiazepines, check out ADAA's Patient Guide to Mood and Anxiety Disorders . No Tricyclic Antidepressants Concerns about long-term use of the benzodiazepines led many doctors to favor tricyclic antidepressants (amitriptyline, imipramine, and nortriptyline). Although effective in the treatment of some anxiety disorders(but not Social Anxiety Disorder), they can cause significant side effects, including orthostatic hypotension (drop in blood pressure on standing), constipation, urinary retention, dry mouth, and blurry vision. Contact your physician if you experience side effects, even if you are not sure a symptom is caused by a medication. Do not stop taking a medication without consulting with the prescribing physician; abrupt discontinuation may cause other health risks. Medications will work only if they are taken according the explicit instructions of your physician, but they may not resolve all symptoms of an anxiety disorder. Learn more about how antidepressants work. To learn more in-depth about Tricyclic Antidepressants, check out ADAA's Patient Guide to Mood and Anxiety Disorders . No Emerging Medications Ketamine (Esketamine) Ketamine represents a major step forward in the treatment of depression and suicide prevention. Read ADAA's Public Statement regarding 2019 FDA approved nasal spray medication- Spravato (esketamine) for treatment resistant depression, available only at a certified doctor’s office or clinic. To learn more in-depth about Ketamine (Esketamine) , check out ADAA's Patient Guide to Mood and Anxiety Disorders . Ketamine: A Rising Star in Mental Health Treatment , ADAA blog post Ketamine Fact Sheet (Infographic) Researchers discover positive effects of intravenous ketamine for treatment-resistant depression , Baylor College of Medicine, Sanjay Mathews, MD Additional Research Studies About Ketamine and Psychedelics: Posted April 2021 AMJ Psychiatry 2020 Issue: S ynthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation , Roger S. McIntyre, M.D., Joshua D. Rosenblat, M.D., M.Sc., (ADAA President Elect and CMO) Charles B. Nemeroff, M.D., Ph.D., Gerard Sanacora, M.D., Ph.D., (ADAA member) James W. Murrough, M.D., Ph.D., Michael Berk, Ph.D., M.B.B.Ch., Elisa Brietzke, M.D., Ph.D., Seetal Dodd, Ph.D.,Philip Gorwood, M.D., Ph.D., Roger Ho, M.D., M.B.B.S., Dan V. Iosifescu, M.D., Carlos Lopez Jaramillo, M.D., Ph.D., Siegfried Kasper, M.D., Kevin Kratiuk, B.Pharm., Jung Goo Lee, M.D., Ph.D., Yena Lee, H.B.Sc., Leanna M.W. Lui, Rodrigo B. Mansur, M.D., Ph.D., George I. Papakostas, M.D., Mehala Subramaniapillai, M.Sc., (ADAA member) Michael Thase, M.D., Eduard Vieta, M.D., Ph.D., Allan H. Young, M.Phil., M.B.Ch.B., Carlos A. Zarate, Jr., M.D., Stephen Stahl, M.D., Ph.D. In this article, an international group of mood disorder experts provides a synthesis of the literature with respect to the efficacy, safety, and tolerability of ketamine and esketamine in adults with treatment-resistant depression. The authors also provide guidance for the implementation of these agents in clinical practice, with particular attention to practice parameters at point of care. Areas of consensus and future research vistas are discussed. A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders , JAMA Psychiatry, April 2017, Gerard Sanacora, MD, PhD; Mark A. Frye, MD; William McDonald, MD; ADAA Board Member Sanjay J. Mathew, MD; Mason S. Turner, MD; ADAA member Alan F. Schatzberg, MD; Paul Summergrad, MD; ADAA Board Member and Chief Medical Officer Charles B. Nemeroff, MD, PhD; for the American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study , American Journal, 2018 Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) , Molecular Psychiatry, September 2018 Medical Marijuana/Cannabis/CBD Can CBD Help with My Anxiety and Depression? ADAA blog post Psychedelics Several psychedelic medicines including psilocybin and MDMA are undergoing FDA-regulated clinical trials for treatment-resistant depression, PTSD, and related conditions. However, as of late 2025, none have received U.S. regulatory approval and they remain classified as DEA Schedule 1 drugs. As this is a rapidly evolving area, ADAA is committed to providing timely updates on this topic as new data emerges. Learn more: Psychedelic Therapy: Promises and Problems , ADAA Professional Webinar (Recorded live October 27,2022) Single-Dose Psilocybin for a Treatment-Resistant Episode - New England Journal if Medicine, November 3, 2022 How MDMA Resensitizes the Brain, Nature, September 28, 2022 MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study , Nature Medicine, October 2021 Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine , The Journal of Neuroscience, February 3, 2021 Psychedelics and Psychedelic-Assisted Psychotherapy . AMJ Psychiatry 2020 Issue: Collin M. Reiff, M.D., Elon E. Richman, M.D., (ADAA President Elect and CMO) Charles B. Nemeroff, M.D., Ph.D., Linda L. Carpenter, M.D., Alik S. Widge, M.D., Ph.D., Carolyn I. Rodriguez, M.D., Ph.D., (ADAA member) Ned H. Kalin, M.D., William M. McDonald, M.D., and the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research Objective : The authors provide an evidenced-based summary of the literature on the clinical application of psychedelic drugs in psychiatric disorders. Results : The most significant database exists for MDMA and psilocybin, which have been designated by the U.S. Food and Drug Administration (FDA) as “breakthrough therapies” for posttraumatic stress disorder (PTSD) and treatment-resistant depression, respectively. The research on LSD and ayahuascais observational, but available evidence suggests that these agents may have therapeutic effects in specific psychiatric disorders. Conclusions : Randomized clinical trials support the efficacy of MDMA in the treatment of PTSD and psilocybin in the treatment of depression and cancer-related anxiety. The research to support the use of LSD and ayahuasca in the treatment of psychiatric disorders is preliminary, although promising. Overall, the database is insufficient for FDA approval of any psychedelic compound for routine clinical use in psychiatric disorders at this time, but continued research on the efficacy of psychedelics for the treatment of psychiatric disorders is warranted. To learn more in-depth about medications, check out ADAA's Patient Guide to Mood and Anxiety Disorders . No Medications That Can Help with Obsessive–Compulsive Disorder (OCD) Medications can help reduce the symptoms of obsessive–compulsive disorder (OCD). The most prescribed are a type of antidepressant called SSRIs (selective serotonin reuptake inhibitors) (see above). Although their name suggests they are only for depression, SSRIs are also effective in treating OCD. These medicines work by helping to balance brain chemicals that affect mood, anxiety, and repetitive thoughts or behaviors. It may take several weeks to start noticing improvements. Your doctor will work with you to find the right dose, explain possible side effects, and answer any questions you have. Medication is often most effective when combined with therapy, especially cognitive behavioral therapy (CBT) that is designed for OCD. ADAA Resources The Role of Antipsychotics in OCD Medication for Treatment of OCD: Understanding the Options What is Obsessive- Compulsive Disorder? (website page) What is Obsessive-Compulsive Disorder (OCD)? (short video) To learn more in-depth about OCD and medication, check out ADAA's Patient Guide to Mood and Anxiety Disorders . No Medications and Cognitive Behavioral Therapy (CBT) for Postpartum Depression Postpartum depression can be treated with certain antidepressant medicines that help balance brain chemicals linked to mood. These medicines can ease sadness, worry, and low energy, making it easier for new parents to feel better and care for themselves and their baby. In addition to medication, Cognitive Behavioral Therapy (CBT) is a highly effective treatment for postpartum depression. CBT helps individuals recognize and change unhelpful thought patterns, develop healthier coping strategies, and build problem-solving skills. It focuses on the connection between thoughts, emotions, and behaviors, empowering new parents to manage stress, reduce negative thinking, and improve overall well-being. Postpartum depression can be treated with certain antidepressant medicines that help balance brain chemicals linked to mood. These medicines can ease sadness, worry, and low energy, making it easier for new parents to feel better and care for themselves and their baby. Learn more about CBT and other therapy types Learn more about postpartum disorders Learn about postpartum depression What is Postpartum Depression? (ADAA Video) Watch ADAA's Video on CBT The Wisdom of Cognitive Behavioral Therapy (CBT): The Perfect Gift for New Moms To learn more in-depth about Postpartum Depression and medication, check out ADAA's Patient Guide to Mood and Anxiety Disorders . No Brain Treatments for Anxiety and Depression Electroconvulsive Therapy (ECT) a nd Transcranial Magnetic Stimulation (TMS) are brain treatments that may help people with depression and anxiety when other treatments, like medicine or talk therapy , have not worked. Electroconvulsive therapy (ECT) is useful for patients who are not responding well to medications or are suicidal. ECT is an effective treatment for patients who do not respond to drug therapy, are psychotic, or are suicidal or dangerous to themselves. Onset of action may be more rapid than that of drug treatments, with benefit often seen within one week of commencing treatment. The indications for the use of ECT include the following: Failure of drug therapies History of good response to ECT Patient preference High risk of suicide High risk of medical morbidity and mortality Although advances in ECT treatment has improved the safety and tolerability of this modality there are some risks such as those associated with postictal confusion, and, more rarely, short-term memory difficulties. Transcranial Magnetic Stimulation, known as TMS or rTMS, may be a safe, effective, and noninvasive option for people who have depression that has not improved with medications. TMS creates a magnetic field to induce a small electric current in a specific part of the brain; the current comes from the magnetic field created by an electromagnetic coil that delivers pulses through the scalp. TMS is an FDA-approved treatment and recently (June 2019), the Brainsway Deep TMS device was approved for the treatment of OCD. There is ongoing research on the use of TMS to treat PTSD and other mental health conditions. TMS does not require sedation, is non-invasive and is virtually pain-free. With modern safety techniques, there is a less than 0.1% risk of seizure or loss of consciousness with TMS. Those receiving TMS usually are treated four or five times every week for four to six weeks. Research shows that TMS produces few side effects. Each treatment session lasts about 40 minutes. A new form of TMS called theta burst stimulation was recently approved by the FDA for the treatment of depression; sessions of theta burst stimulation last only about 10 minutes but still are provided daily for several weeks. To find out if TMS is the right treatment for you, speak to your therapist, doctor, or other mental health treatment provider. Your insurance may provide reimbursement for this treatment. Learn more about TMS To learn more in-depth about TMS check out ADAA's Patient Guide to Mood and Anxiety Disorders . No ADAA Medication Information Resources Psychiatric Medication in Pregnancy and Lactation: What Can Women Take? , ADAA webinar Dear ChatGPT, Can You See Me? The Limits of AI in Healing Anxiety and Emotional Pain , ADAA blog post Medication for Treatment of OCD: Understanding the Options , ADAA blog post SSRIs and Benzodiazepines for General Anxiety Disorders (GAD) , ADAA blog post Anxiety Medication Guide for Parents , AACAP.org, written by ADAA member John Walkup, MD Can CBD Help with My Anxiety and Depression? - ADAA web page Psychotropic Medications: What You Should Ask Your Doctor - ADAA blog post For My Anxiety or Depression: Should I Use Medication or Therapy - ADAA webinar Generalized Anxiety Disorder (GAD) - ADAA Brochure Depression - ADAA Brochure Learn about mental health therapy types Visit ADAA's Find Your Therapist Directory to find a provider near you To learn more about medication and mental health therapy types check out ADAA's Patient Guide to Mood and Anxiety Disorders . No Important Resources and Patient Assistance Programs Most pharmaceutical companies offer patient-assistance programs for uninsured patients. These programs provide prescribed medication at little to no cost. Eligibility varies; see the Partnership for Prescription Assistance website for more information, or contact companies directly about their patient assistance programs. A New Patient Assistance Program Offering from Janssen. For Insured Patients Who Are Facing Access and Affordability Challenges. A Quick Reference Guide NeedyMeds is a 501(c)(3) national non-profit information resource dedicated to helping people locate assistance programs to help them afford their medications and other healthcare costs. Alliance for Safe Online Pharmacies The Alliance for Safe Online Pharmacies (ASOP Global), a 501(c)(4) non-profit organization is dedicated to protecting consumers around the world, ensuring safe access to medications, and combating illegal online drug sellers. Visit ADAA's Find Your Therapist Directory to find a provider near you No #ffffff Boost Search Results Off
Markdown	![](https://www.facebook.com/tr?id=1547202075599663&ev=PageView&noscript=1) [Skip to main content](https://adaa.org/find-help/treatment-help/medication-options#main-content) [![Nav Bar Logo](https://adaa.org/sites/default/files/menu-logos/nav-bar-logo-image.png) Anxiety & Depression Association of America Triumphing Through Science, Treatment, and Education](https://adaa.org/) - [For the public](https://adaa.org/) - [For Professionals](https://adaa.org/professionals) - [ADAA Conference](https://adaa.org/adaa-conference-2026) - [About ADAA](https://adaa.org/find-help/treatment-help/medication-options) - About Us - [ADAA's Impact, Strategic Plan, and Finances](https://adaa.org/about-adaa/adaa-reports) - [ADAA's Mission/Vision and History](https://adaa.org/about-adaa/mission) - [ADAA's 2025-2028 Strategic Plan](https://adaa.org/sites/default/files/ADAA%20STRATEGIC%20PLAN%20INFOGRAPHIC%202.pdf) - [ADAA's Board of Directors](https://adaa.org/about-adaa/board-directors) - [ADAA's Team](https://adaa.org/about-adaa/adaa-staff) - [Join the ADAA Team](https://adaa.org/professionals/adaa-job-opportunities) - [ADAA's Partners](https://adaa.org/about-adaa/partners) - [Advertise with ADAA](https://adaa.org/about-adaa/advertise-with-adaa) - [Donating to ADAA](https://adaa.org/get-involved) - [Contact ADAA](https://adaa.org/contact-us) - News & Media - [Press Room](https://adaa.org/about-adaa/news-media/press-room) - [Position Papers](https://adaa.org/professionals/education/position-papers) - [Members in the News](https://adaa.org/professionals/membership/members-in-the-news) - [Newsletter Signups](https://adaa.org/adaa-newsletters) - [Triumph and Insights Signup](https://adaa.org/adaa-newsletters) - [Ways to Give](https://adaa.org/ways-to-give) - [Ways to Give](https://adaa.org/ways-to-give) - [Donate Online](https://adaa.org/donate) - [Matching Gift Program](https://adaa.org/matching-gift-program) - [Share Your Story](https://adaa.org/educational-resources/from-our-community/stories-of-triumph) - [Events](https://adaa.org/calendar) [Donate Today](https://donate.adaa.org/give/322300) - [What Are Anxiety and Depression?](https://adaa.org/understanding-anxiety) - [What Are Anxiety and Depression?](https://adaa.org/understanding-anxiety) - [Depression](https://adaa.org/understanding-anxiety/depression) - [What is Depression?](https://adaa.org/understanding-anxiety/depression) - [Depression FAQs](https://adaa.org/understanding-anxiety/depression/faqs) - [Symptoms](https://adaa.org/understanding-anxiety/depression/symptoms) - [Treatment & Management](https://adaa.org/understanding-anxiety/depression/treatment-management) - [Tips to Manage Depression](https://adaa.org/understanding-anxiety/depression/tips) - [Postpartum Disorders](https://adaa.org/find-help-for/women/postpartum-disorders) - [What is Seasonal Affective Disorder (SAD)](https://adaa.org/understanding-anxiety/depression/SAD) - [Major Depressive Disorder (MDD) Peer to Peer Community](https://healthunlocked.com/mdd-support) - [Facts & Statistics](https://adaa.org/understanding-anxiety/depression/facts-statistics) - [Anxiety Disorders](https://adaa.org/understanding-anxiety/generalized-anxiety-disorder-gad) - [What is Generalized Anxiety Disorder (GAD)?](https://adaa.org/understanding-anxiety/generalized-anxiety-disorder-gad) - [Tips to Manage Anxiety and Stress](https://adaa.org/tips) - [GAD Myths & Realities](https://adaa.org/understanding-anxiety/generalized-anxiety-disorder-gad/myths-realities) - [Health Anxiety](https://adaa.org/understanding-anxiety/related-illnesses/health-anxiety) - [Facts & Statistics](https://adaa.org/understanding-anxiety/facts-statistics) - [Panic Disorder](https://adaa.org/understanding-anxiety/panic-disorder) - [What are Phobias?](https://adaa.org/understanding-anxiety/additional-disorders/phobias) - [What is Selective Mutism?](https://adaa.org/understanding-anxiety/additional-disorders/selective-mutism) - [Social Anxiety Disorder](https://adaa.org/understanding-anxiety/social-anxiety-disorder) - [Obsessive-Compulsive & Related Disorders](https://adaa.org/understanding-anxiety/co-occurring-disorders/obsessive-compulsive-disorder) - [What is OCD?](https://adaa.org/understanding-anxiety/co-occurring-disorders/obsessive-compulsive-disorder) - [Body Dysmorphic Disorder](https://adaa.org/understanding-anxiety/body-dysmorphic-disorder) - [Body-Focused Repetitive Behaviors (BFRBs)](https://adaa.org/understanding-anxiety/co-occurring-disorders/body-focused-repetitive-behaviors) - [Related Disorders](https://adaa.org/understanding-anxiety/co-occurring-disorders) - [What are Related Disorders?](https://adaa.org/understanding-anxiety/co-occurring-disorders) - [Adult ADHD (Attention Deficit Hyperactive Disorder)](https://adaa.org/understanding-anxiety/related-illnesses/other-related-conditions/adult-adhd) - [What is Autism Spectrum Disorder (ASD)?](https://adaa.org/understanding-anxiety/autism-anxiety-depression) - [BDD (Body Dysmorphic Disorder)](https://adaa.org/understanding-anxiety/body-dysmorphic-disorder) - [Chronic Pain](https://adaa.org/understanding-anxiety/related-illnesses/other-related-conditions/chronic-pain) - [Chronic Illness/Disease](https://adaa.org/understanding-anxiety/chronic-illness-disease-anxiety-depression) - [Eating Disorders](https://adaa.org/understanding-anxiety/related-illnesses/eating-disorders) - [Fibromyalgia](https://adaa.org/understanding-anxiety/related-illnesses/other-related-conditions/fibromyalgia) - [What is Grief Disorder and Grief?](https://adaa.org/understanding-anxiety/related-illnesses/other-related-conditions/grief) - [Headaches](https://adaa.org/understanding-anxiety/related-illnesses/headaches) - [Health Anxiety](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer/health-anxiety-what-it-and-how-beat-it) - [What is Hoarding Disorder?](https://adaa.org/understanding-anxiety/what-is-hoarding-disorder) - [Irritable Bowel Syndrome (IBS)](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer/overcoming-irritable-bowel-syndrome-ibs) - [Sleep Disorders](https://adaa.org/understanding-anxiety/related-illnesses/sleep-disorders) - [Substance Abuse](https://adaa.org/understanding-anxiety/co-occurring-disorders/substance-abuse) - [Stress](https://adaa.org/understanding-anxiety/additional-disorders/stress) - [Post-Traumatic Stress Disorder (PTSD)](https://adaa.org/understanding-anxiety/posttraumatic-stress-disorder-ptsd) - [Postpartum Disorders](https://adaa.org/find-help-for/women/postpartum-disorders) - [Trauma](https://adaa.org/understanding-anxiety/trauma) - [Bipolar Disorder](https://adaa.org/understanding-anxiety/co-occurring-disorders/bipolar-disorder) - [Suicide and Prevention](https://adaa.org/understanding-anxiety/suicide) - [Other Conditions](https://adaa.org/node/7167) - [Stories of Triumph](https://adaa.org/educational-resources/from-our-community/stories-of-triumph) - [Clinical Trials](https://adaa.org/understanding-anxiety/clinical-trials) - [Facts & Statistics](https://adaa.org/understanding-anxiety/facts-statistics) - [Find Help](https://adaa.org/find-help) - [How Can I Find Help?](https://adaa.org/find-help) - [Find Your ADAA Therapist](https://findyourtherapist.adaa.org/) - [ADAA Online Peer to Peer Communities](https://adaa.org/find-help/support) - [Free Webinars](https://adaa.org/resources-news/from-adaa-experts/webinars) - ["What is...?" ADAA Mental Health Animated Videos](https://adaa.org/resources-news/from-adaa-experts/animated-videos) - [Blogs](https://adaa.org/blog) - [Treatment Help](https://adaa.org/find-help/treatment-help) - [Overview](https://adaa.org/find-help/treatment-help) - [Find Your ADAA Therapist](https://findyourtherapist.adaa.org/) - [Mental Health Therapy Types](https://adaa.org/find-help/treatment-help/types-of-therapy) - [Types of Mental Health Care Professionals](https://adaa.org/find-help/treatment-help/types-of-therapy/types-of-mental-health-care-professionals) - [Choosing a Mental Health Therapist](https://adaa.org/finding-help/treatment/choosing-therapist) - [Medication and Other Treatment Options for Anxiety Disorders and Depression](https://adaa.org/find-help/treatment-help/medication-options) - [Residential Treatment Centers](https://adaa.org/find-help/treatment-help/residential-treatment-centers) - [Self-Help Books](https://adaa.org/books) - [Recursos En Español](https://adaa.org/recursos/en-espanol) - [Integrative Behavioral Health](https://adaa.org/find-help/treatment-help/integrative-behavioral-health-mindfulness-yoga-meditation) - [Pediatric Brochure for Pediatric Primary Care Providers and Parents](https://adaa.org/find-help/by-demographics/children-anxiety-brochure-pediatric-care) - [Support](https://adaa.org/find-help/support) - [ADAA's Online Peer-to-Peer Communities](https://adaa.org/find-help/support) - [Find Your ADAA Therapist](https://findyourtherapist.adaa.org/) - [Self-help Books by ADAA Members](https://adaa.org/books) - [Recursos en Espanol](https://adaa.org/recursos/en-espanol) - [Community Resources](https://adaa.org/find-help/support/community-resources) - [By Demographics](https://adaa.org/find-help/by-demographics) - [Overview](https://adaa.org/find-help/by-demographics) - [AMEMSA Communities](https://adaa.org/find-help/by-demographics/amemsa-communities) - [Asian Americans and Pacific Islanders](https://adaa.org/find-help/by-demographics/asian-pacific-islanders) - [BIPOC Communities](https://adaa.org/find-help/by-demographics/bipoc-resources) - [Black and African American Communities](https://adaa.org/find-help/by-demographics/black-african-american-communities) - [Caregivers](https://adaa.org/find-help/by-demographics/caregivers) - [Children](https://adaa.org/find-help/by-demographics/children) - [Diversity, Equity, and Inclusion Resources - Community](https://adaa.org/find-help/by-demographics/diversity-equity-inclusion-resources) - [Friends & Relatives](https://adaa.org/find-help/by-demographics/friends-relatives) - [Latiné/Hispanic Communities](https://adaa.org/find-help/by-demographics/latinx-hispanics) - [LGBTQ+ Community](https://adaa.org/find-help/by-demographics/lgbtq) - [Low Income](https://adaa.org/find-help/by-demographics/low-income) - [Men's Mental Health](https://adaa.org/find-help/by-demographics/mens-mental-health) - [Multiracial Communities](https://adaa.org/find-help/by-demographics/multiracial-communities) - [Native and Indigenous Communities](https://adaa.org/find-help/by-demographics/native-indigenous-communities) - [Older Adults](https://adaa.org/find-help/by-demographics/older-adults) - [Teens/College Students](https://adaa.org/find-help/by-demographics/teens-college-students-anxiety-depression) - [Veterans & Military Families](https://adaa.org/find-help/by-demographics/veterans-military-families) - [Women & Girls](https://adaa.org/find-help/by-demographics/women-young-girls) - [By Disorder](https://adaa.org/find-help-for/by-disorder) - [Overview](https://adaa.org/find-help-for/by-disorder) - [General Anxiety](https://adaa.org/understanding-anxiety/generalized-anxiety-disorder-gad) - [Co-Ocurring Disorders](https://adaa.org/understanding-anxiety/co-occurring-disorders) - [Depression](https://adaa.org/understanding-anxiety/depression) - [Obsessive-Compulsive Disorder (OCD)](https://adaa.org/understanding-anxiety/co-occurring-disorders/obsessive-compulsive-disorder) - [Post-Traumatic Stress Disorder (PTSD)](https://adaa.org/understanding-anxiety/posttraumatic-stress-disorder-ptsd) - [Self-Help Books](https://adaa.org/books) - [Recursos en Espanol](https://adaa.org/recursos/en-espanol) - [Learn and Share](https://adaa.org/educational-resources) - [Overview](https://adaa.org/educational-resources) - [Webinars, Podcasts, and Videos](https://adaa.org/educational-resources/from-adaa-experts) - [Overview](https://adaa.org/educational-resources/from-adaa-experts) - [Webinars](https://adaa.org/resources-news/from-adaa-experts/webinars) - [Videos and Podcasts](https://adaa.org/resources-news/from-adaa-experts/videos) - ["What is...?" ADAA Mental Health Animated Videos](https://adaa.org/resources-news/from-adaa-experts/animated-videos) - [ADAA Inside Mental Health Podcast Series](https://adaa.org/resources/from-adaa-experts/inside-mental-health-podcast) - [Members in the News](https://adaa.org/professionals/membership/members-in-the-news) - [Blogs, Self-Help Books, Infographics, Newsletters and more](https://adaa.org/educational-resources/from-adaa-experts) - [Overview](https://adaa.org/educational-resources/from-adaa-experts) - [Blogs](https://adaa.org/blog) - [Self-Help Books and Reading List](https://adaa.org/books) - [Triumph E-Newsletter](https://adaa.org/educational-resources/from-adaa-experts/triumph-enewsletter) - [Infographics](https://adaa.org/educational-resources/from-adaa-experts/infographics) - [Brochures](https://adaa.org/educational-resources/from-adaa-experts/downloadable-brochures) - [Read and Share Personal Stories](https://adaa.org/educational-resources/from-our-community/stories-of-triumph) - [Read Personal Mental Health Stories](https://adaa.org/educational-resources/from-our-community/stories-of-triumph) - [Share Your Personal Mental Health Story](https://adaa.org/understand-anxiety-depression/share-your-story) - [Personal Stories](https://adaa.org/educational-resources/from-our-community/stories-of-triumph) - [Find Your Therapist](https://members.adaa.org/page/FATMain) - [For the public](https://adaa.org/) - [For Professionals](https://adaa.org/professionals) - [ADAA Conference](https://adaa.org/adaa-conference-2026) [![Nav Bar Logo](https://adaa.org/sites/default/files/menu-logos/Mobile%20Logo.svg)](https://adaa.org/) [![Donate](https://adaa.org/sites/default/files/2022-10/Donate%20Today.png) Donate Today](https://donate.adaa.org/give/322300) [![Button Image](https://adaa.org/sites/default/files/menu-logos/Find%20a%20therapist%20icon.svg) Find Your Therapist](https://members.adaa.org/page/FATMain) [![Button Image](https://adaa.org/themes/bootstrap_sass/images/magnifying-glass-regular-blue.svg) Search](https://search-icon.com/) [![Hamburger](https://adaa.org/themes/bootstrap_sass/images/nav-bar-hamburger-image.svg) Menu](https://adaa.org/find-help/treatment-help/medication-options) Triumphing Through Science, Treatment, and Education [Donate Today](https://donate.adaa.org/give/322300) - [For the public](https://adaa.org/) - [For Professionals](https://adaa.org/professionals) - [ADAA Conference](https://adaa.org/adaa-conference-2026) - [Home](https://adaa.org/) - [What Are Anxiety and Depression?](https://adaa.org/understanding-anxiety) - [Find Help](https://adaa.org/find-help) - [Learn and Share](https://adaa.org/educational-resources) - [Personal Stories](https://adaa.org/educational-resources/from-our-community/stories-of-triumph) - GO BACK - [What Are Anxiety and Depression?](https://adaa.org/understanding-anxiety) - [What Are Anxiety and Depression?](https://adaa.org/understanding-anxiety) - [Depression](https://adaa.org/understanding-anxiety/depression) - [Anxiety Disorders](https://adaa.org/understanding-anxiety/generalized-anxiety-disorder-gad) - [Social Anxiety Disorder](https://adaa.org/understanding-anxiety/social-anxiety-disorder) - [Obsessive-Compulsive & Related Disorders](https://adaa.org/understanding-anxiety/co-occurring-disorders/obsessive-compulsive-disorder) - [Related Disorders](https://adaa.org/understanding-anxiety/co-occurring-disorders) - [Stress](https://adaa.org/understanding-anxiety/additional-disorders/stress) - [Post-Traumatic Stress Disorder (PTSD)](https://adaa.org/understanding-anxiety/posttraumatic-stress-disorder-ptsd) - [Postpartum Disorders](https://adaa.org/find-help-for/women/postpartum-disorders) - [Trauma](https://adaa.org/understanding-anxiety/trauma) - [Bipolar Disorder](https://adaa.org/understanding-anxiety/co-occurring-disorders/bipolar-disorder) - [Suicide and Prevention](https://adaa.org/understanding-anxiety/suicide) - [Other Conditions](https://adaa.org/node/7167) - [Stories of Triumph](https://adaa.org/educational-resources/from-our-community/stories-of-triumph) - [Clinical Trials](https://adaa.org/understanding-anxiety/clinical-trials) - [Facts & Statistics](https://adaa.org/understanding-anxiety/facts-statistics) - GO BACK - [Find Help](https://adaa.org/find-help) - [How Can I Find Help?](https://adaa.org/find-help) - [Find Your ADAA Therapist](https://findyourtherapist.adaa.org/) - [ADAA Online Peer to Peer Communities](https://adaa.org/find-help/support) - [Free Webinars](https://adaa.org/resources-news/from-adaa-experts/webinars) - ["What is...?" ADAA Mental Health Animated Videos](https://adaa.org/resources-news/from-adaa-experts/animated-videos) - [Blogs](https://adaa.org/blog) - [Treatment Help](https://adaa.org/find-help/treatment-help) - [Support](https://adaa.org/find-help/support) - [By Demographics](https://adaa.org/find-help/by-demographics) - [By Disorder](https://adaa.org/find-help-for/by-disorder) - [Self-Help Books](https://adaa.org/books) - [Recursos en Espanol](https://adaa.org/recursos/en-espanol) - GO BACK - [Learn and Share](https://adaa.org/educational-resources) - [Overview](https://adaa.org/educational-resources) - [Webinars, Podcasts, and Videos](https://adaa.org/educational-resources/from-adaa-experts) - [Blogs, Self-Help Books, Infographics, Newsletters and more](https://adaa.org/educational-resources/from-adaa-experts) - [Read and Share Personal Stories](https://adaa.org/educational-resources/from-our-community/stories-of-triumph) - GO BACK - [Depression](https://adaa.org/understanding-anxiety/depression) - [What is Depression?](https://adaa.org/understanding-anxiety/depression) - [Depression FAQs](https://adaa.org/understanding-anxiety/depression/faqs) - [Symptoms](https://adaa.org/understanding-anxiety/depression/symptoms) - [Treatment & Management](https://adaa.org/understanding-anxiety/depression/treatment-management) - [Tips to Manage Depression](https://adaa.org/understanding-anxiety/depression/tips) - [Postpartum Disorders](https://adaa.org/find-help-for/women/postpartum-disorders) - [What is Seasonal Affective Disorder (SAD)](https://adaa.org/understanding-anxiety/depression/SAD) - [Major Depressive Disorder (MDD) Peer to Peer Community](https://healthunlocked.com/mdd-support) - [Facts & Statistics](https://adaa.org/understanding-anxiety/depression/facts-statistics) - GO BACK - [Anxiety Disorders](https://adaa.org/understanding-anxiety/generalized-anxiety-disorder-gad) - [What is Generalized Anxiety Disorder (GAD)?](https://adaa.org/understanding-anxiety/generalized-anxiety-disorder-gad) - [Tips to Manage Anxiety and Stress](https://adaa.org/tips) - [GAD Myths & Realities](https://adaa.org/understanding-anxiety/generalized-anxiety-disorder-gad/myths-realities) - [Health Anxiety](https://adaa.org/understanding-anxiety/related-illnesses/health-anxiety) - [Facts & Statistics](https://adaa.org/understanding-anxiety/facts-statistics) - [Panic Disorder](https://adaa.org/understanding-anxiety/panic-disorder) - [What are Phobias?](https://adaa.org/understanding-anxiety/additional-disorders/phobias) - [What is Selective Mutism?](https://adaa.org/understanding-anxiety/additional-disorders/selective-mutism) - GO BACK - [Obsessive-Compulsive & Related Disorders](https://adaa.org/understanding-anxiety/co-occurring-disorders/obsessive-compulsive-disorder) - [What is OCD?](https://adaa.org/understanding-anxiety/co-occurring-disorders/obsessive-compulsive-disorder) - [Body Dysmorphic Disorder](https://adaa.org/understanding-anxiety/body-dysmorphic-disorder) - [Body-Focused Repetitive Behaviors (BFRBs)](https://adaa.org/understanding-anxiety/co-occurring-disorders/body-focused-repetitive-behaviors) - GO BACK - [Related Disorders](https://adaa.org/understanding-anxiety/co-occurring-disorders) - [What are Related Disorders?](https://adaa.org/understanding-anxiety/co-occurring-disorders) - [Adult ADHD (Attention Deficit Hyperactive Disorder)](https://adaa.org/understanding-anxiety/related-illnesses/other-related-conditions/adult-adhd) - [What is Autism Spectrum Disorder (ASD)?](https://adaa.org/understanding-anxiety/autism-anxiety-depression) - [BDD (Body Dysmorphic Disorder)](https://adaa.org/understanding-anxiety/body-dysmorphic-disorder) - [Chronic Pain](https://adaa.org/understanding-anxiety/related-illnesses/other-related-conditions/chronic-pain) - [Chronic Illness/Disease](https://adaa.org/understanding-anxiety/chronic-illness-disease-anxiety-depression) - [Eating Disorders](https://adaa.org/understanding-anxiety/related-illnesses/eating-disorders) - [Fibromyalgia](https://adaa.org/understanding-anxiety/related-illnesses/other-related-conditions/fibromyalgia) - [What is Grief Disorder and Grief?](https://adaa.org/understanding-anxiety/related-illnesses/other-related-conditions/grief) - [Headaches](https://adaa.org/understanding-anxiety/related-illnesses/headaches) - [Health Anxiety](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer/health-anxiety-what-it-and-how-beat-it) - [What is Hoarding Disorder?](https://adaa.org/understanding-anxiety/what-is-hoarding-disorder) - [Irritable Bowel Syndrome (IBS)](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer/overcoming-irritable-bowel-syndrome-ibs) - [Sleep Disorders](https://adaa.org/understanding-anxiety/related-illnesses/sleep-disorders) - [Substance Abuse](https://adaa.org/understanding-anxiety/co-occurring-disorders/substance-abuse) - GO BACK - [Treatment Help](https://adaa.org/find-help/treatment-help) - [Overview](https://adaa.org/find-help/treatment-help) - [Find Your ADAA Therapist](https://findyourtherapist.adaa.org/) - [Mental Health Therapy Types](https://adaa.org/find-help/treatment-help/types-of-therapy) - [Types of Mental Health Care Professionals](https://adaa.org/find-help/treatment-help/types-of-therapy/types-of-mental-health-care-professionals) - [Choosing a Mental Health Therapist](https://adaa.org/finding-help/treatment/choosing-therapist) - [Medication and Other Treatment Options for Anxiety Disorders and Depression](https://adaa.org/find-help/treatment-help/medication-options) - [Residential Treatment Centers](https://adaa.org/find-help/treatment-help/residential-treatment-centers) - [Self-Help Books](https://adaa.org/books) - [Recursos En Español](https://adaa.org/recursos/en-espanol) - [Integrative Behavioral Health](https://adaa.org/find-help/treatment-help/integrative-behavioral-health-mindfulness-yoga-meditation) - [Pediatric Brochure for Pediatric Primary Care Providers and Parents](https://adaa.org/find-help/by-demographics/children-anxiety-brochure-pediatric-care) - GO BACK - [Support](https://adaa.org/find-help/support) - [ADAA's Online Peer-to-Peer Communities](https://adaa.org/find-help/support) - [Find Your ADAA Therapist](https://findyourtherapist.adaa.org/) - [Self-help Books by ADAA Members](https://adaa.org/books) - [Recursos en Espanol](https://adaa.org/recursos/en-espanol) - [Community Resources](https://adaa.org/find-help/support/community-resources) - GO BACK - [By Demographics](https://adaa.org/find-help/by-demographics) - [Overview](https://adaa.org/find-help/by-demographics) - [AMEMSA Communities](https://adaa.org/find-help/by-demographics/amemsa-communities) - [Asian Americans and Pacific Islanders](https://adaa.org/find-help/by-demographics/asian-pacific-islanders) - [BIPOC Communities](https://adaa.org/find-help/by-demographics/bipoc-resources) - [Black and African American Communities](https://adaa.org/find-help/by-demographics/black-african-american-communities) - [Caregivers](https://adaa.org/find-help/by-demographics/caregivers) - [Children](https://adaa.org/find-help/by-demographics/children) - [Diversity, Equity, and Inclusion Resources - Community](https://adaa.org/find-help/by-demographics/diversity-equity-inclusion-resources) - [Friends & Relatives](https://adaa.org/find-help/by-demographics/friends-relatives) - [Latiné/Hispanic Communities](https://adaa.org/find-help/by-demographics/latinx-hispanics) - [LGBTQ+ Community](https://adaa.org/find-help/by-demographics/lgbtq) - [Low Income](https://adaa.org/find-help/by-demographics/low-income) - [Men's Mental Health](https://adaa.org/find-help/by-demographics/mens-mental-health) - [Multiracial Communities](https://adaa.org/find-help/by-demographics/multiracial-communities) - [Native and Indigenous Communities](https://adaa.org/find-help/by-demographics/native-indigenous-communities) - [Older Adults](https://adaa.org/find-help/by-demographics/older-adults) - [Teens/College Students](https://adaa.org/find-help/by-demographics/teens-college-students-anxiety-depression) - [Veterans & Military Families](https://adaa.org/find-help/by-demographics/veterans-military-families) - [Women & Girls](https://adaa.org/find-help/by-demographics/women-young-girls) - GO BACK - [By Disorder](https://adaa.org/find-help-for/by-disorder) - [Overview](https://adaa.org/find-help-for/by-disorder) - [General Anxiety](https://adaa.org/understanding-anxiety/generalized-anxiety-disorder-gad) - [Co-Ocurring Disorders](https://adaa.org/understanding-anxiety/co-occurring-disorders) - [Depression](https://adaa.org/understanding-anxiety/depression) - [Obsessive-Compulsive Disorder (OCD)](https://adaa.org/understanding-anxiety/co-occurring-disorders/obsessive-compulsive-disorder) - [Post-Traumatic Stress Disorder (PTSD)](https://adaa.org/understanding-anxiety/posttraumatic-stress-disorder-ptsd) - GO BACK - [Webinars, Podcasts, and Videos](https://adaa.org/educational-resources/from-adaa-experts) - [Overview](https://adaa.org/educational-resources/from-adaa-experts) - [Webinars](https://adaa.org/resources-news/from-adaa-experts/webinars) - [Videos and Podcasts](https://adaa.org/resources-news/from-adaa-experts/videos) - ["What is...?" ADAA Mental Health Animated Videos](https://adaa.org/resources-news/from-adaa-experts/animated-videos) - [ADAA Inside Mental Health Podcast Series](https://adaa.org/resources/from-adaa-experts/inside-mental-health-podcast) - [Members in the News](https://adaa.org/professionals/membership/members-in-the-news) - GO BACK - [Blogs, Self-Help Books, Infographics, Newsletters and more](https://adaa.org/educational-resources/from-adaa-experts) - [Overview](https://adaa.org/educational-resources/from-adaa-experts) - [Blogs](https://adaa.org/blog) - [Self-Help Books and Reading List](https://adaa.org/books) - [Triumph E-Newsletter](https://adaa.org/educational-resources/from-adaa-experts/triumph-enewsletter) - [Infographics](https://adaa.org/educational-resources/from-adaa-experts/infographics) - [Brochures](https://adaa.org/educational-resources/from-adaa-experts/downloadable-brochures) - GO BACK - [Read and Share Personal Stories](https://adaa.org/educational-resources/from-our-community/stories-of-triumph) - [Read Personal Mental Health Stories](https://adaa.org/educational-resources/from-our-community/stories-of-triumph) - [Share Your Personal Mental Health Story](https://adaa.org/understand-anxiety-depression/share-your-story) - [Find Your Therapist](https://members.adaa.org/page/FATMain) - [About ADAA](https://adaa.org/find-help/treatment-help/medication-options) - [About Us](https://adaa.org/find-help/treatment-help/medication-options) - [ADAA's Impact, Strategic Plan, and Finances](https://adaa.org/about-adaa/adaa-reports) - [ADAA's Mission/Vision and History](https://adaa.org/about-adaa/mission) - [ADAA's 2025-2028 Strategic Plan](https://adaa.org/sites/default/files/ADAA%20STRATEGIC%20PLAN%20INFOGRAPHIC%202.pdf) - [ADAA's Board of Directors](https://adaa.org/about-adaa/board-directors) - [ADAA's Team](https://adaa.org/about-adaa/adaa-staff) - [Join the ADAA Team](https://adaa.org/professionals/adaa-job-opportunities) - [ADAA's Partners](https://adaa.org/about-adaa/partners) - [Advertise with ADAA](https://adaa.org/about-adaa/advertise-with-adaa) - [Donating to ADAA](https://adaa.org/get-involved) - [Contact ADAA](https://adaa.org/contact-us) - [News & Media](https://adaa.org/find-help/treatment-help/medication-options) - [Press Room](https://adaa.org/about-adaa/news-media/press-room) - [Position Papers](https://adaa.org/professionals/education/position-papers) - [Members in the News](https://adaa.org/professionals/membership/members-in-the-news) - [Newsletter Signups](https://adaa.org/adaa-newsletters) - [Triumph and Insights Signup](https://adaa.org/adaa-newsletters) - [Ways to Give](https://adaa.org/ways-to-give) - [Ways to Give](https://adaa.org/ways-to-give) - [Donate Online](https://adaa.org/donate) - [Matching Gift Program](https://adaa.org/matching-gift-program) - [Share Your Story](https://adaa.org/educational-resources/from-our-community/stories-of-triumph) - [Events](https://adaa.org/calendar) - [Home](https://adaa.org/professionals) - [Conference](https://adaa.org/adaa-conference-2026) - [Education/CE](https://adaa.org/professionals/education) - [Membership](https://adaa.org/professionals/membership) - [Resources](https://adaa.org/professionals/research-practice) - GO BACK - [Education/CE](https://adaa.org/professionals/education) - [Overview](https://adaa.org/professionals/education) - [ADAA Webinars & Continuing Education](https://adaa.org/professionals/education/webinars) - [Member Blogs](https://adaa.org/professionals/education/blog) - [Member Books & Publications](https://adaa.org/professionals/research-practice/publications/member-publications) - [Resources for Early Career and Student Mental Health Professionals](https://adaa.org/early-career-professionals-resources) - [Resources for Underrepresented Communities](https://adaa.org/professionals/education/dei/resources) - GO BACK - [Membership](https://adaa.org/professionals/membership) - [Become a Member/Rejoin](https://adaa.org/professionals/membership) - [Institutional/Group Membership](https://adaa.org/professionals/Institutional-Memberships) - [Managing Your Directory Profile](https://adaa.org/professionals/managing-FYT-profile) - [ADAA Professional Committees, Groups and the Scientific Council](https://adaa.org/professionals/committees-sigs/committees-councils-program) - [Special Interest Groups (SIGs)](https://adaa.org/professionals/committees-sigs/special-interest-groups) - [ADAA's Public/Client Resources](https://adaa.org/) - [ADAA Mental Health Career Center](https://adaa.careerwebsite.com/home/index.cfm) - [Awards Programs](https://adaa.societyconference.com/v2/) - [ADAA Member Content](https://adaa.org/professionals/membership/members-in-the-news) - [Member FAQs](https://adaa.org/professionals/membership/faqs) - GO BACK - [Resources](https://adaa.org/professionals/research-practice) - [ADAA Journal of Mood & Anxiety Disorders](https://adaa.org/professionals/journal) - [ADAA Patient Guide to Mood and Anxiety Disorders](https://adaa.org/books/patient-guide-to-mood-and-anxiety-disorders) - [Stay Current with ADAA’s Professional Insights Newsletter](https://adaa.org/professionals/research-practice/publications/insights-enewsletter) - [Find Your Therapist](https://adaa.org/find-help/support/ask-an-adaa-therapist) - [Member Publications](https://adaa.org/professionals/research-practice/publications/member-publications) - [ADAA Journal of Mood & Anxiety Disorders ®](https://adaa.org/professionals/journal) - [Member Research News](https://adaa.org/professionals/research-practice/publications/member-research-news) - [Events](https://adaa.org/calendar) - [Early Career and Student Mental Health Professionals Resources](https://adaa.org/early-career-professionals-resources) - [ADAA Resources for the Public](https://adaa.org/) - [Position Papers signed by ADAA Leadership](https://adaa.org/professionals/education/position-papers) - [Mental Health Resources for Clinicians](https://adaa.org/professionals/research-practice/Mental-Health-Resources-for-Clinicians) - [Clinical Trials](https://adaa.trialstoday.org/) - [ADAA Mental Health Career Center](https://adaa.careerwebsite.com/home/index.cfm) - [Resources for Underrepresented Communities](https://adaa.org/professionals/education/dei/resources) - GO BACK - [ADAA Webinars & Continuing Education](https://adaa.org/professionals/education/webinars) - [Live and On-Demand Webinars](https://adaa.org/professionals/education/webinars) - [Webinar FAQs](https://adaa.org/professionals/education/professional-webinar-faq) - [CE/CME Information](https://adaa.org/professionals/education/ce-credits) - GO BACK - [Awards Programs](https://adaa.societyconference.com/v2/) - [Awards Overview](https://adaa.org/conference/awards-programs) - [Alies Muskin Career Development Leadership Program](https://adaa.org/conference/conference-education/career-development) - [Klein Early Career Investigator Award](https://adaa.org/conference/conference-education/donald-f-klein-award) - [Member Recognition Awards](https://adaa.org/resources-professionals/conference-education/awards/member-award-winners) - [Membership Award for Early Career Professionals](https://adaa.org/conference/conference-education/membership-scholarship) - [Poster Awards](https://adaa.org/conference/poster-awards) - [Become a Mentor](https://adaa.org/conference/awards/cdlp-mentorship) - GO BACK - [ADAA Member Content](https://adaa.org/professionals/membership/members-in-the-news) - [Member Community](https://community.adaa.org/home) - [Member Blogs](https://adaa.org/professionals/education/blog) - [Members in the News](https://adaa.org/professionals/membership/members-in-the-news) - [Member Publications](https://adaa.org/books) - [Early Career and Student Mental Health Professionals Resources](https://adaa.org/early-career-professionals-resources) - [Join/ Renew](https://members.adaa.org/page/join) - [Member Community](https://community.adaa.org/home) - [Find Your Therapist](https://findyourtherapist.adaa.org/) - [Search](https://search-icon.com/) - [About ADAA](https://adaa.org/find-help/treatment-help/medication-options) - [About Us](https://adaa.org/find-help/treatment-help/medication-options) - [ADAA's Impact, Strategic Plan, and Finances](https://adaa.org/about-adaa/adaa-reports) - [ADAA's Mission/Vision and History](https://adaa.org/about-adaa/mission) - [ADAA's 2025-2028 Strategic Plan](https://adaa.org/sites/default/files/ADAA%20STRATEGIC%20PLAN%20INFOGRAPHIC%202.pdf) - [ADAA's Board of Directors](https://adaa.org/about-adaa/board-directors) - [ADAA's Team](https://adaa.org/about-adaa/adaa-staff) - [Join the ADAA Team](https://adaa.org/professionals/adaa-job-opportunities) - [ADAA's Partners](https://adaa.org/about-adaa/partners) - [Advertise with ADAA](https://adaa.org/about-adaa/advertise-with-adaa) - [Donating to ADAA](https://adaa.org/get-involved) - [Contact ADAA](https://adaa.org/contact-us) - [News & Media](https://adaa.org/find-help/treatment-help/medication-options) - [Press Room](https://adaa.org/about-adaa/news-media/press-room) - [Position Papers](https://adaa.org/professionals/education/position-papers) - [Members in the News](https://adaa.org/professionals/membership/members-in-the-news) - [Newsletter Signups](https://adaa.org/adaa-newsletters) - [Triumph and Insights Signup](https://adaa.org/adaa-newsletters) - [Ways to Give](https://adaa.org/ways-to-give) - [Ways to Give](https://adaa.org/ways-to-give) - [Donate Online](https://adaa.org/donate) - [Matching Gift Program](https://adaa.org/matching-gift-program) - [Share Your Story](https://adaa.org/educational-resources/from-our-community/stories-of-triumph) - [Events](https://adaa.org/calendar) - [Home](https://adaa.org/adaa-conference-2026) - [General Conference Information](https://adaa.org/adaa-conference-2026) - GO BACK - [General Conference Information](https://adaa.org/adaa-conference-2026) - [Submissions](https://adaa.societyconference.com/v2/#card/submission) - [Registration](https://adaa.societyconference.com/v2/#card/registration) - [2026 Conference Committee](https://adaa.org/conference/conference-committee) - [2026 Conference Awards Program](https://adaa.org/conference/awards-programs) - [Conference Blogs](https://adaa.org/conference/blog) - [Future and Past ADAA Conferences](https://adaa.org/conference/future-past-conferences) - [\#ADAA2026 News](https://adaa.informz.net/adaa/pages/ADAA_Conference_Email_Sign_Up) - [Search](https://search-icon.com/) - [About ADAA](https://adaa.org/find-help/treatment-help/medication-options) - [About Us](https://adaa.org/find-help/treatment-help/medication-options) - [ADAA's Impact, Strategic Plan, and Finances](https://adaa.org/about-adaa/adaa-reports) - [ADAA's Mission/Vision and History](https://adaa.org/about-adaa/mission) - [ADAA's 2025-2028 Strategic Plan](https://adaa.org/sites/default/files/ADAA%20STRATEGIC%20PLAN%20INFOGRAPHIC%202.pdf) - [ADAA's Board of Directors](https://adaa.org/about-adaa/board-directors) - [ADAA's Team](https://adaa.org/about-adaa/adaa-staff) - [Join the ADAA Team](https://adaa.org/professionals/adaa-job-opportunities) - [ADAA's Partners](https://adaa.org/about-adaa/partners) - [Advertise with ADAA](https://adaa.org/about-adaa/advertise-with-adaa) - [Donating to ADAA](https://adaa.org/get-involved) - [Contact ADAA](https://adaa.org/contact-us) - [News & Media](https://adaa.org/find-help/treatment-help/medication-options) - [Press Room](https://adaa.org/about-adaa/news-media/press-room) - [Position Papers](https://adaa.org/professionals/education/position-papers) - [Members in the News](https://adaa.org/professionals/membership/members-in-the-news) - [Newsletter Signups](https://adaa.org/adaa-newsletters) - [Triumph and Insights Signup](https://adaa.org/adaa-newsletters) - [Ways to Give](https://adaa.org/ways-to-give) - [Ways to Give](https://adaa.org/ways-to-give) - [Donate Online](https://adaa.org/donate) - [Matching Gift Program](https://adaa.org/matching-gift-program) - [Share Your Story](https://adaa.org/educational-resources/from-our-community/stories-of-triumph) - [Events](https://adaa.org/calendar) # Medication and Other Treatment Options for Anxiety Disorders and Depression ![Medication Options](https://adaa.org/sites/default/files/2023-08/iStock-1383621461%20purchased%20istock%20small%20bad%20thoughts%20OCD.jpg) Medication can be a safe, effective, and evidence-based option for treating anxiety disorders and depression. Many people take medication alone or in combination [with therapy](https://adaa.org/find-help/treatment-help/types-of-therapy) to help manage symptoms and improve daily functioning. It's essential to recognize that medication is only one component of a comprehensive treatment approach. Other evidence-based options, such as psychotherapy, transcranial magnetic stimulation (TMS), and electroconvulsive therapy (ECT), may be recommended depending on an individual’s needs and treatment goals. These approaches can be used alone or in combination with medication to maximize effectiveness. Finding the right medication or treatment plan often requires patience, collaboration with a healthcare provider, and adjustments along the way. When used appropriately, medications can significantly reduce symptoms of anxiety and depression and support a return to balance and quality of life. Always consult a healthcare provider before starting, changing, or stopping medication. The right treatment depends on your symptoms, medical history, and individual needs. Finding the right medication—whether antidepressants, anti-anxiety medications, or a combination, often takes time, patience, and close collaboration with your doctor or nurse practitioner. Discussing Medications - What You Need to Know: Use these guidelines to talk to your health care professional about medications: - To avoid potentially dangerous drug interactions, let your mental health care provider know all medications you are taking, including prescriptions and over-the-counter drugs, herbal or dietary supplements, and vitamins. And make sure your family doctor knows you are taking medicines for an anxiety disorder. - Learn when to take a new medication and how, such as on an empty stomach or with food, in the morning or evening, and how frequently. - Find out how long it should take for the medication to start working and what you should expect when this happens. - Ask: How will the medication help me? What side effects might occur? Should I avoid any foods or beverages? Are drug interactions with other prescriptions a possibility? How often should you see the doctor for a medication check-up? - Ask for the prescribing physician’s after-hours phone number in case you develop side effects. - A good source of information about medications and over-the-counter products is your pharmacist, who should have information about all your prescriptions to advise you about possible drug interactions, side effects, and instructions for use. If your physician does not want to spend the time to answer your questions, you may need a referral to a different physician. Medications are commonly prescribed by physicians (family practice, pediatricians, OB-GYNs, psychiatrists), as well as nurse practitioners in many states. There are four major classes of medications that are used in the treatment of anxiety disorders: Q\&A #### What to Ask Your Doctor Before Starting a New Antidepressant or an Emerging Treatment 1. Is this new drug/treatment appropriate for me? 2. What are the drawbacks, if any of this new treatment? 3. What might be the benefits over my current regimen? 4. Is the price (typically high when a drug is new) worth the added benefit? 5. Is this treatment ready for widespread use? Meaning, does it have safety established? Do we know how long people need to be on this treatment? Do we know about any long term issues that could result from this? No #### Selective Serotonin Reuptake Inhibitors (SSRIs) SSRIs relieve symptoms by blocking the reabsorption, or reuptake, of serotonin by certain nerve cells in the brain. This leaves more serotonin available, which improves mood. SSRIs (citalopram, escitalopram, fluoxetine, paroxetine, and sertraline) generally produced fewer side effects when compared with tricyclic antidepressants. However, common side effects include insomnia or sleepiness, sexual dysfunction, and weight gain. They are considered an effective treatment for all anxiety disorders, although the treatment of obsessive-compulsive disorder, or OCD, typically requires higher doses. [Read this blog about SSRIs and Benzodiazepines](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer/ssris-and-benzodiazepines-general-anxiety). - Trintellix (vortioxetine) is a prescription antidepressant used to treat major depressive disorder in adults. It works by affecting serotonin activity in the brain, which can help improve mood, cognition, and overall functioning. - Viibryd (vilazodone) is a prescription antidepressant used to treat major depressive disorder (MDD) in adults. It works by increasing serotonin activity in the brain and is classified as a selective serotonin reuptake inhibitor (SSRI) and partial serotonin receptor. To learn more in-depth about Selective Serotonin Reuptake Inhibitors (SSRIs), check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https://adaa.org/node/7421). No #### Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) The serotonin-norepinephrine reuptake inhibitor, or SNRI, class (venlafaxine and duloxetine) is notable for a dual mechanism of action: increasing the levels of the neurotransmitters serotonin and norepinephrine by inhibiting their reabsorption into cells in the brain. As with other medications, side effects may occur, including stomach upset, insomnia, headache, sexual dysfunction, weight gain and minor increase in blood pressure. These medications are considered as effective as SSRIs, so they are also considered a first-line treatment for the treatment of anxiety disorders, but not for obsessive compulsive disorder, where SSRI’s are the preferred first line treatment. - Pristiq is used to treat major depressive disorder in adults. It works by increasing levels of serotonin and norepinephrine in the brain to help improve mood, energy, and interest in daily activities. - Fetzima is prescribed for major depressive disorder in adults. It helps balance serotonin and norepinephrine, with a relatively stronger effect on norepinephrine, which may improve mood, concentration, and physical energy. To learn more in-depth about Selective Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https://adaa.org/node/7421). No #### Benzodiazepines This class of drugs is frequently used for short-term management of anxiety and as an add on treatment, in treatment resistant anxiety disorders. They are not recommended as a treatment for Post Traumatic Stress Disorder. Benzodiazepines (alprazolam, clonazepam, diazepam, and lorazepam) are highly effective in promoting relaxation and reducing muscular tension and other physical symptoms of anxiety. Long-term use may require increased doses to achieve the same effect, which may lead to problems related to tolerance and dependence. [Read this blog post about SSRIs and Benzodiazepines](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer/ssris-and-benzodiazepines-general-anxiety). To learn more in-depth about Benzodiazepines, check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https://adaa.org/node/7421). No #### Tricyclic Antidepressants Concerns about long-term use of the benzodiazepines led many doctors to favor tricyclic antidepressants (amitriptyline, imipramine, and nortriptyline). Although effective in the treatment of some anxiety disorders(but not Social Anxiety Disorder), they can cause significant side effects, including orthostatic hypotension (drop in blood pressure on standing), constipation, urinary retention, dry mouth, and blurry vision. Contact your physician if you experience side effects, even if you are not sure a symptom is caused by a medication. Do not stop taking a medication without consulting with the prescribing physician; abrupt discontinuation may cause other health risks. Medications will work only if they are taken according the explicit instructions of your physician, but they may not resolve all symptoms of an anxiety disorder. [Learn more about how antidepressants work.](https://adaa.org/sites/default/files/SomberQuestions_Antidepressants.pdf) To learn more in-depth about Tricyclic Antidepressants, check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https://adaa.org/node/7421). No #### Emerging Medications Ketamine (Esketamine) Ketamine represents a major step forward in the treatment of depression and suicide prevention. Read [ADAA's Public Statement](https://adaa.org/sites/default/files/ADAA%20March%202019%20FDA%20Esketamine%20Statement_0.pdf) regarding 2019 FDA approved nasal spray medication- Spravato (esketamine) for treatment resistant depression,available only at a certified doctor’s office or clinic. To learn more in-depth about Ketamine (Esketamine), check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https://adaa.org/node/7421). - [Ketamine: A Rising Star in Mental Health Treatment](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer-professional/ketamine-rising-star-mental-health), ADAA blog post - [Ketamine Fact Sheet](https://adaa.org/sites/default/files/2024-02/Ketamine%202024%20Fact%20Sheet.pdf) (Infographic) - [Researchers discover positive effects of intravenous ketamine for treatment-resistant depression](http://bcm.edu/news/researchers-discover-positive-effects-of-intravenous-ketamine-for-treatment-resistant-depression), Baylor College of Medicine, Sanjay Mathews, MD Additional Research Studies About Ketamine and Psychedelics: Posted April 2021 AMJ Psychiatry 2020 Issue: [Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation](https://adaa.org/sites/default/files/module%20images/%231153%20Amer%20J%20Psy%20Synthesizing%20the%20Evidence%20for%20Ketamine%20and%20Esketamine%20in%20Treatment-Resistant%20Depression.pdf), Roger S. McIntyre, M.D., Joshua D. Rosenblat, M.D., M.Sc., (ADAA President Elect and CMO) Charles B. Nemeroff, M.D., Ph.D., Gerard Sanacora, M.D., Ph.D., (ADAA member) James W. Murrough, M.D., Ph.D., Michael Berk, Ph.D., M.B.B.Ch., Elisa Brietzke, M.D., Ph.D., Seetal Dodd, Ph.D.,Philip Gorwood, M.D., Ph.D., Roger Ho, M.D., M.B.B.S., Dan V. Iosifescu, M.D., Carlos Lopez Jaramillo, M.D., Ph.D., Siegfried Kasper, M.D., Kevin Kratiuk, B.Pharm., Jung Goo Lee, M.D., Ph.D., Yena Lee, H.B.Sc., Leanna M.W. Lui, Rodrigo B. Mansur, M.D., Ph.D., George I. Papakostas, M.D., Mehala Subramaniapillai, M.Sc., (ADAA member) Michael Thase, M.D., Eduard Vieta, M.D., Ph.D., Allan H. Young, M.Phil., M.B.Ch.B., Carlos A. Zarate, Jr., M.D., Stephen Stahl, M.D., Ph.D. In this article, an international group of mood disorder experts provides a synthesis of the literature with respect to the efficacy, safety, and tolerability of ketamine and esketamine in adults with treatment-resistant depression. The authors also provide guidance for the implementation of these agents in clinical practice, with particular attention to practice parameters at point of care. Areas of consensus and future research vistas are discussed. [A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders](https://adaa.org/sites/default/files/Ketamine%20JAMA%20Journal%20Article%20-%20Charlie%20Nemeroff.pdf), JAMA Psychiatry, April 2017, Gerard Sanacora, MD, PhD; Mark A. Frye, MD; William McDonald, MD; ADAA Board Member Sanjay J. Mathew, MD; Mason S. Turner, MD; ADAA member Alan F. Schatzberg, MD; Paul Summergrad, MD; ADAA Board Member and Chief Medical Officer Charles B. Nemeroff, MD, PhD; for the American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments [Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study](https://adaa.org/sites/default/files/Canuso-AJP-2018.pdf), American Journal, 2018 [Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)](https://adaa.org/sites/default/files/Fava_et_al-2018-Molecular_Psychiatry.pdf), Molecular Psychiatry, September 2018 Medical Marijuana/Cannabis/CBD - [Can CBD Help with My Anxiety and Depression?](https://adaa.org/understanding-anxiety/cbd) ADAA blog post Psychedelics Several psychedelic medicines including psilocybin and MDMA are undergoing FDA-regulated clinical trials for treatment-resistant depression, PTSD, and related conditions. However, as of late 2025, none have received U.S. regulatory approval and they remain classified as DEA Schedule 1 drugs. As this is a rapidly evolving area, ADAA is committed to providing timely updates on this topic as new data emerges. Learn more: - [Psychedelic Therapy: Promises and Problems](https://adaa.org/webinar/professional/psychedelic-therapy-problems-and-promises), ADAA Professional Webinar (Recorded live October 27,2022) - [Single-Dose Psilocybin for a Treatment-Resistant Episode](https://adaa.org/sites/default/files/Goodwin-NEJM-2022-PsilocybinTRD.pdf) - New England Journal if Medicine, November 3, 2022 - [How MDMA Resensitizes the Brain,](https://www.nature.com/articles/d41586-022-02871-w) Nature, September 28, 2022 - [MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study](https://adaa.org/sites/default/files/MDMAPTSD-NatMed2021.pdf), Nature Medicine, October 2021 - [Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine](https://adaa.org/sites/default/files/DeGregorio-Hallucinogens-JNeuro2021.pdf), The Journal of Neuroscience, February 3, 2021 - [Psychedelics and Psychedelic-Assisted Psychotherapy](https://adaa.org/sites/default/files/module%20images/%231128%20AJP%20-%20Psychedelics%20and%20Psychedelic%20Assisted%20Psychotherapy.pdf)*.* AMJ Psychiatry 2020 Issue:Collin M. Reiff, M.D., Elon E. Richman, M.D., (ADAA President Elect and CMO) Charles B. Nemeroff, M.D., Ph.D., Linda L. Carpenter, M.D., Alik S. Widge, M.D., Ph.D., Carolyn I. Rodriguez, M.D., Ph.D., (ADAA member) Ned H. Kalin, M.D., William M. McDonald, M.D., and the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research - Objective: The authors provide an evidenced-based summary of the literature on the clinical application of psychedelic drugs in psychiatric disorders. - Results: The most significant database exists for MDMA and psilocybin, which have been designated by the U.S. Food and Drug Administration (FDA) as “breakthrough therapies” for posttraumatic stress disorder (PTSD) and treatment-resistant depression, respectively. The research on LSD and ayahuascais observational, but available evidence suggests that these agents may have therapeutic effects in specific psychiatric disorders. - Conclusions: Randomized clinical trials support the efficacy of MDMA in the treatment of PTSD and psilocybin in the treatment of depression and cancer-related anxiety. The research to support the use of LSD and ayahuasca in the treatment of psychiatric disorders is preliminary, although promising. Overall, the database is insufficient for FDA approval of any psychedelic compound for routine clinical use in psychiatric disorders at this time, but continued research on the efficacy of psychedelics for the treatment of psychiatric disorders is warranted. - To learn more in-depth about medications, check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https://adaa.org/node/7421). No #### Medications That Can Help with Obsessive–Compulsive Disorder (OCD) Medications can help reduce the symptoms of obsessive–compulsive disorder (OCD). The most prescribed are a type of antidepressant called SSRIs (selective serotonin reuptake inhibitors) (see above). Although their name suggests they are only for depression, SSRIs are also effective in treating OCD. These medicines work by helping to balance brain chemicals that affect mood, anxiety, and repetitive thoughts or behaviors. It may take several weeks to start noticing improvements. Your doctor will work with you to find the right dose, explain possible side effects, and answer any questions you have. Medication is often most effective when combined with therapy, especially cognitive behavioral therapy (CBT) that is designed for OCD. ADAA Resources - [The Role of Antipsychotics in OCD](https://adaa.org/learn-from-us/from-the-experts/blog-posts/professional/role-antipsychotics-ocd) - [Medication for Treatment of OCD: Understanding the Options](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer-professional/medication-treatment-ocd) - [What is Obsessive- Compulsive Disorder?](https://adaa.org/understanding-anxiety/co-occurring-disorders/obsessive-compulsive-disorder) (website page) - [What is Obsessive-Compulsive Disorder (OCD)?](https://adaa.org/about-adaa/press-room/multimedia/what-obsessive-compulsive-disorder-ocd) (short video) - To learn more in-depth about OCD and medication, check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https://adaa.org/node/7421). No #### Medications and Cognitive Behavioral Therapy (CBT) for Postpartum Depression Postpartum depression can be treated with certain antidepressant medicines that help balance brain chemicals linked to mood. These medicines can ease sadness, worry, and low energy, making it easier for new parents to feel better and care for themselves and their baby. In addition to medication, Cognitive Behavioral Therapy (CBT) is a highly effective treatment for postpartum depression. CBT helps individuals recognize and change unhelpful thought patterns, develop healthier coping strategies, and build problem-solving skills. It focuses on the connection between thoughts, emotions, and behaviors, empowering new parents to manage stress, reduce negative thinking, and improve overall well-being. Postpartum depression can be treated with certain antidepressant medicines that help balance brain chemicals linked to mood. These medicines can ease sadness, worry, and low energy, making it easier for new parents to feel better and care for themselves and their baby. - [Learn more about CBT and other therapy types](https://adaa.org/find-help/treatment-help/types-of-therapy) - [Learn more about postpartum disorders](https://adaa.org/find-help-for/women/postpartum-disorders?utm_source=chatgpt.com) - [Learn about postpartum depression](https://adaa.org/living-with-anxiety/women/postpartum-depression) - [What is Postpartum Depression?](https://youtu.be/6kV2_L3uSS0) (ADAA Video) - [Watch ADAA's Video on CBT](https://adaa.org/about-adaa/press-room/multimedia/what-cbt-cognitive-behavioral-therapy) - [The Wisdom of Cognitive Behavioral Therapy (CBT): The Perfect Gift for New Moms](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer/wisdom-cognitive-behavioral-therapy-cbt-perfect) - To learn more in-depth about Postpartum Depression and medication, check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https://adaa.org/node/7421). No #### Brain Treatments for Anxiety and Depression Electroconvulsive Therapy (ECT) and Transcranial Magnetic Stimulation (TMS) are brain treatments that may help people with depression and anxiety when other treatments, like medicine or [talk therapy](https://adaa.org/find-help/treatment-help/types-of-therapy), have not worked. Electroconvulsive therapy (ECT) is useful for patients who are not responding well to medications or are suicidal. ECT is an effective treatment for patients who do not respond to drug therapy, are psychotic, or are suicidal or dangerous to themselves. Onset of action may be more rapid than that of drug treatments, with benefit often seen within one week of commencing treatment. The indications for the use of ECT include the following: - Failure of drug therapies - History of good response to ECT - Patient preference - High risk of suicide - High risk of medical morbidity and mortality Although advances in ECT treatment has improved the safety and tolerability of this modality there are some risks such as those associated with postictal confusion, and, more rarely, short-term memory difficulties. Transcranial Magnetic Stimulation, known as TMS or rTMS, may be a safe, effective, and noninvasive option for people who have depression that has not improved with medications. TMS creates a magnetic field to induce a small electric current in a specific part of the brain; the current comes from the magnetic field created by an electromagnetic coil that delivers pulses through the scalp. TMS is an FDA-approved treatment and recently (June 2019), the Brainsway Deep TMS device was approved for the treatment of OCD. There is ongoing research on the use of TMS to treat PTSD and other mental health conditions. TMS does not require sedation, is non-invasive and is virtually pain-free. With modern safety techniques, there is a less than 0.1% risk of seizure or loss of consciousness with TMS. Those receiving TMS usually are treated four or five times every week for four to six weeks. Research shows that TMS produces few side effects. Each treatment session lasts about 40 minutes. A new form of TMS called theta burst stimulation was recently approved by the FDA for the treatment of depression; sessions of theta burst stimulation last only about 10 minutes but still are provided daily for several weeks. To find out if TMS is the right treatment for you, speak to your therapist, doctor, or other mental health treatment provider. Your insurance may provide reimbursement for this treatment. - [Learn more about TMS](https://adaa.org/finding-help/transcranial-magnetic-stimulation) - To learn more in-depth about TMS check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https://adaa.org/node/7421). No #### ADAA Medication Information Resources - [Psychiatric Medication in Pregnancy and Lactation: What Can Women Take?](https://adaa.org/webinar/consumer/psychiatric-medication-pregnancy-and-lactation-what-can-women-take), ADAA webinar - [Dear ChatGPT, Can You See Me? The Limits of AI in Healing Anxiety and Emotional Pain](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer/ai-imits-with-healing-anxiety), ADAA blog post - [Medication for Treatment of OCD: Understanding the Options](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer-professional/medication-treatment-ocd), ADAA blog post - [SSRIs and Benzodiazepines for General Anxiety Disorders (GAD)](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer/ssris-and-benzodiazepines-general-anxiety), ADAA blog post - [Anxiety Medication Guide for Parents](https://adaa.org/sites/default/files/anxiety-parents-medication-guide.pdf), AACAP.org, written by ADAA member John Walkup, MD - [Can CBD Help with My Anxiety and Depression?](https://adaa.org/understanding-anxiety/cbd) - ADAA web page - [Psychotropic Medications: What You Should Ask Your Doctor](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer/psychotropic-medications-what-you-should-ask) - ADAA blog post - [For My Anxiety or Depression: Should I Use Medication or Therapy](https://adaa.org/webinar/consumer/my-anxiety-or-depression-should-i-use-medication-or-therapy) \- ADAA webinar - [Generalized Anxiety Disorder (GAD)](https://adaa.org/sites/default/files/ADAA%20General%20Anxiety%20Brochure%20vF_digital.pdf) \- ADAA Brochure - [Depression](https://adaa.org/sites/default/files/ADAA%20Depression%20Brochure%20Final.pdf) - ADAA Brochure - [Learn about mental health therapy types](https://adaa.org/find-help/treatment-help/types-of-therapy) - [Visit ADAA's Find Your Therapist Directory to find a provider near you](https://findyourtherapist.adaa.org/) - To learn more about medication and mental health therapy types check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https://adaa.org/node/7421). No #### Important Resources and Patient Assistance Programs Most pharmaceutical companies offer patient-assistance programs for uninsured patients. These programs provide prescribed medication at little to no cost. Eligibility varies; see the [Partnership for Prescription Assistance website](https://www.pparx.org/) for more information, or contact companies directly about their patient assistance programs. - [A New Patient Assistance Program Offering from Janssen. For Insured Patients Who Are Facing Access and Affordability Challenges. A Quick Reference Guide](https://adaa.org/sites/default/files/New%20Patient%20Assistance%20Offering%20From%20Janssen%20-%20Quick%20Reference%20Guide.pdf) - [NeedyMeds](http://www.needymeds.org/) is a 501(c)(3) national non-profit information resource dedicated to helping people locate assistance programs to help them afford their medications and other healthcare costs. [Alliance for Safe Online Pharmacies](https://buysaferx.pharmacy/) The Alliance for Safe Online Pharmacies (ASOP Global), a 501(c)(4) non-profit organization is dedicated to protecting consumers around the world, ensuring safe access to medications, and combating illegal online drug sellers. [Visit ADAA's Find Your Therapist Directory to find a provider near you](https://findyourtherapist.adaa.org/) No \#ffffff Boost Search Results Off [![What Is.. youtube series](https://adaa.org/sites/default/files/ADAA-what-is-eudcational-videos.png)](https://www.youtube.com/playlist?list=PLfw5WkuDE3-4MY3fHAAIOUNVWWHzqcKzL) [Advertisement](https://adaa.org/advertising "More about the ads we serve") [![Better Help Small](https://adaa.org/sites/default/files/Betterhelp_Logo_Simplified_0.png)](https://www.betterhelp.com/online-therapy/) [Advertisement](https://adaa.org/advertising "More about the ads we serve") Educational Resources Tips & Strategies from our Member Experts and Public Community Block reference [![Image of woman with insomnia](https://adaa.org/sites/default/files/styles/large/public/2026-03/iStock-1629208680%20purchased%20insomnia%20female%20large_0.jpg?itok=VCOWinqc)](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer/perimenopause-menopausal-transition-and-mental-health) [![Image of woman with insomnia](https://adaa.org/sites/default/files/styles/large/public/2026-03/iStock-1629208680%20purchased%20insomnia%20female%20large.jpg?itok=4vXxy34I)](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer/perimenopause-menopausal-transition-and-mental-health) Blog [Menopausal Transition and Mental Health: You're Not Crazy](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer/perimenopause-menopausal-transition-and-mental-health) The menopausal transition remains a period that is confusing for many women and medical doctors… [Read More](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer/perimenopause-menopausal-transition-and-mental-health) [Load More](https://adaa.org/find-help/treatment-help/medication-options "Load more") Webinar [PMDD: When the Menstrual Cycle Affects Mental Health](https://adaa.org/webinar/consumer/pmdd-when-menstrual-cycle-affects-mental-health) This presentation will review the symptoms of premenstrual dysphoric disorder (PMDD) and how to… [Read More](https://adaa.org/webinar/consumer/pmdd-when-menstrual-cycle-affects-mental-health) [Load More](https://adaa.org/find-help/treatment-help/medication-options "Load more") [![Ale Lasas smiling while she helps two people hold hands and meditate](https://adaa.org/sites/default/files/styles/large/public/2026-03/Ale%20Lasas.jpg?itok=cwK21OmK)](https://adaa.org/living-with-anxiety/personal-stories/burnout-mental-health-finding-community) PERSONAL STORY [When High Performance Hid My Struggle With Mental Health](https://adaa.org/living-with-anxiety/personal-stories/burnout-mental-health-finding-community) Ale Lasas shares her experience with anxiety, depression, ADHD, and severe burnout and how… [Read More](https://adaa.org/living-with-anxiety/personal-stories/burnout-mental-health-finding-community) [Load More](https://adaa.org/find-help/treatment-help/medication-options "Load more") [Go to Educational Resources](https://adaa.org/educational-resources) Take Action Find Help. Learn More. Support ADAA. [![Post Image](https://adaa.org/sites/default/files/styles/img350x200/public/module%20images/donate-today.png?itok=-sgVrK2m)](https://adaa.org/donate) [Donate Today](https://adaa.org/donate) Your support changes lives. Thank you\! [Learn More](https://adaa.org/donate) [![Post Image](https://adaa.org/sites/default/files/styles/img350x200/public/module%20images/get-involved-today.png?itok=grsh0NTP)](https://adaa.org/ways-to-give) [Get Involved Today](https://adaa.org/ways-to-give) Share your personal story. Start a fundraiser. Shop to support our mission and more. [Learn More](https://adaa.org/ways-to-give) [![Post Image](https://adaa.org/sites/default/files/styles/img350x200/public/2021-02/find-therapist.png?itok=Tg0AqYcY)](https://findyourtherapist.adaa.org/) [ADAA's Find Your Therapist](https://findyourtherapist.adaa.org/) ADAA’s Find Your Therapist Directory connects YOU with licensed mental health professionals who are experts in anxiety, depression, OCD, PTSD and co-occurring disorders. [Learn More](https://findyourtherapist.adaa.org/) [![Post Image](https://adaa.org/sites/default/files/styles/img350x200/public/module%20images/Triumph%20Newsletter_Public%20Link%20Module.png?itok=HH1M9xqv)](https://adaa.informz.net/adaa/pages/Triumph_Subscribe_page) [Triumph - Learn, Share Your Story, Access Resources](https://adaa.informz.net/adaa/pages/Triumph_Subscribe_page) ADAA's free monthly newsletter for our public community. Subscribe today\! [Subscribe](https://adaa.informz.net/adaa/pages/Triumph_Subscribe_page) [![Post Image](https://adaa.org/sites/default/files/styles/img350x200/public/2023-08/ADAA%20Free%20Peer-to-Peer%20Communities%20800%20X%20600.png?itok=36iLC_Z1)](https://adaa.org/find-help/support) [Free Peer to Peer Support Communities](https://adaa.org/find-help/support) ADAA's four free online peer-to-peer communities for people suffering from mental health disorders provides a safe space for support, sharing experiences, and connecting with others. [Learn More](https://adaa.org/find-help/support) [![Post Image](https://adaa.org/sites/default/files/styles/img350x200/public/thumbnails-feature/books-small.png?itok=FFVC8h8y)](https://adaa.org/books) [ADAA Self-Help Books – Bookstore/Reading List](https://adaa.org/books) Explore self-help and research-focused mental health books focusing on anxiety disorders and depression written by ADAA mental health experts. Purchases through Amazon benefit ADAA. [Learn More](https://adaa.org/books) Share: [Facebook](https://adaa.org/#facebook) [X](https://adaa.org/#x) [LinkedIn](https://adaa.org/#linkedin) [Email](https://adaa.org/#email) This page was updated 10/15/25 ![Logo](https://adaa.org/sites/default/files/menu-logos/Footer%20Logo.svg) *If you are in crisis please dial 988 for the Suicide & Crisis Lifeline.* *Please note that ADAA is not a direct service organization. ADAA does not provide psychiatric, psychological, or medical advice, diagnosis, or treatment.* [Donate Today](https://donate.adaa.org/give/322300#!/donation/checkout) [Find Your Therapist](https://members.adaa.org/page/FATMain) Contact us 8701 Georgia Avenue Suite \#412 Silver Spring, MD 20910 [Contact Us Now](https://adaa.org/contact-us) [Professional Site](https://adaa.org/professionals) [Conference Site](https://adaa.org/adaa-conference-2026) - [Find Help](https://adaa.org/find-help) - [What Are Anxiety and Depression?](https://adaa.org/understanding-anxiety) - [Resources & News](https://adaa.org/educational-resources) - [About ADAA](https://adaa.org/about-adaa/mission) - [Impact Report](https://adaa.org/sites/default/files/ADAA%202025%20Impact%20Report.pdf) - [Get Involved](https://adaa.org/donate) - [Partnerships](https://adaa.org/about-adaa/partners) - [Media Kit](https://adaa.org/about-adaa/advertise-with-adaa) - [Media Inquiries](https://adaa.org/about-adaa/press-room/media-inquiries) - [Triumph Newsletter](https://adaa.informz.net/adaa/pages/Triumph_Subscribe_page) [FAQs](https://adaa.org/professionals/membership/faqs) - [Do I have an anxiety disorder?](https://adaa.org/understanding-anxiety/faqs#n16) - [Are there different types of depression?](https://adaa.org/understanding-anxiety/depression/faqs) - [What causes anxiety disorders?](https://adaa.org/understanding-anxiety/faqs#n17) - [How do I find the right mental health professional?](https://adaa.org/understanding-anxiety/faqs#n20) Follow Us - [Twitter](https://twitter.com/ADAA_Anxiety) - [Facebook](https://www.facebook.com/AnxietyAndDepressionAssociationOfAmerica?notif_t=page_new_likes) - [Instagram](https://www.instagram.com/anxietyanddepression_adaa/?hl=en) - [Youtube](https://www.youtube.com/user/GotAnxiety) - [Linkedin](https://www.linkedin.com/company/anxiety-and-depression-association-of-america/) Founded in 1979, ADAA is an international nonprofit organization dedicated to the prevention, treatment, and cure of anxiety, depression, OCD, PTSD, and co-occurring disorders through aligning research, practice and education. [![American Brain Coalition Proud Member](https://adaa.org/sites/default/files/2021-03/2008-ABC-member-seal-NP-1080.png)](https://www.americanbraincoalition.org/) [![https://www.americanbraincoalition.org/](https://adaa.org/sites/default/files/2021-03/GuideStar.1_0.png)](https://www.guidestar.org/profile/52-1248820) [![Combined Federal Campaign (CFC)](https://adaa.org/sites/default/files/2021-03/CFCLogo2011.png)](https://www.opm.gov/combined-federal-campaign/) [![National Institute for Behavioral Health](https://adaa.org/sites/default/files/2021-03/nimh-logo.png)](https://www.nimh.nih.gov/outreach/partnership-program/index.shtml) [![Mental Health Liaison Group](https://adaa.org/sites/default/files/2021-03/MHLGLogo-1_0.png)](https://www.mhlg.org/) [![Health and Medical Research](https://adaa.org/sites/default/files/2021-03/HMRLogo_Web.png)](https://www.hmr.org/home/) © 2026 ADAA. All rights reserved. - [Privacy Policy](https://adaa.org/privacy-policy) - [Website Disclaimer](https://adaa.org/website-disclaimer) - [Webinar Notice](https://adaa.org/webinar-notice) ## We use cookies on this site to enhance your user experience By clicking the Accept button, you agree to us doing so. More info Accept No, thanks ✓ Thanks for sharing\! [AddToAny](https://www.addtoany.com/ "Share Buttons") [More…](https://adaa.org/find-help/treatment-help/medication-options#addtoany "Show all")
Readable Markdown	Medication can be a safe, effective, and evidence-based option for treating anxiety disorders and depression. Many people take medication alone or in combination [with therapy](https://adaa.org/find-help/treatment-help/types-of-therapy) to help manage symptoms and improve daily functioning. It's essential to recognize that medication is only one component of a comprehensive treatment approach. Other evidence-based options, such as psychotherapy, transcranial magnetic stimulation (TMS), and electroconvulsive therapy (ECT), may be recommended depending on an individual’s needs and treatment goals. These approaches can be used alone or in combination with medication to maximize effectiveness. Finding the right medication or treatment plan often requires patience, collaboration with a healthcare provider, and adjustments along the way. When used appropriately, medications can significantly reduce symptoms of anxiety and depression and support a return to balance and quality of life. Always consult a healthcare provider before starting, changing, or stopping medication. The right treatment depends on your symptoms, medical history, and individual needs. Finding the right medication—whether antidepressants, anti-anxiety medications, or a combination, often takes time, patience, and close collaboration with your doctor or nurse practitioner. Discussing Medications - What You Need to Know: Use these guidelines to talk to your health care professional about medications: - To avoid potentially dangerous drug interactions, let your mental health care provider know all medications you are taking, including prescriptions and over-the-counter drugs, herbal or dietary supplements, and vitamins. And make sure your family doctor knows you are taking medicines for an anxiety disorder. - Learn when to take a new medication and how, such as on an empty stomach or with food, in the morning or evening, and how frequently. - Find out how long it should take for the medication to start working and what you should expect when this happens. - Ask: How will the medication help me? What side effects might occur? Should I avoid any foods or beverages? Are drug interactions with other prescriptions a possibility? How often should you see the doctor for a medication check-up? - Ask for the prescribing physician’s after-hours phone number in case you develop side effects. - A good source of information about medications and over-the-counter products is your pharmacist, who should have information about all your prescriptions to advise you about possible drug interactions, side effects, and instructions for use. If your physician does not want to spend the time to answer your questions, you may need a referral to a different physician. Medications are commonly prescribed by physicians (family practice, pediatricians, OB-GYNs, psychiatrists), as well as nurse practitioners in many states. There are four major classes of medications that are used in the treatment of anxiety disorders: Q\&A What to Ask Your Doctor Before Starting a New Antidepressant or an Emerging Treatment 1. Is this new drug/treatment appropriate for me? 2. What are the drawbacks, if any of this new treatment? 3. What might be the benefits over my current regimen? 4. Is the price (typically high when a drug is new) worth the added benefit? 5. Is this treatment ready for widespread use? Meaning, does it have safety established? Do we know how long people need to be on this treatment? Do we know about any long term issues that could result from this? No Selective Serotonin Reuptake Inhibitors (SSRIs) SSRIs relieve symptoms by blocking the reabsorption, or reuptake, of serotonin by certain nerve cells in the brain. This leaves more serotonin available, which improves mood. SSRIs (citalopram, escitalopram, fluoxetine, paroxetine, and sertraline) generally produced fewer side effects when compared with tricyclic antidepressants. However, common side effects include insomnia or sleepiness, sexual dysfunction, and weight gain. They are considered an effective treatment for all anxiety disorders, although the treatment of obsessive-compulsive disorder, or OCD, typically requires higher doses. [Read this blog about SSRIs and Benzodiazepines](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer/ssris-and-benzodiazepines-general-anxiety). - Trintellix (vortioxetine) is a prescription antidepressant used to treat major depressive disorder in adults. It works by affecting serotonin activity in the brain, which can help improve mood, cognition, and overall functioning. - Viibryd (vilazodone) is a prescription antidepressant used to treat major depressive disorder (MDD) in adults. It works by increasing serotonin activity in the brain and is classified as a selective serotonin reuptake inhibitor (SSRI) and partial serotonin receptor. To learn more in-depth about Selective Serotonin Reuptake Inhibitors (SSRIs), check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https://adaa.org/node/7421). No Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) The serotonin-norepinephrine reuptake inhibitor, or SNRI, class (venlafaxine and duloxetine) is notable for a dual mechanism of action: increasing the levels of the neurotransmitters serotonin and norepinephrine by inhibiting their reabsorption into cells in the brain. As with other medications, side effects may occur, including stomach upset, insomnia, headache, sexual dysfunction, weight gain and minor increase in blood pressure. These medications are considered as effective as SSRIs, so they are also considered a first-line treatment for the treatment of anxiety disorders, but not for obsessive compulsive disorder, where SSRI’s are the preferred first line treatment. - Pristiq is used to treat major depressive disorder in adults. It works by increasing levels of serotonin and norepinephrine in the brain to help improve mood, energy, and interest in daily activities. - Fetzima is prescribed for major depressive disorder in adults. It helps balance serotonin and norepinephrine, with a relatively stronger effect on norepinephrine, which may improve mood, concentration, and physical energy. To learn more in-depth about Selective Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https://adaa.org/node/7421). No Benzodiazepines This class of drugs is frequently used for short-term management of anxiety and as an add on treatment, in treatment resistant anxiety disorders. They are not recommended as a treatment for Post Traumatic Stress Disorder. Benzodiazepines (alprazolam, clonazepam, diazepam, and lorazepam) are highly effective in promoting relaxation and reducing muscular tension and other physical symptoms of anxiety. Long-term use may require increased doses to achieve the same effect, which may lead to problems related to tolerance and dependence. [Read this blog post about SSRIs and Benzodiazepines](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer/ssris-and-benzodiazepines-general-anxiety). To learn more in-depth about Benzodiazepines, check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https://adaa.org/node/7421). No Tricyclic Antidepressants Concerns about long-term use of the benzodiazepines led many doctors to favor tricyclic antidepressants (amitriptyline, imipramine, and nortriptyline). Although effective in the treatment of some anxiety disorders(but not Social Anxiety Disorder), they can cause significant side effects, including orthostatic hypotension (drop in blood pressure on standing), constipation, urinary retention, dry mouth, and blurry vision. Contact your physician if you experience side effects, even if you are not sure a symptom is caused by a medication. Do not stop taking a medication without consulting with the prescribing physician; abrupt discontinuation may cause other health risks. Medications will work only if they are taken according the explicit instructions of your physician, but they may not resolve all symptoms of an anxiety disorder. [Learn more about how antidepressants work.](https://adaa.org/sites/default/files/SomberQuestions_Antidepressants.pdf) To learn more in-depth about Tricyclic Antidepressants, check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https://adaa.org/node/7421). No Emerging Medications Ketamine (Esketamine) Ketamine represents a major step forward in the treatment of depression and suicide prevention. Read [ADAA's Public Statement](https://adaa.org/sites/default/files/ADAA%20March%202019%20FDA%20Esketamine%20Statement_0.pdf) regarding 2019 FDA approved nasal spray medication- Spravato (esketamine) for treatment resistant depression,available only at a certified doctor’s office or clinic. To learn more in-depth about Ketamine (Esketamine), check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https://adaa.org/node/7421). - [Ketamine: A Rising Star in Mental Health Treatment](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer-professional/ketamine-rising-star-mental-health), ADAA blog post - [Ketamine Fact Sheet](https://adaa.org/sites/default/files/2024-02/Ketamine%202024%20Fact%20Sheet.pdf) (Infographic) - [Researchers discover positive effects of intravenous ketamine for treatment-resistant depression](http://bcm.edu/news/researchers-discover-positive-effects-of-intravenous-ketamine-for-treatment-resistant-depression), Baylor College of Medicine, Sanjay Mathews, MD Additional Research Studies About Ketamine and Psychedelics: Posted April 2021 AMJ Psychiatry 2020 Issue: [Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation](https://adaa.org/sites/default/files/module%20images/%231153%20Amer%20J%20Psy%20Synthesizing%20the%20Evidence%20for%20Ketamine%20and%20Esketamine%20in%20Treatment-Resistant%20Depression.pdf), Roger S. McIntyre, M.D., Joshua D. Rosenblat, M.D., M.Sc., (ADAA President Elect and CMO) Charles B. Nemeroff, M.D., Ph.D., Gerard Sanacora, M.D., Ph.D., (ADAA member) James W. Murrough, M.D., Ph.D., Michael Berk, Ph.D., M.B.B.Ch., Elisa Brietzke, M.D., Ph.D., Seetal Dodd, Ph.D.,Philip Gorwood, M.D., Ph.D., Roger Ho, M.D., M.B.B.S., Dan V. Iosifescu, M.D., Carlos Lopez Jaramillo, M.D., Ph.D., Siegfried Kasper, M.D., Kevin Kratiuk, B.Pharm., Jung Goo Lee, M.D., Ph.D., Yena Lee, H.B.Sc., Leanna M.W. Lui, Rodrigo B. Mansur, M.D., Ph.D., George I. Papakostas, M.D., Mehala Subramaniapillai, M.Sc., (ADAA member) Michael Thase, M.D., Eduard Vieta, M.D., Ph.D., Allan H. Young, M.Phil., M.B.Ch.B., Carlos A. Zarate, Jr., M.D., Stephen Stahl, M.D., Ph.D. In this article, an international group of mood disorder experts provides a synthesis of the literature with respect to the efficacy, safety, and tolerability of ketamine and esketamine in adults with treatment-resistant depression. The authors also provide guidance for the implementation of these agents in clinical practice, with particular attention to practice parameters at point of care. Areas of consensus and future research vistas are discussed. [A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders](https://adaa.org/sites/default/files/Ketamine%20JAMA%20Journal%20Article%20-%20Charlie%20Nemeroff.pdf), JAMA Psychiatry, April 2017, Gerard Sanacora, MD, PhD; Mark A. Frye, MD; William McDonald, MD; ADAA Board Member Sanjay J. Mathew, MD; Mason S. Turner, MD; ADAA member Alan F. Schatzberg, MD; Paul Summergrad, MD; ADAA Board Member and Chief Medical Officer Charles B. Nemeroff, MD, PhD; for the American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments [Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study](https://adaa.org/sites/default/files/Canuso-AJP-2018.pdf), American Journal, 2018 [Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)](https://adaa.org/sites/default/files/Fava_et_al-2018-Molecular_Psychiatry.pdf), Molecular Psychiatry, September 2018 Medical Marijuana/Cannabis/CBD - [Can CBD Help with My Anxiety and Depression?](https://adaa.org/understanding-anxiety/cbd) ADAA blog post Psychedelics Several psychedelic medicines including psilocybin and MDMA are undergoing FDA-regulated clinical trials for treatment-resistant depression, PTSD, and related conditions. However, as of late 2025, none have received U.S. regulatory approval and they remain classified as DEA Schedule 1 drugs. As this is a rapidly evolving area, ADAA is committed to providing timely updates on this topic as new data emerges. Learn more: - [Psychedelic Therapy: Promises and Problems](https://adaa.org/webinar/professional/psychedelic-therapy-problems-and-promises), ADAA Professional Webinar (Recorded live October 27,2022) - [Single-Dose Psilocybin for a Treatment-Resistant Episode](https://adaa.org/sites/default/files/Goodwin-NEJM-2022-PsilocybinTRD.pdf) - New England Journal if Medicine, November 3, 2022 - [How MDMA Resensitizes the Brain,](https://www.nature.com/articles/d41586-022-02871-w) Nature, September 28, 2022 - [MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study](https://adaa.org/sites/default/files/MDMAPTSD-NatMed2021.pdf), Nature Medicine, October 2021 - [Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine](https://adaa.org/sites/default/files/DeGregorio-Hallucinogens-JNeuro2021.pdf), The Journal of Neuroscience, February 3, 2021 - [Psychedelics and Psychedelic-Assisted Psychotherapy](https://adaa.org/sites/default/files/module%20images/%231128%20AJP%20-%20Psychedelics%20and%20Psychedelic%20Assisted%20Psychotherapy.pdf)*.* AMJ Psychiatry 2020 Issue:Collin M. Reiff, M.D., Elon E. Richman, M.D., (ADAA President Elect and CMO) Charles B. Nemeroff, M.D., Ph.D., Linda L. Carpenter, M.D., Alik S. Widge, M.D., Ph.D., Carolyn I. Rodriguez, M.D., Ph.D., (ADAA member) Ned H. Kalin, M.D., William M. McDonald, M.D., and the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research - Objective: The authors provide an evidenced-based summary of the literature on the clinical application of psychedelic drugs in psychiatric disorders. - Results: The most significant database exists for MDMA and psilocybin, which have been designated by the U.S. Food and Drug Administration (FDA) as “breakthrough therapies” for posttraumatic stress disorder (PTSD) and treatment-resistant depression, respectively. The research on LSD and ayahuascais observational, but available evidence suggests that these agents may have therapeutic effects in specific psychiatric disorders. - Conclusions: Randomized clinical trials support the efficacy of MDMA in the treatment of PTSD and psilocybin in the treatment of depression and cancer-related anxiety. The research to support the use of LSD and ayahuasca in the treatment of psychiatric disorders is preliminary, although promising. Overall, the database is insufficient for FDA approval of any psychedelic compound for routine clinical use in psychiatric disorders at this time, but continued research on the efficacy of psychedelics for the treatment of psychiatric disorders is warranted. - To learn more in-depth about medications, check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https://adaa.org/node/7421). No Medications That Can Help with Obsessive–Compulsive Disorder (OCD) Medications can help reduce the symptoms of obsessive–compulsive disorder (OCD). The most prescribed are a type of antidepressant called SSRIs (selective serotonin reuptake inhibitors) (see above). Although their name suggests they are only for depression, SSRIs are also effective in treating OCD. These medicines work by helping to balance brain chemicals that affect mood, anxiety, and repetitive thoughts or behaviors. It may take several weeks to start noticing improvements. Your doctor will work with you to find the right dose, explain possible side effects, and answer any questions you have. Medication is often most effective when combined with therapy, especially cognitive behavioral therapy (CBT) that is designed for OCD. ADAA Resources - [The Role of Antipsychotics in OCD](https://adaa.org/learn-from-us/from-the-experts/blog-posts/professional/role-antipsychotics-ocd) - [Medication for Treatment of OCD: Understanding the Options](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer-professional/medication-treatment-ocd) - [What is Obsessive- Compulsive Disorder?](https://adaa.org/understanding-anxiety/co-occurring-disorders/obsessive-compulsive-disorder) (website page) - [What is Obsessive-Compulsive Disorder (OCD)?](https://adaa.org/about-adaa/press-room/multimedia/what-obsessive-compulsive-disorder-ocd) (short video) - To learn more in-depth about OCD and medication, check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https://adaa.org/node/7421). No Medications and Cognitive Behavioral Therapy (CBT) for Postpartum Depression Postpartum depression can be treated with certain antidepressant medicines that help balance brain chemicals linked to mood. These medicines can ease sadness, worry, and low energy, making it easier for new parents to feel better and care for themselves and their baby. In addition to medication, Cognitive Behavioral Therapy (CBT) is a highly effective treatment for postpartum depression. CBT helps individuals recognize and change unhelpful thought patterns, develop healthier coping strategies, and build problem-solving skills. It focuses on the connection between thoughts, emotions, and behaviors, empowering new parents to manage stress, reduce negative thinking, and improve overall well-being. Postpartum depression can be treated with certain antidepressant medicines that help balance brain chemicals linked to mood. These medicines can ease sadness, worry, and low energy, making it easier for new parents to feel better and care for themselves and their baby. - [Learn more about CBT and other therapy types](https://adaa.org/find-help/treatment-help/types-of-therapy) - [Learn more about postpartum disorders](https://adaa.org/find-help-for/women/postpartum-disorders?utm_source=chatgpt.com) - [Learn about postpartum depression](https://adaa.org/living-with-anxiety/women/postpartum-depression) - [What is Postpartum Depression?](https://youtu.be/6kV2_L3uSS0) (ADAA Video) - [Watch ADAA's Video on CBT](https://adaa.org/about-adaa/press-room/multimedia/what-cbt-cognitive-behavioral-therapy) - [The Wisdom of Cognitive Behavioral Therapy (CBT): The Perfect Gift for New Moms](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer/wisdom-cognitive-behavioral-therapy-cbt-perfect) - To learn more in-depth about Postpartum Depression and medication, check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https://adaa.org/node/7421). No Brain Treatments for Anxiety and Depression Electroconvulsive Therapy (ECT) and Transcranial Magnetic Stimulation (TMS) are brain treatments that may help people with depression and anxiety when other treatments, like medicine or [talk therapy](https://adaa.org/find-help/treatment-help/types-of-therapy), have not worked. Electroconvulsive therapy (ECT) is useful for patients who are not responding well to medications or are suicidal. ECT is an effective treatment for patients who do not respond to drug therapy, are psychotic, or are suicidal or dangerous to themselves. Onset of action may be more rapid than that of drug treatments, with benefit often seen within one week of commencing treatment. The indications for the use of ECT include the following: - Failure of drug therapies - History of good response to ECT - Patient preference - High risk of suicide - High risk of medical morbidity and mortality Although advances in ECT treatment has improved the safety and tolerability of this modality there are some risks such as those associated with postictal confusion, and, more rarely, short-term memory difficulties. Transcranial Magnetic Stimulation, known as TMS or rTMS, may be a safe, effective, and noninvasive option for people who have depression that has not improved with medications. TMS creates a magnetic field to induce a small electric current in a specific part of the brain; the current comes from the magnetic field created by an electromagnetic coil that delivers pulses through the scalp. TMS is an FDA-approved treatment and recently (June 2019), the Brainsway Deep TMS device was approved for the treatment of OCD. There is ongoing research on the use of TMS to treat PTSD and other mental health conditions. TMS does not require sedation, is non-invasive and is virtually pain-free. With modern safety techniques, there is a less than 0.1% risk of seizure or loss of consciousness with TMS. Those receiving TMS usually are treated four or five times every week for four to six weeks. Research shows that TMS produces few side effects. Each treatment session lasts about 40 minutes. A new form of TMS called theta burst stimulation was recently approved by the FDA for the treatment of depression; sessions of theta burst stimulation last only about 10 minutes but still are provided daily for several weeks. To find out if TMS is the right treatment for you, speak to your therapist, doctor, or other mental health treatment provider. Your insurance may provide reimbursement for this treatment. - [Learn more about TMS](https://adaa.org/finding-help/transcranial-magnetic-stimulation) - To learn more in-depth about TMS check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https://adaa.org/node/7421). No ADAA Medication Information Resources - [Psychiatric Medication in Pregnancy and Lactation: What Can Women Take?](https://adaa.org/webinar/consumer/psychiatric-medication-pregnancy-and-lactation-what-can-women-take), ADAA webinar - [Dear ChatGPT, Can You See Me? The Limits of AI in Healing Anxiety and Emotional Pain](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer/ai-imits-with-healing-anxiety), ADAA blog post - [Medication for Treatment of OCD: Understanding the Options](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer-professional/medication-treatment-ocd), ADAA blog post - [SSRIs and Benzodiazepines for General Anxiety Disorders (GAD)](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer/ssris-and-benzodiazepines-general-anxiety), ADAA blog post - [Anxiety Medication Guide for Parents](https://adaa.org/sites/default/files/anxiety-parents-medication-guide.pdf), AACAP.org, written by ADAA member John Walkup, MD - [Can CBD Help with My Anxiety and Depression?](https://adaa.org/understanding-anxiety/cbd) - ADAA web page - [Psychotropic Medications: What You Should Ask Your Doctor](https://adaa.org/learn-from-us/from-the-experts/blog-posts/consumer/psychotropic-medications-what-you-should-ask) - ADAA blog post - [For My Anxiety or Depression: Should I Use Medication or Therapy](https://adaa.org/webinar/consumer/my-anxiety-or-depression-should-i-use-medication-or-therapy) \- ADAA webinar - [Generalized Anxiety Disorder (GAD)](https://adaa.org/sites/default/files/ADAA%20General%20Anxiety%20Brochure%20vF_digital.pdf) \- ADAA Brochure - [Depression](https://adaa.org/sites/default/files/ADAA%20Depression%20Brochure%20Final.pdf) - ADAA Brochure - [Learn about mental health therapy types](https://adaa.org/find-help/treatment-help/types-of-therapy) - [Visit ADAA's Find Your Therapist Directory to find a provider near you](https://findyourtherapist.adaa.org/) - To learn more about medication and mental health therapy types check out [ADAA's Patient Guide to Mood and Anxiety Disorders](https://adaa.org/node/7421). No Important Resources and Patient Assistance Programs Most pharmaceutical companies offer patient-assistance programs for uninsured patients. These programs provide prescribed medication at little to no cost. Eligibility varies; see the [Partnership for Prescription Assistance website](https://www.pparx.org/) for more information, or contact companies directly about their patient assistance programs. - [A New Patient Assistance Program Offering from Janssen. For Insured Patients Who Are Facing Access and Affordability Challenges. A Quick Reference Guide](https://adaa.org/sites/default/files/New%20Patient%20Assistance%20Offering%20From%20Janssen%20-%20Quick%20Reference%20Guide.pdf) - [NeedyMeds](http://www.needymeds.org/) is a 501(c)(3) national non-profit information resource dedicated to helping people locate assistance programs to help them afford their medications and other healthcare costs. [Alliance for Safe Online Pharmacies](https://buysaferx.pharmacy/) The Alliance for Safe Online Pharmacies (ASOP Global), a 501(c)(4) non-profit organization is dedicated to protecting consumers around the world, ensuring safe access to medications, and combating illegal online drug sellers. [Visit ADAA's Find Your Therapist Directory to find a provider near you](https://findyourtherapist.adaa.org/) No \#ffffff Boost Search Results Off
Shard	60 (laksa)
Root Hash	15493478601857663260
Unparsed URL	org,adaa!/find-help/treatment-help/medication-options s443